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CHAPTER 1 
General introduction 
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BACKGROUND 
Spinal cord injury: “an ailment not to be treated.” This statement was made about 
4,000 years ago by a copyist who commented on what may be the first scientific 
description of two cases of a cervical spinal injury, which was written 1,000 years 
earlier [1]. It has now been established that acute treatment of a severe trauma is 
followed by a multidisciplinary rehabilitation approach. Patients who experience a 
spinal cord injury (SCI) today have an almost normal life expectancy [2-4]. Regaining 
the ability to ambulate on one’s own legs is, among others, an important rehabilita-
tion goal [5, 6]. Fortunately this is not an unrealistic scenario for numerous patients 
with incomplete spinal lesions. Spontaneous recovery processes and targeted physi-
cal rehabilitation measures help patients achieve this goal. 
 
Nevertheless, the lives of most other people with spinal cord injuries are governed 
by remaining impairment. Recently, substantial endeavors have been made to re-
lieve their lives, as much as possible, of detrimental sequelae by partial or complete 
cure of the SCI. These novel interventions will likely comprise a combination of well-
shaped agents applied locally at the spinal cord and a goal-oriented rehabilitation 
intervention [7, 8]. This thesis is intended to help understand the processes underly-
ing the recovery of ambulation during rehabilitation and may contribute to further 
shaping these interventions in order to optimally support future patients with SCIs. 
 
The thesis focuses on the clinical perspective of the rehabilitation of ambulatory 
function. Rehabilitation interventions are increasingly based on pre-clinical studies. 
Furthermore, the thesis addresses the assessment of walking function in adult pa-
tients with SCIs. Important anatomical and physiological issues are presented as a 
basis for understanding the clinical picture of an SCI and the approaches used for 
rehabilitative training.  
Structure and function of the spinal cord 
The spinal cord (SC) is the interconnection between the brain and the peripheral 
nervous system that conducts sensory information and motor commands. In addi-
tion, the SC contains its own neural circuitry with the ability to modify reflexes and 
to control and generate elementary movements strongly involved in the walking 
function. 
Structure of the spinal cord 
The SC and the brain make up the central nervous system (CNS). The SC originates 
at the medulla oblongata of the brain stem and extends down the bony spinal canal 
to the upper lumbar spine. Notably, an adult’s SC is shorter than the spine itself due 
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to the different growth of the nerves and bony structures (Figure 1.1). The average 
length of the SC is about 44 cm with a diameter of approximately 0.6 to 1.3 cm. Two 
regions at the cervical and lumber levels of the SC have a greater diameter; they 
contain the neurons which connect the CNS to the peripheral nervous system. The 
SC narrows at the caudal end, forms the conus medullaris and finally passes into the 
filum terminale, a non-nervous structure that attaches the SC to the coccyx. In the 
spinal canal below the conus medullaris, spinal nerves form the cauda equina. These 
nerves belong to the peripheral nervous system while the SC belongs to the CNS [9]. 
 
 
Figure 1.1 Position of the human spinal cord within the spinal 
canal. The spinal cord segments are numbered and marked with a 
grey scale: cervical: white; thoracic: dark grey; lumbar: light grey; 
sacral: black; coccygeal: white. At the caudal end of the spinal 
column is the cauda equina. Note the relationship between spinal 
cord segments and the vertebral segments. (from: Sobotta Atlas 
der Anatomie des Menschen © Elsevier GmbH, Urban & Fischer, 
München). 
 
Both the brain and the SC are embedded in multilayer meninges and float in the 
cerebrospinal fluid. The SC is divided into 31 segments (Figure 1.1). A spinal nerve 
branches out from each segment on both sides (Figure 1.2). These nerves contain 
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sensory and motor nerve fibers; in the thoracic and lumbar regions, the nerves have 
vegetative nerve fibers as well. The target organs of these nerves are somatotopi-
cally arranged. It is known from which segment a given muscle is innervated (myo-
tome) and which segment corresponds to a given area on the skin (dermatome) 
[10]. This fact is the basis for the determination of the neurological level of injury 
(NLI) in the case of a damaged SC. The signs and symptoms pertaining to the auto-
nomic nerve system do not correspond as clearly to a segmental region.  
 
A cross section of the human SC shows two distinct regions. The centrally located 
grey matter is shaped like an H or a butterfly and contains cell bodies and interneu-
rons. The ventral horns mainly contain the motor neurons which travel via anterior 
root to the target muscles. The dorsal horns are formed by the cell bodies of the 
ascending nerves (Figure 1.2). 
 
 
Figure 1.2 Cross-section of the human spinal cord. The H-shaped grey matter is 
located centrally, surrounded by the white matter. The ventral and dorsal nerve 
roots are shown for one side (left) only. 
 
Blood supply to the spinal cord 
Three main arteries ensure that blood is supplied to the SC. About two-thirds of the 
anterior portion of the SC is perfused by the anterior spinal artery, a blood vessel 
which runs alongside anteriorly in the middle of the SC. The posterior portion of the 
SC is supplied by the two posterior spinal arteries, which are located in a posterior-
lateral position alongside the SC. 
Pathways 
The white matter which surrounds the central grey matter contains ascending and 
descending axons with multiple pathways. For the clinical work, two afferent and 
one efferent pathway are most important. 
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The dorsal column pathway conveys light touch, vibration and proprioceptive in-
formation essential to the coordination of movements. Nerve fibers enter the SC 
through the dorsal root and ascend ipsilaterally in the dorsal column to the region 
of the medulla oblongata, where they are connected to secondary neurons (internal 
actuate fibers) which decussate to the opposite side and project into the thalamus. 
Fibers from the lower parts of the body are embedded in the fasciculus gracilis; 
those fibers from the upper parts travel along the more laterally located fasciculus 
cuneatus (Figure 1.3). 
 
The spinothalamic tract lies in the anterolateral region and transmits temperature 
and pain sensation. Afferents from this system enter the SC via the dorsal root and 
cross to the opposite side either at the level where they entered the SC or in one of 
the adjacent segments. In the anterolateral portion, the fibers ascend directly to the 
thalamus (Figure 1.3). 
 
The efferent motor fibers travel caudally from the motor cortex, decussate in the 
medulla oblongata and descend into the lateral region of the SC as corticospinal 
tract (or pyramidal tract). These fibers largely connect with their target motor neu-
rons in the ventral horn. Part of the tract ends in spinal interneuronal circuits that 
indirectly mediate signals to the motor neurons. The axons of those neurons project 
without further synapsing to the respective skeletal muscles (Figure 1.3). 
 
The proximate positioning of the spinothalamic and the corticospinal tracts is clini-
cally significant. A spared function for temperature and pain, indicating a partial 
integrity of the spinothalamic pathway, is of high prognostic value for motor recov-
ery following an SCI. 
 
The somatotopic organization is discernible in each pathway. Fibers travelling to the 
upper extremities are located more centrally and those travelling to the legs are 
located more laterally [11]. This fact is the basis for the clinical presentation of the 
central cord syndrome. 
 
In addition to the long pathways projecting between the brain, brain stem and the 
periphery, there are additional connections which begin and end within the SC. 
These interneurons and propriospinal systems are involved in the processing of 
afferent input such as the reciprocal inhibition or polysynaptic reflexes. 
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Figure 1.3 Schematic draw-
ing of three clinically impor-
tant spinal pathways: dorsal 
column, spinothalamic and 
corticospinal tracts. Note the 
decussation of the different 
tracts on different levels.  
The grey shaded area on the 
right side of the middle seg-
ment shows the area affected 
by a lesion leading to a Brown-
Séquard syndrome. (from: 
Tattersall R, Turner B. Brown-
Séquard and his syndrome. 
Lancet. 2000 Jul 1;356(9223): 
61-3.). 
 
Central pattern generator, spinal locomotor center 
The SC not only transmits information between the brain and the peripheral organs, 
but neuronal circuitries within the SC are capable of generating and controlling 
more complex movements. The network that is generally referred to as the central 
pattern generator (CPG) can generate coordinated rhythmic and synergistic activa-
tion of flexor and extensor motor neurons independent of afferent proprioceptive 
feedback or supraspinal control. This phenomenon has been extensively studied in 
numerous animal models [12]. 
 
The CPG-driven activity is also present in humans with clinically complete SCIs and 
can be analyzed by means of electromyographic (EMG) recordings [13]. Interest-
ingly, this activity is not a rigid and stereotypical EMG pattern of the leg muscles, 
but becomes adapted and modulated according to peripheral proprioceptive affer-
ent sensory feedback information [14, 15]. An increase in EMG amplitude and a 
decrease in inappropriate activity can be observed by providing adequate proprio-
ceptive stimulation during a series of experimental therapy sessions, which indi-
cates that these neural centers can be trained [16]. However, when the training 
stopped in patients with complete SCIs where voluntary effort did not result in any 
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muscle activation below the NLI, the EMG amplitude dropped to a level similar to 
that prior to the training. Patients who regain ambulatory function maintain their 
level of EMG activity (Chapter 2, [17]). The spinal locomotor pattern generator is 
both a resource and a target for rehabilitation efforts aimed at improving walking 
function in those patients who are likely to recover motor function, as is often the 
case in incomplete SCI. 
SPINAL CORD INJURY 
Damage to the SC’s nervous structure results in a clinical syndrome that is charac-
terized by impaired or lost motor, sensory and autonomic functions. Accordingly the 
clinical presentation of an SCI involves paralysis, reduced or lost sensations and 
symptoms associated with autonomic dysfunctions [18]. 
Motor impairment 
The motor impairment which results from an SCI can vary between complete loss of 
voluntary motor function and mild paresis. The number of affected muscles de-
pends on the location and extent of the SCI. Based on the knowledge of myotomes, 
the level of SCI can be derived from the paralysis pattern. For this purpose, certain 
key muscles have been defined which are known to be innervated by a known SC 
segment. 
 
If the SCI involves the corticospinal tract (which is also referred to as the upper mo-
tor neuron), a spastic plegia will result. However, the damaged segments will exhibit 
a flaccid paresis and abolished reflexes due to the Wallerian degeneration of the 
affected lower motor neurons. The same finding is made when the cauda equina is 
damaged; in such situations, the lesion affects the peripheral nerve system. Al-
though the extent of motor impairment is critical for regaining the ability to perform 
activities of daily living (ADL), it has been shown that it is not the only determinant 
(Chapter 3, [19]). 
Sensory impairment 
A dorsal column lesion results in impaired touch, vibration and proprioception sen-
sation. If only one side of the SC is affected, the sensory loss will affect the ipsilat-
eral side of the body below the NLI. Temperature and pain perception are affected 
when the anterolateral portion of the SC is damaged. If the damage is restricted to 
one side, the loss will be found on the contralateral side. By examining the single 
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dermatomes, the level at which the SC lost its function in response to the injury can 
be determined. 
Autonomic dysfunction 
In contrast to the motor and sensory impairments which can be related to a certain 
segmental level, the autonomic dysfunctions can vary considerably. Most prominent 
in almost all SCI cases are the loss of voiding function related to bladder and bowel. 
Typical signs and symptoms in an SCI above the mid-thoracic level are bradycardia, 
orthostatic hypotension and autonomic dysreflexia due to the disruption of sympa-
thetic pathways. Also notable is the loss of body temperature regulation in patients 
with a high thoracic or cervical lesion. 
Classification of spinal cord injuries 
The classification is geared to the leading SCI symptoms: motor and sensory im-
pairment. In 1982, the American Spinal Injury Association (ASIA) developed and 
published a standardized examination form for patients with SCIs [20]. These inter-
national standards for neurological classification of spinal cord injury (ISNCSCI) have 
been revised repeatedly. In 1992, the standards were also adopted by the Interna-
tional Spinal Cord Society (ISCoS). The most recent version dates to 2011 (Figure 
1.4) [21]. 
 
Classification is based on a clinical neurological examination for which the patient 
has to be awake and able to cooperate. This examination comprises motor and 
sensory tests. The classification follows a defined algorithm to define the neurologi-
cal level and completeness of the SCI (Figure 1.4B). 
Motor testing 
The level of paralysis is assessed using a muscle function test that grades the 
strength of a voluntary muscle contraction in one of six categories (Figure 1.4B, 
Muscle function grading). Five key muscles from the upper and lower extremities 
are examined. The respective values of the muscle grading are summed up to the 
upper extremity motor score (UEMS), the lower extremity motor score (LEMS) or 
the total motor score (MS). UEMS and LEMS ranges between 0 and 50 (25 for each 
side) and total MS between 0 and 100. In addition to the muscles on the extremi-
ties, the anal sphincter is examined and the presence (or absence) of a voluntary 
contraction is evaluated. 
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Sensory testing 
Two sensory modalities are examined: light touch (dorsal column tract) and pin 
prick (spinothalamic tract). Every segment is given a score between 0 and 2 (Figure 
1.4A). The total sensory scores range between 0 and 112 for each of the two mo-
dalities. In addition to the examination of the abovementioned dermatomes, the 
patients are examined to see whether they perceive deep anal pressure (DAP), 
which is a gentle pressure exerted to the anorectal wall that is innervated by the 
pudental nerve (S4-S5). 
Level of spinal cord injury 
The ISNCSCI distinguishes between the motor and sensory levels for both sides and 
a single neurological level. A level is defined as the lowest segment with normal 
function. Lesions related to the cervical cord or the first thoracic segment will affect 
the arms, legs and trunk; this form of SCI is referred to as tetraplegia or quadriple-
gia. Lesions in lower regions of the SC that result in symptoms in the legs (and 
trunk) are labeled paraplegia. 
Completeness of spinal cord injury/ASIA impairment scale 
The sacral sparing is essential for the categorization of an injury as either complete 
or incomplete. Sacral sparing means that the patients have preserved motor (volun-
tary anal sphincter contraction) or sensory function (perianal sensation or DAP) in 
segments S4-S5. A complete injury is categorized as ASIA impairment scale (AIS) A 
(Figure 1.4B). Incomplete injuries are further subdivided according to preserved 
motor function into AIS B, C or D. Patients who recover completely from their SCI 
symptoms are considered to be AIS E. 
Spinal cord injury clinical syndromes 
In addition to tetraplegia and paraplegia, special forms of clinical presentations can 
be found depending on the location and extent of the SC lesion [22]. 
Central cord syndrome 
Central cord syndrome (CCS) is characterized by a more pronounced paralysis of the 
upper extremities compared to the lower extremities, which remain less affected. It 
is caused by a lesion in the center of the cervical SC involving the grey matter and 
the axons lying more central projecting to the motor neurons of the upper body. 
The more laterally located axons that travel to the ventral horns and contain the 
lower body’s motor neurons become less compromised. 
 
CCS frequently occurs in older persons with preexisting myelopathy due to degen-
erative processes of the cervical spine. An inadequate minor trauma associated with 
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a trip or a fall then results in CCS. CCS is not restricted to elderly people; it can also 
occur in younger patients following a trauma. The prognosis for regaining ambula-
tory function after experiencing CCS is generally good (Chapter 4, [23]). 
Brown-Séquard syndrome 
Brown-Séquard syndrome (BSS) results from a SC injury that mainly occurs to one 
side of the SC (Figure 1.3). Clinically, a paresis and loss of touch sensation are pre-
sent on the ipsilateral side and the perceptions of temperature and pain are im-
paired on the contralateral side. A pure BSS is rare but lateralized paresis with more 
or less clear dissociated somatosensory deficits is more frequent. These BSS lesions 
are referred to as BSS plus syndrome [24]. Like CCS, patients with BSS have a good 
prognosis for regaining ambulatory function (Chapter 4, [23]). 
Anterior cord syndrome 
Anterior cord syndrome (ACS) is characterized by damage to about two-thirds of the 
anterior portion of the SC, resulting in a loss of motor and sensory functions for pain 
and temperature. The perception of touch is not affected. This type of lesion occurs 
when the blood supply from the anterior spinal artery is interrupted. 
Posterior cord syndrome 
In its pure form, this syndrome rarely occurs; typically, those patients present with a 
loss of touch, vibration and proprioception due to a dorsal column lesion. Since the 
anterior portion of the SC is unaffected, motor function and sensations of pain and 
temperature are preserved. Although motor function is not affected, these patients 
exhibit substantial difficulties performing coordinated movements consistent with a 
spinal ataxia. People with severe cases may be dependent on a wheelchair for their 
mobility. 
Cauda equina syndrome 
When the spinal lesion is below the conus medullaris, the cauda equina is damaged 
rather than the SC itself. The patients will show a flaccid paresis with abolished 
reflexes. In these patients, it is not appropriate to activate and train spinal locomo-
tor centers since the reflex arcs have been disrupted. However, this lesion type 
represents a low SCI and the proximal leg muscles (i.e., hip flexors (L2) and knee 
extensors (L3)) are normally under voluntary control. With adapted ankle-foot or-
thoses (AFO) or knee-ankle-foot orthoses (KAFO) these patients may regain ambula-
tory function even if the SCI is classified as AIS A. 
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Etiology 
Most SC injuries are acquired; these types are presented in the first and second of 
the following categories. The third category deals with congenital SC injuries, which 
are not included in this thesis. 
Traumatic injury 
In most cases, a lesion to the SC is associated with spinal instability due to torn lig-
aments and/or fractures of one or multiple vertebrae. The main causes of those 
lesions include motor vehicle accidents and falls [25]. The cervical spine is more 
exposed than the thoracic and lumbar regions, so a relatively small impact there can 
result in an SCI. In contrast, stronger forces are required to lesion the SC in the tho-
racic, lumbar and sacral regions. Often these traumas result not only in a spine frac-
ture but in multiple lesions of surrounding structures (e.g., ribs, lung). The greatest 
number of lesions is found in the regions which are biomechanically predisposed 
(i.e., the conjunctions between head and thorax or thorax and pelvis) (Figure 1.5). 
Only in rare cases is the SC completely torn apart; more often the anatomical 
structure remains partially intact. Due to the trauma, the spinal canal narrows and 
the SC and/or the blood supply is compressed. Zones of lesion severity can be dis-
tinguished around the lesion site. Axons and nerves are completely damaged in the 
center of maximum compression. Nerves around that zone lose some of their func-
tion but remain structurally intact. The temporary loss of function is known as neu-
rapraxia and the recovery of a patient after SCI can partially be attributed to the 
resolution of the neurapraxia [18]. 
 
Figure 1.5 Frequency distribution of traumatic SCI in relation to neurological level of injury. Data 
originate from the European Multicenter Study about Spinal Cord Injury (EMSCI). Numbers are percent-
ages; n=2054. 
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Non-traumatic 
Non-traumatic SCIs are caused by vascular, inflammatory, immunological or neo-
plastic conditions. Because of the variety of etiologies, the group of non-traumatic 
SCIs is more heterogenous than the group of traumatic injuries. A non-traumatic SCI 
can emerge acutely (e.g., due to an acute hemorrhage) or develop over several 
months (e.g., myelopathy due to a degenerative narrowing of the spinal canal). 
Non-traumatic SCIs are often incomplete although complete loss of function is not 
uncommon. The clinical pathway of the German Society for Neurology (Deutsche 
Gesellschaft für Neurologie) classifies non-traumatic SCIs according to Table 1.1. 
 
Table 1.1 Causes of non-traumatic spinal cord injury 
1. Spinal cord compression 2. Myelitis 3. Myelopathy 4. Demyelination 
̶ Tumors 
̶ Disc herniation 
̶ Spondylodiscitis 
̶ Hemorrhage 
̶ Spinal canal stenosis 
̶ Viral 
̶ Bacterial 
̶ Mykogene 
̶ Arteriovenous malformation 
̶ Ischemia 
̶ Radiation damage 
̶ Toxic 
̶ Multiple sclerosis 
̶ Acute disseminated 
encephalomyelitis 
(ADEM) 
̶ Neuromyelitis optica 
̶ Acute transverse myelitis 
̶ Collagenosis 
 
SCI symptoms can also be caused by multiple small gas embolisms that occur when 
external pressure on the body is suddenly relieved (e.g., in the water). The ‘decom-
pression sickness’ or Caisson disease emerges when scuba divers ascend to the 
surface too quickly. During fast depressurization, physically dissolved gas in the 
blood forms bubbles that block perfusion. 
Congenital 
Severe forms of developmental congenital malformations (spina bifida or myelo-
meningocele) result in the signs and symptoms of an SCI. This thesis does not in-
clude patients with congenital SCIs. 
Epidemiology 
Incidence/prevalence 
According to a recently published literature review, the incidence rates for trau-
matic SCI vary across geographical regions: the number of new cases per million 
inhabitants ranged from 2.3 (Canada) to 83 (Alaska) [26]. Other researchers re-
ported similar variations in their results [27, 28]. Prevalence seems to be less accu-
rately recorded; available data showed prevalence per million persons ranging from 
236 (India) to 1,800 (USA) [26]. Compared to stroke [29], SCIs occur relatively rarely. 
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There are fewer epidemiologic data available for non-traumatic SCIs. However, two 
large population-based studies showed that the number of patients with non-
traumatic SCIs exceeds that of traumatic cases [30, 31]. In a nationwide Australian 
study, the incidence of non-traumatic SCI was reported to be 26.3 cases per million 
per year [31]. 
Age at injury 
The average age at which a traumatic SCI occurs has increased over the last dec-
ades. In the USA, the average age at injury grew from 29 years (in 1973-1979) to 41 
(in 2005-2010). In a European network of SCI rehabilitation centers [32], the aver-
age age at injury was 45 years (in 2005-2010) (Wirz, unpublished). With an average 
age of approximately 61 years, patients with non-traumatic SCIs are clearly older at 
onset [28, 30, 31, 33, 34]. 
Male/female distribution 
Though about 80% of traumatic SCI cases occur in men [25-28], the ratio is balanced 
in the group of patients with non-traumatic SCIs [30, 31, 33, 34]. 
Lesion characteristics 
According to registers in the USA [2] and Europe [32], the most frequent condition 
after a traumatic SCI is incomplete tetraplegia (41% and 33%) followed by complete 
paraplegia (22% and 27%), incomplete paraplegia (21% and 23%) and complete 
tetraplegia (16% and 17%). Non-traumatic SCI tends to result more frequently in 
incomplete paraplegia [33, 34]. 
REHABILITATION 
After an SCI of any origin, patients undergo a multidisciplinary rehabilitation where 
the primary aim is to maximize patients’ independence in performing daily life ac-
tivities and participating in life situations. Until about the 1990s, rehabilitation after 
a neurological event (e.g., SCI) focused primarily on preventing complications that 
resulted from impairment [35, 36]. Driven by the results and conclusions of physio-
logical and behavioral animal studies [7, 8, 37], the rationale behind intervention 
strategies started to fundamentally change. A more comprehensive understanding 
of the neurological conditions became increasingly established; it not only focused 
on impairment but also on activities, participation and environmental factors. The 
framework of the International Classification of Functioning Disability and Health 
[38], which evolved from Nagi’s seminal work [39], expresses that new understand-
ing. In accordance with this change of paradigm, interventions and assessments 
were challenged and new approaches were developed. For example, activity-
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dependent neural plasticity became a major concept within neurological rehabilita-
tion [40]. Physiotherapists are confronted with the tasks of implementing knowl-
edge derived from basic research and providing scientific backgrounds for their 
empirically based interventions. 
Prognosis/recovery 
The impairments seen after an SCI exhibit not only a large variation in terms of their 
clinical presentation at onset but also with regard to their recovery [41]. Patients 
with a complete SCI (i.e., AIS A) tend to remain at that level and show only some 
recovery in the segments adjacent to the lesion [42, 43]. However, activity-related 
changes can also be observed in this patient group [44]. Most likely, the basis for 
these improvements is compensation and adaptation. For example, the use of a 
wheelchair can be considered to be a compensatory strategy for overcoming the 
loss of motor function in the lower extremities, or an indwelling catheter can com-
pensate for the impaired voiding function of the bladder. 
 
In contrast, patients with incomplete SCI lesions frequently show marked recovery 
from impairment within the first year after injury [41, 45, 46]. The main changes in 
walking function can be observed within the first half year [47], a time period when 
rehabilitation usually takes place. Improvements in impairment level and activities 
seem to be based on compensation/adaptation but also on activity-dependent neu-
ral plasticity that is exploited by functional training and spontaneous recovery of 
function [48, 49]. 
Rehabilitation of mobility 
Among other domains, mobility is a typical target for physical therapy interventions 
[50]. Depending on the neurological motor deficit, mobility is attained either by 
using a wheelchair or regaining locomotor ability. In the latter case, walking aids 
and orthotics may be required. 
 
Predictors for regaining ambulation after an SCI are the initial motor score (specifi-
cally that of the lower extremities), partial sensory sparing, age, somatosensory 
evoked potentials [51-53] and mobility assessments made by physical therapists 
[54]. Patients with an incomplete AIS B or C SCI typically exhibit an extensive im-
pairment at the beginning of rehabilitation. Volitional leg muscle activation is not 
possible or hardly possible and mobility is restricted to the wheelchair. However, as 
highlighted earlier about these cases (i.e., AIS B and C), the prognosis for regaining 
walking function is high. But that can be hampered if during the period of impaired 
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mobility and non-use of the locomotor system a secondary worsening by maladap-
tive plasticity takes place (which is elsewhere referred to as ‘learned non-use’) [55]. 
 
From this point of view, it is important to start locomotor training as early as possi-
ble, even though patients do not yet have voluntary motor control of their leg 
movements. The locomotor system can be activated (Chapter 2, [17]) in this early 
phase by using adequate supporting training devices (Chapter 7, [56]). In such a 
way, the spinal locomotor centers are activated when adequate proprioceptive 
afferent input is provided. When patients eventually start to regain some voluntary 
control of their leg movements, the support can gradually be reduced. Studies have 
shown that the improvement of function exceeds that of neurological deficit (Chap-
ter 3). The goal of the supported locomotor training is to enable patients to ambu-
late over ground. 
AIM OF THE THESIS 
This thesis focuses on the rehabilitation of ambulatory function. Rehabilitation in-
terventions and the ways their effectiveness is assessed have undergone substantial 
development in the last few years. 
 
This thesis includes three main sections: 
i) Are concepts derived from basic research applicable to human subjects 
with an SCI? 
a. the spinal locomotor center (Chapter 2) 
b. the interrelation of the ICF (Chapter 3) 
c. an animal lesion model (Chapter 4) 
ii) Is the use of robots feasible and effective? (Chapters 7, 8 and 9) 
iii) How valid and reliable are measurements of walking function and falls 
which were originally developed for other patient populations? 
(Chapters 5 and 6) 
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Long term effects of locomotor training 
in spinal humans 
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ABSTRACT 
The long term effects of locomotor training in patients with spinal cord injury (SCI) 
were studied. In patients with complete or incomplete SCI coordinated stepping 
movements were induced and trained by bodyweight support and standing on a 
moving treadmill. The leg extensor muscle EMG activity in both groups of patients 
increased significantly over the training period, associated with improved locomotor 
ability in those with incomplete SCI. During a period of more than 3 years after 
training, the level of leg extensor EMG remained about constant in incomplete SCI 
in those who regularly maintained locomotor activity. By contrast the EMG signifi-
cantly fell in those with complete SCI. The results suggest a training induced plastic-
ity of neuronal centres in the isolated spinal cord which may be of relevance for 
future interventional therapies. 
 
Keywords. locomotion; spinal cord injury; leg muscle EMG activity; motor learning 
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INTRODUCTION 
It has been known for several years that patients with spinal cord injury (SCI) profit 
from specific locomotor training experiments, [1-3] based on cat studies. In the 
spinal cat the generation of coordinated leg muscle EMG activity on a moving 
treadmill was first described in 1980 [4]. Similar step-like automatic movements are 
present at birth and in anencephalic children [5]. Evidence arose that in adult hu-
mans also, spinal interneuronal circuits exist which are involved in the generation of 
locomotor activity [2, 6]. The locomotor function of incomplete paraplegic patients 
was shown to profit by specific training on a treadmill with partial body weight sup-
port [3, 7]. Certain guidelines must be followed to make the training effective [2, 6, 
7]. The beneficial effect of this training critically depends on a physiological proprio-
ceptive afferent input - for example, from load receptors [8] - to the spinal locomo-
tor centres. Even in patients with a complete SCI, a locomotor pattern could be 
induced [1]. The aim of this study was to investigate the course of locomotor EMG 
activity after the end of locomotor training in patients with complete and incom-
plete SCI.  
PATIENTS AND METHODS 
General procedures 
Consent was obtained from patients and the local ethics committee to make re-
cordings in 32 patients with SCI. The clinical diagnosis of spinal cord lesion was con-
firmed by electrophysiological [9] and radiological [10] examinations. Patients with 
peripheral nerve damage were excluded. Thirty two patients had either a complete 
motor SCI according to the American Spinal Cord Injury Association (ASIA) classifica-
tion [11] (A or B (n=16; mean age 35 (SD 12) years)) or had an incomplete motor SCI 
(ASIA C (n=2) or D (n=14) (mean 35 (SD 16 years)) (Table 2.1). The level of lesion 
ranged from C4 to T12 (one patient with incomplete SCI at L3) with about one third 
at the cervical and two thirds at the thoracic level (see Table 2.1). 
 All patients were admitted to our centre between 1993 and 1997 for primary 
rehabilitation. They underwent daily locomotor training on a treadmill (roughly 300 
m of walking (about 15 minutes), 1.5 km/h speed, 5 days a week) starting between 
day 32 to 347 after SCI (mean 96 (SD 64)). The training on average lasted 137 days 
(SD (SD 72). In all patients with complete SCI and at the beginning of the training in 
most patients with incomplete SCI (13 of 16), leg movements had to be assisted by 
physiotherapists and body weight had to be partially unloaded. Unloading was 
achieved by suspending the patients over the treadmill by a parachute harness 
connected to counterweights. The amount of unloading was adapted to the  
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Table 2.1 Patients with SCI included in the study 
Patient No Sex Age (y) Level of lesion 
ASIA score at 
beginning of  
treadmill training 
ASIA score at  
end of  
treadmill training 
Duration of 
treadmill 
training (days) 
Complete SCI 
 1 M 46 C5 A A 343 
 2 M 23 C6 A A 219 
 3 M 28 C6 B B 158 
 4 M 42 C7 A A 101 
 5 M 21 C7 A A 210 
 6 M 42 T1 A A 139 
 7 M 41 T1 A A  85 
 8 F 19 T1 A A 112 
 9 M 53 T1 B B 148 
10 M 27 T1 A A  71 
11 M 35 T10 A A  90 
12 F 14 T3 A A 120 
13 M 50 T4 A A 273 
14 M 33 T6 A A  84 
15 M 26 T6 A A 103 
16 M 53 T8 B B 113 
     Mean: 148 
 
Incomplete SCI 
17 M 24 C4 C C 288 
18 M 51 C4 C D 126 
19 M 47 C4 D D 107 
20 M 72 C6 D D 174 
21 M 13 C7 D D 147 
22 M 20 C8 D D 165 
23 M 33 L3 D D  98 
24 M 37 T10 C D  36 
25 M 30 T11 C D  49 
26 M 32 T11 D D  91 
27 F 29 T11 C D 175 
28 M 39 T11 D D  35 
29 M 31 T12 C D 196 
30 M 23 T12 C D 103 
31 M 59 T7 D D 154 
32 M 11 T7 C C  60 
     Mean: 125 
Abbreviation: SCI, spinal cord injury 
 
patients’ capability of performing stepping movements (up to 80% of body weight). 
After training had finished, 11 patients with incomplete SCI needed neither unload-
ing nor external assistance and were able to perform stepping movements on nor-
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mal ground conditions; two patients could walk without unloading but needed 
some assistance. In all patients with complete SCI body weight support could be 
reduced during the course of the training, although none of these patients could 
perform stepping movements without assistance after finishing locomotor training. 
Recordings at three points were made weekly: EMG activity from the gastrocnemius 
medialis muscle using surface electrodes; the force exerted on the treadmill using 
force plates located underneath the treadmill; and from movements of the knee 
joints using mechanical goniometers fixed at the lateral aspect of the right and left 
knees. Follow up recordings were also made after finishing the locomotor training 
as outpatients. The number of outpatient measurements and the intervals between 
them varied due to the availability of the patients (a mean of five measurements 
over a mean period of 1.9 years (SD 1.4), range 0.13–5.8 years)). We also analysed 
the time course of the amplitude of muscle action potentials (MAPs) of the abduc-
tor hallucis muscle evoked by tibial nerve stimulation in four patients with complete 
SCI, for more than 4 years.  
Data analysis 
The EMG recordings were amplified (μV amplifier; bandpass filter, 30–300 Hz) and, 
together with the biomechanical signals, were converted (a/d) into a digital signal 
and transferred to a PC system. Signals were sampled at 500 Hz. The EMG signals 
were rectified and averaged over 20 step cycles. The force signal indicating the heel 
strike and beginning of the stance phase served as a trigger to average the EMG 
signal and to normalize the recordings to one stride cycle (for further details see 
Dietz et al [1, 6]. To investigate changes in amplitude of EMG activity in the gas-
trocnemius medialis muscle as a function of time, the signal energy (root mean 
square (RMS)) was determined for the stance (5%–25% before the end of the stance 
phase) and for the swing phase (5%–25% after the end of stance). The knee joint 
signal was used to detect the end of the stance phase. During the stance phase, the 
main activation and during swing no activation of the gastrocnemius medialis mus-
cle was expected to occur [6]. The RMS during swing was subtracted from the RMS 
during stance to eliminate noise and tonic muscle activation. To allow intersubject 
comparison within the two groups of patients with complete and incomplete SCI, 
measurements were normalised to the mean RMS amplitude of the three final re-
cordings before finishing locomotor training. These values have been correlated 
with the time elapsing after discharge. Because the number of the recordings dif-
fered between patients, Pearson’s weighted correlation coefficient was taken for 
calculation. A Dantec Keypoint 1000 EMG machine was used to record M waves. 
The maximal amplitude of muscle action potentials was obtained by a supramaximal 
stimulation (single rectangular wave stimuli of 0.5 ms duration, <100 mA) of the 
tibial nerve at the level of the ankle. The M waves (MAPs) were recorded in four 
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patients over the abductor hallucis muscle using surface electrodes. The maximal 
MAP amplitude (baseline to peak) was determined. The registration was done be-
fore, during, and after the locomotor training in patients with complete SCI to as-
sess whether muscle atrophy due to disuse had occurred. The MAP amplitude of the 
four patients has been correlated with the time elapsing after discharge (Pearson’s 
correlation coefficient).  
RESULTS 
Figure 2.1 shows two examples of gastrocnemius muscle EMG during one step cycle 
of (A) a patient with complete paraplegia T4 and (B) a patient with incomplete tet-
raplegia C4 (central cord syndrome). The EMG signals were rectified, averaged 
(n=20 step cycles), and smoothed. The black lines represent EMG activity of the 
gastrocnemius medialis muscle at the end of locomotor training. The grey lines 
indicate the EMG activity at (A) 335 days and (B) 893 days after finishing locomotor 
training. In the patient with incomplete SCI the amplitude of the EMG signal was 
somewhat larger during early stance during the late recording, but otherwise similar 
at the two time points. In the patient with complete SCI the EMG signal was consid-
erably reduced in amplitude during the late recording.
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Figure 2.1 Rectified and averaged (n=20 strides) gastrocnemius EMG during one step cycle
of a patient with (A) complete paraplegia T4 and (B) a patient with incomplete tetraplegia C4. 
The black lines represent the EMG activity at the end of the locomotor training. The grey lines 
indicate the activity at (A) 335 days and (B) 893 days after finishing locomotor training. Note 
the different calibrations of the EMG signal in (A) and (B). 
 
Figure 2.2 shows the course of locomotor activity in patients (A) with complete and, 
(B) incomplete SCI over time after locomotor training had finished. In both groups of 
patients there was a significant (p>0.001) increase of EMG activity of the gas-
trocnemius muscle during the period of locomotor training (left side of time=0). This 
increase seemed to be greater in the group of patients with incomplete SCI. In pa-
tients with complete SCI the absolute level of RMS amplitude at this time was about 
one third of the corresponding activity level seen in incomplete paraplegic patients. 
After finishing locomotor training all patients with incomplete SCI used their loco-
motor capability every day on normal ground conditions (see methods). In these 
patients EMG activity of the gastrocnemius medialis muscle changed marginally 
over time after the end of training (r=−0.01; p>0.05, see fig 2.2 A. No patient 
showed a significant decline). By contrast, all patients with complete SCI never per-
formed stepping movements after locomotor training stopped. These patients de-
veloped a significant decrease of gastrocnemius medialis muscle EMG activity over 
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time (r=−0.29; p<0.01, see fig 2.2 B). The regressions between patients with com-
plete and those with incomplete SCI were significantly different (p<0.01). Neuro-
graphic recordings were performed over time in four patients with complete SCI to 
assess eventual signal changes in EMG activity due to muscle atrophy. The MAP 
amplitude (abductor hallucis muscle) evoked by tibial nerve stimulation did not 
change over time (r=0.05; p>0.05). 
 
 
Figure 2.2 Course of gastrocnemius EMG activity after finishing locomotor training: (A) at
t=0, 16 patients with complete motor paraplegia (ASIA A or B; n=99 recordings) and (B) 16
patients with incomplete paraplegia (ASIA C or D; n=55 recordings). The RMS values were 
normalised to the mean of the final three EMG recordings before finishing locomotor training
(filled squares). Each point represents one recording (average 5/patient). The filled triangle
reflects the normalised mean RMS amplitude of the first three recordings of all patients at the 
beginning of locomotor training. In patients with complete paraplegia the EMG amplitude 
declines over the time course (y=−0.0006x+1.3039; r=−0.29; p<0.01) whereas in incomplete 
paraplegic patients the level of EMG activity remains about constant (y=0.0000424x+1.3527; 
r=−0.008; p>0.05). 
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DISCUSSION 
Several reports indicate that patients with incomplete SCI profit from locomotor 
training [2, 6]. The basis for this improvement in locomotor activity seems to be 
mainly due to an adaption of spinal neuronal networks to a physiological proprio-
ceptive input after SCI. In patients with incomplete SCI a strengthening of cortical 
input [12] might also contribute to the functional improvement. The aim of this 
study was to evaluate the long term effects of such training on the leg extensor 
EMG activity in patients with incomplete and complete SCI. We concentrated on the 
EMG activity of the gastrocnemius medialis muscle, as this muscle was shown ear-
lier [1, 6] to be most sensitive to locomotor training (by contrast with the tibialis 
anterior muscle) and as a consequence was overriding antigravitational function 
during locomotion. The results indicate that a regular locomotor training is effective 
in improving locomotor (gastrocnemius medialis EMG) activity in both patients with 
complete and those with incomplete SCI. Different long term effects of this training 
on locomotor activity between the two groups of patients was found. In patients 
with incomplete SCI who regained ambulatory capacity, either functional or thera-
peutic [9] leg extensor EMG activity did not change over time after finishing locomo-
tor training. All these patients used their “learned” locomotor activity daily to walk 
at least short distances. Obviously this practice is sufficient to maintain the level of 
locomotor activity achieved during training. However, there is evidently no futher 
improvement in the more practical use of the locomotor pattern.  
 Patients with complete SCI could not use their acquired locomotor activity after 
finishing locomotor training as they remained unable to induce stepping move-
ments. These patients lost the “learned” capacity of spinal neuronal networks to 
produce reasonable leg extensor EMG activity during assisted walking. The pre-
served MAP amplitude over time indicates that the decline in EMG activity is not 
due to muscle atrophy because of disuse, or peripheral nerve degeneration. It is 
recommended that locomotor training is started in patients with incomplete SCI as 
early as possible so as to use a long training period and to establish optimal condi-
tions for the time when some supraspinal control is regained. By such an approach a 
high level of locomotor function can be achieved. For patients with complete SCI the 
results may be of importance for future interventional therapies promoting some 
regeneration. In such a situation a maintained level of trained locomotor activity 
may be of benefit to regain locomotion.  
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ABSTRACT 
Objectives. To relate locomotor function improvement, within the first 6 months 
after spinal cord injury (SCI), with an increase in Lower Extremity Motor Score 
(LEMS) and to assess the extent to which the level of lesion influenced the outcome 
of ambulatory capacity. Design: Longitudinal and cross-sectional analyses. Setting. 
Seven SCI rehabilitation centers. Participants. Patients (N=178) were analyzed longi-
tudinally (group A, motor complete; group B, motor incomplete  nonwalking or 
group C, motor incomplete and able to stand). The cross-sectional analysis included 
86 patients (paraplegic, n=46; tetraplegic, n=40; group 1 with limited and group 2 
with unrestricted walking function 6mo after SCI). Interventions. Not applicable. 
Main outcome measures. Walking Index for Spinal Cord Injury (WISCI), gait speed, 
and LEMS. Results. For group A, 24.8% of the patients improved in LEMS (median 
range, 0–10) and 7.7% in walking function (WISCI median range, 0–8; mean gait 
speed range, 0 to .14±.10m/s). For group B, LEMS improved in 93.5% of the patients 
(median range, 14–28) and walking function in 84.8% of the patients (WISCI median 
range, 0–10; mean gait speed range, 0 to .41±.45m/s) (P<.001). For group C, LEMS 
and walking function improved in 100% of the patients (LEMS median range, 29–41; 
WISCI median range, 8–16; mean gait speed range, .36±.29m/s to .88±.44m/s) 
(P=.001). In groups B and C, the improvement of walking function was greater than 
in LEMS. The cross-sectional analysis showed that group 1 patients with tetraplegia 
had more muscle strength (median LEMS, 31.5), and equal walking function (WISCI, 
8; walking speed, 0.4±0.3m/s) compared with patients with paraplegia (LEMS, 23; 
P<.01; WISCI, 12; P=0.6; speed, 0.4±0.3m/s; P=.68). In group 2, patients with tetra-
plegia had slightly more strength (LEMS, 48) and equal walking function (WISCI, 20; 
walking speed, 1.4±0.4m/s) compared with patients with paraplegia (LEMS, 45; 
P<.05; WISCI, 20; P=1.0; speed, 1.4±0.3m/s; P=.89). Conclusions. An improvement in 
locomotor function does not always reflect an increase in LEMS, and LEMS im-
provement is not necessarily associated with improved locomotor function. LEMS 
and ambulatory capacity are differently associated in patients with tetra- and para-
plegia. Functional tests seem to complement clinical assessment. 
 
Keywords. Locomotion; Paraparesis; Rehabilitation; Spinal cord injuries; Treatment 
outcome. 
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INTRODUCTION 
In the United States 11,000 people experience a spinal cord injury (SCI) every year 
[1]. Nearly 53% of these injuries are incomplete, that is, some sensory and/or motor 
function is preserved below the level of the spinal cord lesion. About 70% of initial 
incomplete SCI subjects regain some ambulatory function [2-4]. 
 To quantify rehabilitation outcomes after SCI and other disorders, internation-
ally standardized measures should be applied. Such a classification system grades 
the extent of pathology and serves as a valid measure that accurately reflects the 
patient’s actual impairment. For subjects with SCI, the American Spinal Injury Asso-
ciation (ASIA) established a standardized neurologic assessment (ie, the ASIA classi-
fication) [5]. The ASIA classification focuses on the motor and sensory deficits after a 
spinal lesion. More recently developed classifications, such as the International 
Classification of Functioning, Disability and Health (ICF) [6], cover a much broader 
aspect of functioning and disability. The ICF encompasses different domains, includ-
ing the perspective of the body, the individual, and the society. In this conceptual 
framework, functioning and disability are subdivided into the components of (1) 
body functions and structures and (2) activities and participation. These compo-
nents are interacting, but not in a linear and predictable one-to-one relationship. 
 The ASIA protocol has been extensively used as a standardized assessment tool 
to document the neurologic deficit after a SCI [7-12]. Additional assessments have 
to be applied for the assessment of the activity limitation in order to enhance com-
prehensive outcome measurement. Previous studies have shown that after an SCI, 
preserved voluntary muscle contraction measured using the ASIA protocol is highly 
correlated with walking ability [2, 4, 13-15]. Nevertheless, some aspects of the rela-
tionship between muscle “force and function” are not yet solved.  
 About 51% of all patients with an incomplete SCI experience a cervical lesion 
[1]. In these patients, not only the lower extremities and trunk muscles are affected 
but also muscles of the upper extremities, that is, the supportive function of the 
arms is weak. Hence, for the achievement of a comparable walking ability we hy-
pothesized, that subjects with tetraplegia compared with subjects with paraplegia 
require higher motor scores of lower extremities to compensate for this deficit. 
 The aim of this study was to evaluate the relationship between locomotor func-
tion improvement and an increase in lower-limb motor scores. This was analyzed 
using a longitudinal approach. In addition, we studied to what extent the level of 
lesion influenced outcome of locomotor function using a cross-sectional approach. 
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METHODS 
General procedures and participants 
The study was part of the European Multicenter Study about Human Spinal Cord 
Injury (EMSCI) and was carried out in 7 European SCI rehabilitation centers over a 
period of 20 months. The protocol of the study was approved by the local ethics 
committee and all participants were informed and gave written consent. 
 In the 7 SCI rehabilitation centers, all subject with traumatic or ischemic SCI 
who had been referred for primary rehabilitation were examined with the same 
clinical assessments according to a fixed timeframe: within the first week after the 
injury and consecutively after 1, 2, 6, and 12 months [16]. The results of these as-
sessments were stored anonymously in a central electronic database. For this retro-
spective study, a query of this database was performed in June 2005. The query 
included a key identifier, age, sex, level of lesion, date of the lesion, test dates, re-
sults of the Lower Extremity Motor Score (LEMS), Walking Index For Spinal Cord 
Injury (WISCI), and gait speed using the 10-meter walking test (10MWT) 1 and 6 
months after injury. We excluded participants who were aged under 15 or over 70 
or with an incomplete database record. In addition, subjects with SCI who exceeded 
75% of a scale (for LEMS: 0.75x50=37; for WISCI, 0.75x20=15) 1 month after SCI 
were excluded. Chances for further improvement in such patients are small. More-
over, ceiling effects cannot be excluded. Such ceiling effects are likely to occur with 
both the WISCI and the LEMS but less with the self-selected walking speed using the 
10MWT. 
 For the comparison between the improvement of ambulatory function and 
motor impairment, a longitudinal approach with 2 time points was chosen. To pool 
patients with comparable potential to recover voluntary muscle force and ambula-
tory function patients were categorized to 1 of 3 groups based on the assessment 
made 1 month after SCI: (1) group A (motor complete and nonwalking): patients 
with neither voluntary muscle contraction in the lower extremity nor walking func-
tion (LEMS, 0; WISCI, 0); (2) group B (motor incomplete and nonwalking): patients 
with some preserved voluntary muscle strength but no walking function 
(1≤LEMS≤37; WISCI, 0); and (3) group C (motor incomplete and standing or walking): 
patients with preserved voluntary muscle contraction and walking function 
(1≤LEMS≤37; 1≤WISCI≤15). 
 In addition, a cross-sectional analysis of patients who regained ambulatory 
function 6 months after SCI was performed. The goal of this analysis was to com-
pare the differences in LEMS, WISCI, and gait speed between patients with paraple-
gia and tetraplegia in 2 separate groups: patients who achieved only limited walking 
function with the help of walking aids (WISCI <20) were categorized to group 1. All 
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patients who regained unrestricted ambulatory function (WISCI, 20) were summa-
rized in group 2. 
Outcome measures 
Examinations were performed 1, 3, 6, and 12 months after the injury by experi-
enced physicians (ASIA assessment) and physical therapists (assessment of walking). 
For this analysis, results of the first- and sixth-month examinations were used. To 
standardize the testing procedure, regular workshop meetings and additional train-
ing were organized for the examiners. 
 The voluntary muscle strength of 5 key muscles (hip flexors, knee extensors, 
ankle dorsiflexors, toe extensors, ankle plantarflexors) of both lower extremities 
(LEMS) was tested in accordance with the standard neurologic assessment devel-
oped by ASIA [5]. Each muscle was given a value between 0 and 5 according to the 
strength of voluntary muscle contraction. Maximum and minimum LEMS were 50 
and 0, respectively. 
 To assess walking performance, the revised version of the Walking Index for 
Spinal Cord Injury (WISCI II) [17,18] and the 10MWT [19] were used. The WISCI II 
describes the walking status of a patient based on the requirements of assistance 
and/or bracing and/or walking aids. The ordinal scale ranges from 0 (neither stand-
ing nor walking function) to 20 (independent walking). The 10MWT reflects the time 
necessary for walking 10m. Subjects were instructed to walk in a straight line at a 
comfortable self-selected pace over the distance of 14m. Walking time was taken 
after the subject walked 2m and was stopped 2m before the finish line to account 
for potential acceleration and deceleration effects. They could use their preferred 
assistive device, including minimal physical assistance. Gait speed (in m/s) was cal-
culated from the results of the 10MWT. 
Data analysis 
Given the fact that LEMS and WISCI are ordinal-scaled variables, nonparametric 
tests were applied and medians are given. Gait speed is presented as mean ± stan-
dard deviation. SPSSa for Windows was used for the statistical analysis. 
 Patient groups A, B, and C. Wilcoxon signed-rank test was used to analyze longi-
tudinally the course of LEMS and walking function (ie, WISCI, gait speed) between 
the first and the sixth month after SCI. To compare the improvements between 
LEMS, WISCI, and gait speed, results obtained 1 month after the injury were sub-
tracted from those obtained 6 months after the injury. These differences were di-
vided by the respective normative value. The normative value for LEMS is 50; for 
WISCI, 20; and for gait speed, 1.46m/s [20]. The Wilcoxon signed-rank test was used 
to compare these normalized differences. 
C h a p t e r  3  
 42 
Patient groups 1 and 2. For this cross-sectional analysis, Mann-Whitney U tests were 
applied to compare LEMS, WISCI, and gait speed between patients with paraplegia 
and tetraplegia within each group. 
RESULTS 
The database contained 504 records when the query was performed. Of these pa-
tients, 284 had incomplete data records, that is, not all 3 tests were completed at 
both time points, or information about age or date of measurement were lacking. 
Thirteen patients were excluded because of their age (<15y, >70y). For the longitu-
dinal analysis, 31 patients were excluded because the LEMS and/or WISCI exceeded 
75% of the maximum value 1 month after SCI. The analysis was performed on 178 
patients. For the cross-sectional analysis, a subgroup of 86 patients who regained 
ambulatory function 6 months postinjury was included. For further characteristics 
see Table 3.1. 
 
Table 3.1 Characteristics of the Patient Groups 
Sex 
Group Tetraplegia Paraplegia Age (y) 
Female Male 
Aa 49 68 35.3±14.1 25 91 
Ba 24 22 44.1±16.4 16 30 
Ca  3 12 42.1±14.4  7  8 
Tetra 16  46.2±12.8  2 14 
1b 
Para  33 37.7±15.4 14 19 
Tetra 24  42.2±14.1  3 21 
2b 
Para  13 37.1±10.6  2 11 
NOTE. The assignment to the groups A, B, and C was made according to the disability 1 month after SCI.  
a Group A, motor complete and non-walking; group B, motor incomplete and non-walking; and group C, 
motor incomplete and standing or walking.  
b Groups 1 and 2 consist of patients who regained ambulatory function 6 months after SCI: (1) patients 
with limited walking function (WISCI <20); and (2) patients with unrestricted walking function (WISCI, 20). 
Course of motor scores and walking function 
In group A (i.e. motor complete and non-walking 1 month after the injury, n=117), 
29 (24.8%) patients improved their LEMS from 0 to a median of 10. The most fre-
quent improvement was from 0 to 1. Eighty-eight (75.2%) patients remained at a 0 
value, which means complete paralysis. Nine (7.7%) patients improved in the WISCI 
from 0 to a median of 8, and in the 10MWT to an average gait speed of .14±10m/s. 
In 108 (92.3%) patients, walking function (ie, WISCI, gait speed) did not change. 
Although the changes in LEMS and WISCI had no clinical impact, the Wilcoxon 
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signed-rank test revealed a significant improvement of the total group (for LEMS, 
P<.001; for WISCI, P<.01). 
 In group B (ie, motor incomplete and nonwalking, n=46), LEMS improved in 43 
(93.5%) patients, from a median of 14 to 28, that is, a relative improvement of 
24%±18%. However, in 3 (6.5%) patients, LEMS decreased.  
 WISCI improved in 39 (84.8%) patients, from 0 to a median of 10, that is, rela-
tive improvement of 52%±33%. In 7 (15.2%) patients, WISCI did not change.  
 Gait speed improved in 35 (76.1%) patients, from 0 to an average value of 
.41±.45m/s, that is, relative improvement of 28%±31%. No change in gait speed was 
observed in 11 (23.9%) patients.  
 For the total group, the overall improvement in LEMS, WISCI, and gait speed 
was significant (P<.001). WISCI improved to a larger extent compared with LEMS 
(P<.001). No difference was evident between the relative improvements of LEMS 
and gait speed (P=.54). 
 In group C (ie, motor incomplete and standing or walking, n=15), all patients 
improved in LEMS, WISCI, and gait speed. The median LEMS 1 month after the in-
jury was 29 and improved to 41 at the sixth month after the SCI, which corresponds 
to a relative improvement of 23%±12%. The corresponding values for WISCI were 8 
one month postinjury and 16 five months later. This reflects a relative improvement 
of 46%±20%. Gait speed improved from .36±.29m/s to .88±.44m/s, that is, a relative 
improvement of 36%±23%. The overall improvements of LEMS, WISCI, and gait 
speed was significant (P=.001). WISCI (P<.01) and gait speed (P<.05) showed a 
greater relative improvement than LEMS. See also Table 3.2 and Figure 3.1. 
 
Table 3.2 LEMS, WISCI, and gait speed at the first and sixth months after SCI of patients in  
groups A, B, and C 
Group LEMS WISCI Gait Speed 
 1 M 6 M RI (%) 1 M 6 M RI (%) 1 M 6 M RI (%) 
A  0  0  6±12 0  0 3±11 0  .01±.05  0.7±3 
B 14 28 24±18 0 10 52±33 0  .41±.45 28±31 
C 29 41 23±12 8 16 46±20  .36±.29  .88±.44 36±23 
NOTE. Values are median and mean ± SD. 
Abbreviation: LEMS, lower extremity motor score; WISCI, Walking Index for Spinal Cord Injury; M, month; 
RI, relative improvement. 
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Figure 3.1  Relative improvements of LEMS, WISCI, and gait speed (difference between
measurement at 6 months and at 1 month divided by the respective normative value). (A)
Motor incomplete patients who were not able to stand or walk 1 month after SCI; and (B) 
patients who were motor incomplete and able to stand or walk 1 month after SCI. *P<.05;
†P<.01; ‡P<.001. 
Outcome of subjects with tetraplegia versus paraplegia 
Subjects with tetraplegia of group 1 who achieved only limited walking function 6 
months after the injury (WISCI <20, n=16) showed a median LEMS of 31.5, a median 
WISCI of 8, and a mean walking speed of 0.4±0.3m/s. By comparison, the corre-
sponding values of patients with paraplegia (n=33) were 23 for the LEMS (P<.01), 12 
for the WISCI (P=.6), and 0.4±0.3m/s for the walking speed (P=.68). 
 Subjects with tetraplegia in group 2 (n=24), who could walk without restrictions 
(WISCI, 20), showed a median LEMS of 48, a median WISCI of 20, and a mean walk-
ing speed of 1.4±0.4m/s. Patients with paraplegia (n=13) showed a median LEMS of 
45 (P<.05), a median WISCI of 20 (P=1.0), and a mean walking speed of 1.4±0.3m/s 
(P=.89). See also Table 3.3 and Figure 3.2. 
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Table 3.3 Comparison of LEMS, WISCI, and gait speed between patients with tetraplegia and  
paraplegia in 2 groups 
 Group 1 Group 2 
Test 
Tetraplegia 
(n=16) 
Paraplegia 
(n=33) 
Tetraplegia 
(n=24) 
Paraplegia 
(n=13) 
LEMS 31.5 23 48 45 
WISCI  8 12 20 20 
Gait speed  0.4±0.3  0.4±0.3  1.4±0.4  1.4±0.3 
NOTE. Values are median and mean ± SD.  
Group 1 is patients with limited walking function (WISCI <20); group 2 is patients with unrestricted walk-
ing function (WISCI, 20). 
 
 
Figure 3.2 Comparison of LEMS, WISCI, and gait speed between patients with tetraplegia
(Tetra) and paraplegia (Para) who achieved (A) limited, and (B) unrestricted walking func-
Ɵon 6 months aŌer the injury. *P<.05; †P<.01. 
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DISCUSSION 
After an SCI, the remaining voluntary muscle force of key muscles can be quantified 
by internationally accepted protocols, such as the ASIA classification [5]. The ASIA 
motor scores represent a simple clinical measure reflecting the walking ability of 
patients with SCI [13,14]. Other studies showed that particular muscles around the 
hip [15] or knee extensor strength [4] are associated with ambulatory function. 
These studies focused on correlations or predictions at a certain point in time. We 
evaluated the relationship between ASIA motor scores and the locomotor function 
during the first 6 months after a SCI. Our results indicated that (1) ASIA motor score 
and locomotor function are closely related, even in subgroups of patients with SCI, 
which is in line with other studies (eg, Burns et al [2]), (2) the degree of recovery of 
locomotor function does not parallel the change in motor scores obtained during 
the first 6 months after SCI, and (3) among patients who achieved limited ambula-
tory function 6 months after SCI, patients with tetraplegia need a substantially 
higher LEMS compared with patients with paraplegia. Nevertheless, if patients with 
tetraplegia achieve a basic walking function, they are more likely to become unre-
stricted walkers.  
Course of LEMS and locomotor function 
As has been shown in this study, an increase in motor score is not always associated 
with an improvement in function. Conversely, an improvement in locomotor func-
tion between 1 and 6 months after SCI in patients both with incomplete tetraplegia 
and paraplegic is associated with a variable increase in LEMS. Along the same line 
Wirz et al [21] showed that locomotor training by a robotic device (Lokomat) in 
patients with chronic SCI resulted in a significant improvement of locomotor ability, 
which was not associated with an increase in LEMS. This might be due to an extra-
activation of lower-extremity muscles by the automatic proprioceptive feedback 
during locomotion [22]. In addition, locomotor training affects many muscles and 
activates them in a functional way, resulting in a better coordination of synergistic 
muscles [22, 23]. This might lead to a better functional result than any other physi-
cal therapy because training effects were shown to be specific to the focus of the 
therapy [24]. 
 Another study [25] which focused on the efficacy of a treatment, that is, the 
application of high doses of methylprednisolone, has shown a small increment in 
ASIA score compared with controls. However, in this study it remained open wheth-
er the observed improvements on the level of the body functions were associated 
with an improved activity i.e. ambulatory function. Recently, this treatment has 
been questioned (eg, Hurlbert [26]). According to our observations the effect of this 
M u s c l e  f o r c e  a n d  g a i t  p e r f o r m a n c e :  R e l a t i o n s h i p s  a f t e r  s p i n a l  c o r d  i n j u r y  
 47 
treatment on outcome, that is, a small increase of ASIA score, might not reflect 
improvement in function in all patients.  
Difference between outcome in subjects paraplegia and tetraplegia 
Patients with paraplegia and tetraplegia who became ambulatory 6 months after 
SCI demonstrated a similar locomotor function according to WISCI and walking 
speed. However, in patients with tetraplegia all lower-extremity “key” muscles had 
to reach a functional level of muscle contraction to permit locomotor function. In 
contrast, patients with paraplegia achieved this performance already at lower LEMS. 
This became evident in patients with limited walking function (ie, WISCI<20). This 
difference is suggested to be due to the additional weakness of trunk and upper-
limb muscles in patients with tetraplegia, which requires substantially more lower-
extremity muscle force to compensate for the postural instability. If this stability is 
provided, a further increase in LEMS was associated with a steep improvement in 
locomotor ability. Consequently, ambulatory patients with tetraplegia achieved a 
higher level of walking function than patients with paraplegia. In contrast, if the 
LEMS remains below a certain level, only patients with paraplegia become ambula-
tory while patients with tetraplegia remain wheelchair-bound. 
Methodological considerations 
This study has some limitations. First, incomplete data records are inherent to a 
multicenter database, reflected by a high exclusion rate. Second, on the one hand, 
the multicenter nature of this study enables access to a substantial number and 
broad spectrum of subjects. However, reliability of the procedures is hard to ensure 
due to multiple examiners. This applies in particular to the clinical, non-apparative 
assessments. To keep random and systematic error as small as possible, regular 
workshop meetings were organized and datasets were tested for plausibility by an 
independent person. The assessment of reliability was not a focus of this study and 
was therefore not further explored. Third, for the assessment of voluntary muscle 
force, a limitation and source of bias might be the use of clinical motor scores rather 
than objective measures (eg, dynamometry). Fourth, despite the straightforward 
aim of this study (ie, comparing muscle force and functional walking scores), no 
unambiguous statistical method is available to directly compare the different vari-
ables.  
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CONCLUSIONS 
The effectiveness of new interventional physical or drug therapy should be assessed 
not only by a standardized neurologic examination (e.g. ASIA), but also by interna-
tionally accepted activity assessments. Motor and sensory scores reflect spontane-
ous recovery of spinal cord function as they depend on the integrity of corticospinal 
connections (i.e. voluntary muscle contraction). By a combined assessment of force 
and function, the effectiveness of any new interventional therapy might become 
comprehensively assessed.  
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ABSTRACT 
Study design. Retrospective analysis of prospectively collected data. Objective. A 
hemisection of the spinal cord is a frequently used animal model for spinal cord 
injury (SCI), the corresponding human condition, i.e. the Brown- Sequard syndrome 
(BS), is relatively rare compared to the central cord syndrome (CC). The time-course 
of neurological deficit, functional recovery, impulse conductivity and rehabilitation 
length of stay (LOS) in BS and CC subjects were compared. Setting. Nine European 
Spinal Cord Injury Rehabilitation Centers. Methods. Motor score, walking function, 
daily life activities, somatosensory evoked potentials and LOS were evaluated one 
and six months after SCI and were compared between age-matched groups of 
tetraparetic BS and CC subjects. Results. For all analyzed measures no difference in 
the time-course of improvement was found in 15 matched pairs. Conclusion. In 
contrast to the assumption of a better outcome of subjects with BS, no difference 
was found between the two incomplete SCI groups. This is of interest with respect 
to the different potential mechanisms leading to a recovery of functions in these 
two SCI subgroups.  
 
Keywords. Quadriplegia, Central cord syndrome, Brown-Sequard syndrome, Recov-
ery of function, Walking, Electrophysiology. 
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INTRODUCTION 
The consequence of trauma to the spinal cord is a partial or complete loss of motor, 
sensory and autonomic functions below the level of lesion. According to European 
and American databases the proportion of traumatic patients experiencing an in-
complete spinal cord injury (SCI) amounts to 52.8% and 44.3% respectively [1]. 
Within the spectrum of incomplete damage to the neural structures within the 
spinal canal five distinct syndromes can be separated: the Central Cord- (CC), the 
Brown-Sequard- (BS), the Anterior Cord-, the Conus Medullaris- and the Cauda 
Equina syndromes [2, 3].  
 A comprehensive overview of the clinical characteristics of these syndromes is 
provided elsewhere [4]. Most common is the CC, occurring in approximately 9% of 
all traumatic SCIs [4]. It is characterized by a pronounced loss of motor function in 
the upper extremities due to a lesion of the central region of the cervical spinal cord 
[5]. Typically, the CC results from a hyperextension of the cervical spine during a fall, 
mainly in older patients with a pre-existing cervical spondylosis [6]. The prognosis 
for a functional recovery of the CC has been suggested to be rather favorable, de-
pending on the age of the subject [5-12]. 
 The BS is caused by an injury restricted to one side of the spinal cord resulting in 
an ipsilateral paresis and loss of deep sensation and a contralateral loss of pain and 
temperature sensation [13]. The BS accounts for only about 3% of all traumatic SCI 
[4]. A pure form of BS occurs rarely. Therefore, clinically the criteria for classifying a 
BS were broadened. The “Brown-Sequard-plus” syndrome encompasses SCI sub-
jects suffering from an asymmetric paresis combined with relatively pronounced 
analgesia on the less paretic side [14, 15]. Patients with a BS are suggested to have a 
favorable prognosis for functional recovery [4, 15, 16]. According to textbooks [17], 
the BS is thought to have a better outcome than the CC. Such a difference in out-
come is of interest with respect to the possibility of different mechanisms underly-
ing spontaneous functional recovery after an incomplete SCI in humans. Further-
more, unilateral lesions of the spinal cord, i.e. injuries that correspond to the BS, are 
frequently used in animal research as models to investigate new interventions for 
spinal cord repair [18].  
 The aim of the present study was to determine whether different types of in-
complete SCI differ in outcome. Specifically it was of interest to evaluate and com-
pare the course of neurological, functional and electrophysiological measures in BS 
and CC subjects.  
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MATERIALS AND METHODS 
This retrospective review encompassed data from an European network of nine SCI 
rehabilitation centers (EMSCI) [19]. Local Ethics Committee of all centers approved 
the data collection and all subjects gave written, informed consent. 
Subjects and general procedures 
All patients experienced a traumatic or ischemic SCI and were referred to one of the 
participating centers. They were examined according to the EMSCI protocol [19]. 
Patients with a traumatic brain lesion, peripheral nerve damage or polyneuropathy 
were excluded. 
 For this study, the EMSCI database was screened for tetraparetic patients with 
either a pronounced loss of motor function of the upper extremities (CC) or re-
stricted to one side (BS). The criterion for differential paresis in this study was an 
arbitrarily defined difference in ASIA motor score of 19 or more points between the 
upper and lower extremities (CC) or the right and left side of the body (BS), respec-
tively (see ‘Clinical, functional and electrophysiological examinations’). Previous 
studies applied different cut-off values which in general were lower [3, 8, 11]. The 
relatively greater difference in ASIA motor score allowed us to include patients with 
clear representations of the respective syndromes. In order to ensure comparable 
groups regarding neurological level of lesion and age, we formed two matched 
groups from all patients who fulfilled the above-mentioned criteria. 
Data assessments 
Examinations were performed at one and six months after SCI by specialized and 
trained physicians (neurological examination and neurophysiological recordings) 
and therapists (walking and daily life functional tests). The results of these examina-
tions were sent anonymously to a central database. 
Clinical, functional and electrophysiological measures 
Motor score (MS) was assessed according to the international standard classifica-
tion of the American Spinal Injury Association (ASIA) [2]. Total MS and MS of more 
and less impaired extremities of the body were used for comparison of the two 
groups. While the total MS and its recovery is expected to be similar in both groups 
of patients one would assume a substantial difference in the distribution of the 
voluntary muscle strength as measured with the MS. Therefore MS sum was calcu-
lated for upper (more impaired) and lower limbs (less impaired) for CC subjects and 
for the weak (more impaired) and the strong (less impaired) sides for patients pre-
senting with BS, respectively. 
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Walking function was assessed using the Walking Index for Spinal Cord Injury II 
(WISCI II) [20] and the ten Meter Walk Test (TMW) [21]. 
 The degree of disability during daily tasks performance (i.e. self-care, respira-
tion and sphincter management as well as mobility) was examined using the Spinal 
Cord Independence Measure (SCIM II) [22].  
 Neurophysiological recordings were obtained from ascending (somatosensory 
evoked potentials-SSEP) pathways. For the present study, signal amplitudes were 
used for analysis [19]. As shown recently 1SSEP amplitudes reflect to some extent 
recovery of function in incomplete SCI, while spinal conductivity does little change 
during the course of a SCI. Analogous to the analysis of the motor scores, the ampli-
tudes of the more and less affected extremities were separately explored. 
Data analysis 
The level for statistical significance for all analyses was set at p=0.05.  
Chi-Square and T-tests were used to control for equality of groups regarding sex, 
age and neurological level. 
 Differences between one and six months after SCI were calculated to evaluate 
changes in the outcome measures. These changes were compared within and be-
tween the two groups. 
 Given the limited number of participants, non-parametric methods were ap-
plied, i.e. for the within-group comparisons Wilcoxon’s Signed Rank test, and for the 
between-group comparisons the Mann-Whitney U test. 
 Not all data were available for all patients at both time points. For every com-
parison, we therefore checked if matching was violated by the drop-outs the above 
mentioned methods (i.e. Chi-Square for sex and neurological level and T-tests for 
age). 
 Microsoft Excel 2002 (Microsoft, Redmont, WA) and SPSS for Windows 14.0 
(SPSS Inc, Chicago, IL) were used for the analysis. 
RESULTS 
Sample characteristics 
Two groups were formed, i.e. (i). 15 subjects with BS and (ii). 15 subjects with CC. In 
the BS group the mean motor score difference between the strong and weak side 
was 26.93±5.69 points. In addition, the sensory criterion relating to pain (contralat-
eral reduction of ASIA pin prick sensation) was present in 9/15 individuals and touch 
sensation (ipsilateral ASIA light touch) was reduced in 2/15 patients. In CC subjects 
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the difference in motor score between lower and upper extremities was 23.14±3.84 
points. 
 The groups were similar regarding age, neurological level of the lesion and sex 
(Table 4.1). This was true also for all comparisons that did not include the whole 
sample. The etiology of the SCI was traumatic, except for two cases in the BS group 
where ischemia was the reason for the paralysis.  
 
 
Table 4.1  Characteristics of subjects included in the study 
 Central Cord Brown-Sequard 
n 15 15 
Sex m/f 8/7 10/5 
Age mean (SD/range) 49.2 (18.55/19-82) 48.4 (18.29/20-78) 
Neurological Level C2 
   C3 
   C4 
   C5 
   C6 
 1 
 1 
 8 
 3 
 2 
 2 
 2 
 6 
 5 
 0 
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ASIA motor score 
The total MS improved significantly from the first to the sixth month after SCI for 
both BS and CC groups. Between groups, there was neither a difference in total MS 
at the first or sixth month. 
 In the BS group, the MS of arms and legs improved on both the more and less 
impaired sides, but to a greater degree on the more affected side. The same obser-
vation was made in the CC group. The MS of the arms (more impaired) and legs (less 
impaired) improved significantly but the recovery was more pronounced in the 
arms. No difference between BS and CC was found for the sum scores from the 
more and the less affected limbs (Table 4.2(a) and Fig 4.1). In order to recognize the 
influence of a possible ceiling effect on the course of recovery, MS values of the 
early examination (i.e. one month after SCI) were evaluated. Only 2/15 patients 
scored 25 points on the upper extremity motor score (UEMS) and 6/15 on the lower 
extremity motor score (LEMS) on the less impaired side of the BS group. In the CC 
group only 2/15 patients achieved maximum scores in LEMS in the early examina-
tion. 
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Figure 4.1 Mean values of the ASIA motor scores examined one and six months after SCI 
for patients with a Central Cord and Brown-Sequard syndrome (*P≤0.05, **P≤0.01; 
***P≤0.001). Dashed lines represent the maximum values of the motor scores. 
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Walking function 
Both groups of subjects showed significant improvement in walking function (Table 
4.2(b) and Fig 4.2). There was no statistical difference between the groups regarding 
the initial and final values in the TMW and WISCI II tests. 
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Figure 4.2 Changes in walking tests achieved between one and six months after SCI for
patients with Central Cord and Brown-Sequard syndrome (Walking speed assessed using 
the 10-Meter Walk test, WISCI: Walking Index for Spinal Cord Injury; ** p<0.01). 
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Table 4.2 Mean standard deviation (a) ASIA motor score; (b) walking function; (c) SCIM; and  
(d) amplitudes of SSEPs examined at 1 (1M) and 6 (6M) months after SCI 
 Central Cord Brown-Séquard  
(a) Motor scores    
Total score 
 1M 
 6M 
 
59.43 ± 17.61 (14) 
81.69 ± 13.14 (13) 
 
53.09 ± 14.73 (15) 
71.69 ± 14.48 (13) 
 
p= 0.295 
p= 0.072 
 
More impaired extremities a 
 1M 
 6M 
 
18.14 ± 9.72 (14) 
35.23 ± 10.46 (13) 
 
13.07± 7.92 (15) 
27.15 ± 11.58 (13) 
 
p= 0.155 
p= 0.095 
 
Less impaired extremities a 
 1M 
 6M 
 
40.80 ± 8.16 (15) 
46.46 ± 4.12 (13) 
 
40.00 ± 7.87 (15) 
44.54 ± 5.43 (13) 
 
p= 0.677 
p= 0.309 
 
Change between 1st and 6th month  
 More affected extremities a 18.67 ± 8.88 (12) 15.15 ± 10.22 (13) p= 0.320 
 Less affected extremities a  6.85 ± 5.03 (13)  5 ± 5.35 (13) p= 0.336 
 p= 0.002 p= 0.006  
 
(b) Walking tests    
 Walking speed (ms-1) 
 1M 
 6M 
 Change 
 
0.3 ± 0.46 (15) 
1.31 ± 0.83 (12) 
1.12 ± 0.66 (12) 
 
0.11 ± 0.37 (15) 
1.09 ± 0.91 (9) 
0.91 ± 0.9 (9) 
 
p= 0.104 
p= 0.454 
p= 0.355 
 
 WISCI II b 
 1M 
 6M 
 Change 
 
 0 (15) 
20 (13) 
16 (13) 
 
 0 (15) 
13 (13) 
 9 (13) 
 
p= 0.192 
p= 0.078 
p= 0.161 
Continued on next page 
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Table 4.2 cont. 
 Central Cord Brown-Séquard  
(c) Spinal Cord Independence Measure   
Total score 
 1M 
 6M 
 Change 
 
29.15 ± 24.31 (13) 
74.69 ± 31.51 (13) 
45.54 ± 47.25 (13) 
 
30.07 ± 22.82 (15) 
68.15 ± 26.65 (13) 
38 ± 24.89 (13) 
 
p= 0.747 
p= 0.303 
p= 0.137 
 
 Self-care 
 1M 
 6M 
 Change 
 
 3.23 ± 5.22 (13) 
13.5 ± 6.83 (12) 
11.58 ± 5.65 (12) 
 
 4.8 ± 5.39 (15) 
13.85 ± 5.6 (13) 
 8.77 ± 5.66 (13) 
 
p= 0.228 
p= 0.890 
p= 0.209 
 
 Respiration and sphincter management   
 1M 
 6M 
18.77 ± 10.68 (13) 
32.77 ± 11.92 (13) 
p= 0.023 
18.87 ±  9.77 (15) 
31.38 ± 10.41 (13) 
p= 0.005 
p= 0.625 
p= 0.630 
 Change 14 ± 18.66 (13) 13.15 ± 10.73 (13) p= 0.328 
 
 Mobility 
 1M 
 6M 
 Change 
 
 7.15 ± 11.21 (13) 
29.46 ± 15.13 (13) 
22.31 ± 21.79 (13) 
 
 6.4 ± 9.93 (15) 
22.92 ± 13.14 (13) 
16.1 ± 13.14 (13) 
 
p= 0.608 
p= 0.239 
p= 0.123 
 
(d) Somatosensory evoked potentials  
Change between first and sixth month 
  
 More affected extremities a 1 ± 2.54 (8)  0.94 ± 0.84 (9) p= 0.386 
 Less affected extremities a 0.65 ± 1.14 (8) ̶  0.39 ± 2.18 (9) p= 0.177 
 p= 0.779 p= 0.051  
Abbreviations: ASIA, American Spinal Injury Association; SCIM, Spinal Cord Independence Measure; SSEP, 
somatosensory evoked potential; WISCI, Walking Index for Spinal Cord Injury. 
The number of included subjects is indicated in parentheses. 
a The more affected limbs are both arms in CC and the arm and leg of the paretic side in BS. The same 
applies for the less affected sides.  
b median values are reported; significant differences are given in bold. 
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Spinal Cord Independence Measure 
There was a significant improvement in the total scores of the SCIM and its sub 
scores in both groups. No difference between BS and CC was found in the values 
obtained at one and six months after SCI, or in the mean changes (Table 4.2(c) and 
Fig 4.3). 
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Figure 4.3 Changes in the Spinal Cord Independence Measure for the total score, and 
two sub-scores, between one and six months after SCI for patients with Central Cord and 
Brown-Sequard syndrome (*p≤0.05, **p≤0.01, ***p≤0.001). 
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Somatosensory evoked potentials 
No significant change was observed in SSEP amplitudes of N. ulnaris and N. tibialis. 
In the BS group there was a positive trend in improvement (p=0.051) of the 
summed amplitudes of N. ulnaris and N. tibialis on the more affected side. However, 
there was no group difference in initial and final values (Table 4.2(d) and Fig 4.4A). 
The clinical examination provides a rather rough measure of the sensory deficit. 
Therefore no correlation with SSEP can be expected. 
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Figure 4.4 SSEP amplitudes at one and six months after SCI for the group of subjects with
Central Cord and Brown-Sequard syndrome. 
Rehabilitation length of stay 
Subjects with CC stayed shorter in rehabilitation than BS subjects (113.5±81.8 days 
vs. 131.9±52.2 days). However this difference was not statistically significant. 
DISCUSSION 
The aim of this study was to explore the extent to which the neurological, functional 
and electrophysiological recovery differs between BS and CC subjects which might 
be due to a different anatomical damage of spinal tracts associated with these two 
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types of an incomplete SCI. Studies with reasonable number of participants compar-
ing specifically the outcome of BS and CC are rare. In humans, the incidence of the 
BS is lower compared to the CC, but lateral hemisections of the spinal cord are fre-
quently used in animal research to model SCI. However, no clear-cut criteria are 
defined for BS and CC. Therefore, we followed the algorithm proposed elsewhere 
[4]. Compared to the MS, the evaluation of sensory scores is generally less reliable 
[23]. Nevertheless the differential sensation criterion of the BS group was fulfilled in 
most subjects.  
 A bimodal age-distribution of patients with CC suggested that this group might 
consist of two different populations regarding etiology and outcome [7, 9, 11, 12, 
14]. At the time of the analysis, the EMSCI network included approximately 1000 SCI 
patients. From this population, only 30 patients who were matched regarding age 
and neurological level of lesion fulfilled our inclusion criteria. The age of our sample 
was slightly older than the age at injury of the general SCI population [24]. 
 In two BS patients the reason for the SCI was an ischemia. We did not consider 
this fact further since the results of a previous study suggest that the outcome is 
similar in ischemic and traumatic SCI [25].  
 It was assumed that BS has a better outcome than the CC [17]. Such a differ-
ence might also be expected on the basis of animal experiments [26, 27]. Mecha-
nisms underlying functional recovery after unilateral SCI (BS) in animals, e.g. com-
pensatory sprouting of spared fibre tracts above and below the lesion site might 
also play a role in the human situation [26]. Interestingly, BS and CC subjects recov-
ered to about the same extent suggesting equally efficient mechanisms of func-
tional recovery in these two anatomically dissimilar types of SCI. However, one has 
to be aware that the human Brown-Sequard Syndrome can only insufficiently reflect 
the hemisection animal model. However, the small patient group studied here can 
hardly allow drawing serious conclusions about the mechanisms underlying the 
recovery of function after a SCI. 
Course of motor deficit 
In line with the literature, recovery of motor deficits was seen in both syndromes [5, 
10, 11, 13, 17-19]. Notably, the change in MS was significant on both the more and 
the less impaired limbs. Nevertheless, the rate of recovery was greater on the more 
than less affected limbs, which might be due to 2 facts: 1. A greater gradient on the 
more affected side might lead to stronger effects on neuronal plasticity to become 
maximally exploited; 2. On the less affected side a ceiling effect might lead to a less 
powerful recovery, i.e. the less impaired limbs may have already early achieved 
scores near the maximum. However, even when the subjects were excluded who 
achieved maximum scores already in the early examination the result did not 
change.  
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Recovery of walking function 
In line with the literature [12], the favorable recovery of walking function in CC 
subjects corresponds to the fact that arms are more impaired than legs in this syn-
drome by definition. Most incomplete SCI subjects regain ambulatory function [8, 
10, 13]. However, in our sample, approximately two thirds of CC and only one third 
of BS patients became unrestricted walkers within the first 6 months after a SCI. 
Overall the difference in outcome of walking function was not significant. The ob-
servation that walking function in BS subjects changes to a similar extent was also 
noted elsewhere [8, 5]. While in the study of McKinley the subscore “mobility” of 
the Functional Independence Measure (FIM) was similar at admission, patients with 
BS achieved even higher discharge values as compared to CC [4]. In our study, pa-
tients with BS had lower admission and discharge values in the WISCI II test but 
showed similar changes as patients with CC.  
Course of somatosensory recordings 
Since the number of measurements was limited, the results of the neurophysiologi-
cal recordings have to be considered carefully. The observation that somatosensory 
evoked potentials (SSEP) showed little change, i.e. behaved differently from the 
recovery in function after a SCI is in line with an earlier study on incomplete and 
complete SCI subjects 1. The SSEP recordings reflect the sensory deficits after a SCI, 
while the clinical examination provides only a rough measure (3 items). Therefore 
no close relationship between these measures can be expected. 
Study limitations 
In the animal model, the pure form of the BS syndrome can be investigated due to a 
controlled experimental lesion of the spinal cord (the lateral hemisection). The ac-
curacy of these lesions can be verified by histological examinations. In contrast, the 
occurrence of a pure BS in humans is rare. For practical reasons, the categorization 
to either the CC or BS group was based on MS. This might have led to some misclas-
sifications since the BS is further characterized by a contralateral loss of pain and 
temperature sensation below the level of lesion [15], which was not present in all 
BS subjects included. In addition, the classification of patients as CC based on upper 
to lower limb MS differences without imaged verification of pathology, is at risk of 
including patients with bilateral cortico-spinal (i.e. dorsifunicular) involvement ra-
ther than central neuropathology alone. This limits the interpretation about which 
tracts recover function. 
 Additionally, the samples of CC and BS subjects were of limited size which 
raised the chance that we accepted the Null-Hypotheses although there were real 
differences in the change of the measures evaluated. 
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CONCLUSIONS 
This study shows that there is no difference in the functional recovery between BS 
and CC subjects over the first six months after a SCI, although spinal tracts were 
differentially affected.  
 The spinal cord seems to have the capacity to compensate for a damage that 
does not depend on the integrity of a specific tract [28]. Finally, such a study on a 
sub-population of SCI subjects requires the formation of clinical networks which 
apply standardized examinations at distinct time-points are a prerequisite to enable 
the study of such a subpopulation of spinal cord injured subjects. 
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ABSTRACT 
Objectives. After a spinal cord injury (SCI), walking function is an important outcome 
measure for rehabilitation and new treatment interventions. The current status of 
four walking capacity tests that are applied to SCI subjects is presented: the revised 
Walking Index for Spinal Cord Injury (WISCI II), the 6 minute walk test (6MinWT), 10 
meter walk test (10MWT) and the timed up and go (TUG) test. Then, we investi-
gated (1) which categories of the WISCI II apply to SCI subjects who participated in 
the European Multicenter Study of Human Spinal Cord Injury (EM-SCI), and (2) the 
relationship between the 10MWT and the TUG. Methods. In the EM-SCI, the walking 
tests were applied 2 weeks and 1, 3, 6 and 12 months after SCI. We identified the 
WISCI II categories that applied to the EM-SCI subjects at each time point and quan-
tified the relationship between the 10MWT and the TUG using Spearman’s correla-
tion coefficients (ρ) and linear regression. Results. Five WISCI II categories applied to 
71% of the EM-SCI subjects with walking ability, while 11 items applied to 11% of 
the subjects. The 10MWT correlated excellently with the TUG at each time point 
(ρ>0.80). However, this relationship changed over time. At one year after SCI, the 
time needed to accomplish the TUG was 1.25 times greater than the 10MWT time. 
Discussion. Some categories of the WISCI II appear to be redundant, while some 
discriminate to an insufficient degree. In addition, there appear to be ceiling effects, 
which limit its usefulness. The relationship between the 10MWT and TUG is high, 
but changes over time. We suggest that, at present, the 10MWT appears to be the 
best tool to assess walking capacity in SCI subjects. Additional valuable information 
is provided by assessing the needs for walking aids or personal assistance. To ensure 
comparability of study results, proposals for standardized instructions are pre-
sented. 
 
Keywords. Standardization; Instructions; Guidelines; Timed walking test; WISCI II; 
SCI; Gait; Neurorehabilitation. 
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INTRODUCTION 
The need for sensitive assessment tools in the field of neurological rehabilitation is 
obvious [1]. Current assessment tools have been designed largely to document 
functional outcome changes great enough to monitor clinically relevant improve-
ments. These large changes are what have been considered as being most relevant 
for the patients and health insurance companies, and their assessment influences 
both (post) clinical and rehabilitation decision making (e.g. can a patient already be 
discharged from rehabilitation? Is this patient independent enough to return to his 
or her home environment?). However, today, we are full of expectations that in the 
near future new interventions will restore or repair damaged neural structures. 
Therefore, assessment tools should be able to detect smaller changes in function. 
On the one hand, more sensitive tools should be capable of detecting small im-
provements, thus demonstrating possible positive treatment effects. Although 
small, clinically-irrelevant treatment effects might be considered meaningless for 
the patient, they could demonstrate the ‘proof of principle’ of a new intervention. 
On the other hand, harmful interventions could be stopped as early as possible by 
the use of more sensitive measures, before the patient’s condition becomes seri-
ously affected. Thus, all of these considerations should be taken into account when 
evaluating assessment tools on their usefulness for clinical studies at present (see 
also [2]). 
European Multicenter Study of Human Spinal Cord Injury 
The European Multicenter Study of Human Spinal Cord Injury (EM-SCI; see also 
www.emsci.org) was founded in 2003 [3]. Five (at present 19) spinal cord injury 
rehabilitation centers across Europe standardized the assessment of their acutely 
injured patients. The aims of this initiative were (1) to document the time course 
and extent of natural recovery after a spinal cord injury (SCI) achieved with current 
rehabilitative approaches, (2) to introduce and to validate assessment procedures, 
(3) to improve diagnosis and prediction of outcomes after SCI and (4) to prepare the 
clinical basis for new interventional studies. The multicenter approach of this pro-
ject ensured the capture of a sufficient number of cases with a broad spectrum of 
neurological and functional deficits. Assessments were chosen to cover several 
domains of a spinal cord injury i.e. impairment and disability. Time points of as-
sessments were set according to the natural recovery and practical aspects. SCI 
subjects were assessed within 2 weeks after SCI and after 1 month (time window: 
16 – 40 days), 3 months (70 – 98 days), 6 months (150 – 186 days) and 12 months 
(300 – 400 days).  
 The neurological examinations encompassed the standardized assessment es-
tablished by the American Spinal Injury Association (ASIA) [4]. In addition, neuro-
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physiological recordings were performed on the long sensory and motor tracts (so-
mato-sensory evoked potentials and motor evoked potentials, respectively) and on 
the segmental level (electromyography and nerve conduction velocity). To assess 
the level of independence in SCI subjects, the revised Spinal Cord Independence 
Measure (SCIM II) [5] was applied, while walking capacity was assessed using the 
revised version of the Walking Index for Spinal Cord Injury (WISCI II; Fig. 5.1) [6], the 
6 minute walk test (6MinWT) [7], the 10 meter walk test (10MWT) [7] and the timed 
up and go test (TUG) [7].  
 There were several reasons for performing these particular walking capacity 
tests. The WISCI was already tested for validity and reliability for SCI subjects [8] and 
was replaced in 2001 by the WISCI II (Fig. 5.1) [6]. Indeed, valuable information can 
be obtained by scoring the walking aids and / or physical assistance needed by the 
patient. The three timed tests were chosen as each of them was expected to reflect 
different aspects of walking capacity. The 6MinWT was chosen because of its rela-
tionship with cardio-vascular endurance [9], while the 10MWT was chosen as a 
measure to determine short duration speed that could be relevant for in-home 
activities. The TUG should relate with balance [10]. All tests were performed at 
preferred speed, as this might reflect the level of performance of the SCI subject in 
the community.  
 
Figure 5.1  Revised version of the Walking Index for Spinal Cord Injury (WISCI II). Reprinted by permis-
sion from Macmillan Publishers Ltd 6. 
Level Description 
 0 Client is unable to stand and/or participate in assisted walking. 
 1 Ambulates in parallel bars, with braces and physical assistance of two persons, less than 10 meters. 
 2 Ambulates in parallel bars, with braces and physical assistance of two persons, 10 meters. 
 3 Ambulates in parallel bars, with braces and physical assistance of one person, 10 meters. 
 4 Ambulates in parallel bars, no braces and physical assistance of one person, 10 meters. 
 5 Ambulates in parallel bars, with braces and no physical assistance, 10 meters. 
 6 Ambulates with walker, with braces and physical assistance of one person, 10 meters. 
 7 Ambulates with two crutches, with braces and physical assistance of one person, 10 meters. 
 8 Ambulates with walker, no braces and physical assistance of one person, 10 meters. 
 9 Ambulates with walker, with braces and no physical assistance, 10 meters. 
10 Ambulates with one cane/crutch, with braces and physical assistance of one person, 10 meters. 
11 Ambulates with two crutches, no braces and physical assistance of one person, 10 meters. 
12 Ambulates with two crutches, with braces and no physical assistance, 10 meters. 
13 Ambulates with walker, no braces and no physical assistance, 10 meters. 
14 Ambulates with one cane/crutch, no braces and physical assistance of one person, 10 meters. 
15 Ambulates with one cane/crutch, with braces and no physical assistance, 10 meters. 
16 Ambulates with two crutches, no braces and no physical assistance, 10 meters. 
17 Ambulates with no devices, no braces and physical assistance of one person, 10 meters. 
18 Ambulates with no devices, with braces and no physical assistance, 10 meters. 
19 Ambulates with one cane/crutch, no braces and no physical assistance, 10 meters. 
20 Ambulates with no devices, no braces and no physical assistance, 10 meters. 
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Validity, reliability and responsiveness of the WISCI II 
The Walking Index for Spinal Cord Injury (WISCI) was carefully and specifically de-
signed by Ditunno and colleagues for SCI subjects [8] (for a review see ASIA/ISCOS 
[11]). Clinical experts described 19 items based on literature review and consulta-
tion with colleagues. These items were hierarchically rank ordered by several inter-
national experts from most-impaired to least. This was followed by several stages 
investigating concurrent and face validity, which resulted finally in a group consen-
sus. This version was then subject to an international reliability study, in which vid-
eotapes of a representative group of patients was shown to several experts. Indeed, 
an excellent reliability was found. In the revised scale (WISCI II; Fig. 5.1) two catego-
ries were added and this scale has been used in several international studies [6]. 
The WISCI II correlated well with several other scales indicating concurrent validity: 
the Barthel Index (BI) and the Rivermead Mobility Index (RMI; for both: Spearman’s 
correlation coefficient ρ=0.67), the Spinal Cord Independence Measure (SCIM; 
ρ=0.97) and the Functional Independence Measure (FIM; ρ=0.70) [12]. It should be 
noted, however, that the SCIM, FIM and WISCI II were retrospectively scored, based 
on the description of walking in the SCI subjects charts. Furthermore, the WISCI II 
correlated with the Lower Extremity Motor Score (LEMS; ρ=0.58). It also showed 
good correlations with the 6MinWT (Spearman’s correlation coefficient ρ=0.60), the 
10MWT (ρ=‒0.68), and the TUG (ρ= ‒0.76) [7]. 
 Sensitivity to detect changes over time (responsiveness) was also investigated 
[12]. It was concluded that the WISCI II was more sensitive to walking recovery, as 
the WISCI II score distribution was wider at discharge (12/21 items) compared to 
other scores (BI, 3/16 items; RMI, 2/3 items; SCIM, 5/9 items and FIM, 4/7 items). 
However, in another study, the responsiveness of the WISCI II was lower compared 
to the 6 MinWT and 10MWT in a select group of SCI subjects with good walking 
ability (WISCI II score >1 within the first month after SCI) [13]. While the timed tests 
could determine improvement in walking capacity between 1 and 3 months and 3 
and 6 months after SCI, the WISCI II showed improvement only within the first 3 
months. Similar results were observed in SCI subjects with poorer walking ability, 
who achieved a WISCI II score above one within 3 months after SCI [14]. In that 
study, the WISCI II showed significant improvement also between 3 and 6 months 
after SCI, although the median improvement was zero. 
Critical reflection of the WISCI II 
The authors of the WISCI wrote that ‘the ranking of severity is based on the severity 
of the impairment and not on functional independence in the environment [6]. 
However, as the WISCI is applied to test an activity (walking), it can be questioned 
whether ranking based on impairment can be justified. For example, motor impair-
ment recovers differently compared to walking ability [15]. The actual WISCI II rank-
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ing results in a somewhat confusing order of the items and a strong non-linearity. 
From a physical therapist’s point of view, independent walking should be scored 
better compared to walking that depends on the assistance of another person [7]. 
Such aspects are not considered in the WISCI II, as for example, category 16 (ambu-
lates with two crutches, no braces and no physical assistance, 10 meters; see Fig. 
5.1) is scored poorer than to 17 (ambulates with no devices, no braces and physical 
assistance of one person, 10 meters). Furthermore, non-linearity can be observed if 
a SCI subject always needs braces. This patient could improve theoretically from 1 
to 2, 3, 5, 6, 7, 9, 10, 12, 15, to a maximum score of 18. Such jumps in score are 
difficult to interpret. 
 Reliability of the WISCI has been reported to be excellent [8]. However, the 
authors have investigated reliability by scoring photos or videos. This has the disad-
vantage that the initial process of determining what walking aids or physical assis-
tance are needed by this patient is not included in the reliability testing. It can be 
considered relatively easy to observe and score what devices and/or assistance a 
chronic SCI patient uses to walk. However, at the acute stage, the decision as to 
what aids or assistance the SCI patient needs is determined by the therapist to-
gether with the patient. This decision making process has not been tested for reli-
ability and might cause most variability in determining the appropriate WISCI II 
category. 
 The responsiveness of the WISCI II, i.e. its ability to detect changes over time, 
appears to be poor compared to the timed walking tests. On the one hand, this 
could be explained by the ceiling effect of the WISCI II: SCI subjects that need no 
aids or assistance (WISCI II score 20) cannot further improve, although for example 
walking speed might increase [12, 13]. On the other hand, the categories of the 
WISCI II can cover a broad range of dependency. Physical assistance is described as 
‘any physical contact with the subject, including contact guard’, which could cover a 
broad spectrum of physical support. Similarly, a wide variety in braces is available 
with different levels of support. Therefore, some patients might still need braces, 
but smaller ones, or need physical assistance, but considerably less and walk at a 
higher speed. All this is not reflected in changes in WISCI II category. 
 An assessment tool such as the WISCI II is subjected to cultural differences. 
Some differences between Europe and the USA are reflected in the preferences for 
walking aids. For example, while axilla crutches are predominantly used in the USA, 
in Europe, forearm or Canadian crutches are more common. Forearm crutches are 
considered as 'partial bearing' devices, because they do not support the full weight 
and are primarily used to give body stability (as opposed to leverage, like axilla 
crutches provide). Furthermore, initially, the WISCI II considered a walker to be 
rigid, without the use of wheels [6]. However, walkers with wheels are regularly 
used in European centers. Now, the WISCI II also considers walkers with wheels, 
although this should be identified in the descriptors. Similarly, other devices used 
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for bracing such as ace wraps or splints should be coded as brace and described 
under ‘other’. In German speaking countries, orthopedic shoes (Künzli - SwissSchuh 
AG, Windisch, Switzerland) are widely used to reduce drop foot and increase lateral 
stability. We suggest that these shoes should also be considered as ‘braces’. How-
ever, should alpine boots that increase the passive stability around the ankle-foot 
joint be considered braces as well? 
 Furthermore, the WISCI II is subjected to new inventions in the field of walking 
devices. Therefore, the guidelines should be adapted from time to time (as stated 
by the authors). For example, we were recently confronted with a relatively new 
device that provides a seat and trunk support for the patient (Meywalk® 2000, Mey-
land-Smith, Taars, Denmark, Fig. 5.2). Should this be considered a wheelchair that 
allows forward movements by the legs (in this case, WISCI II category 0 might ap-
ply)? Or is this a walker with wheels and additional bodyweight support that com-
pensates for the loss of upper extremity supportive function in tetraplegic patients 
(WISCI II category 13), as these patients need more leg muscle strength for walking 
compared to paraplegic patients [15]? 
 
 
 
 
Figure 5.2  Meywalk® 2000 walking aid: WISCI II category 0 or 13?  
Reprinted by kind permission from Meyland-Smith, Taars, Denmark. 
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General validity, reliability and responsiveness of the 6MinWT 
We assume that no test has been more thoroughly investigated than the 6MinWT. 
The 6MinWT was originally applied to patients with respiratory diseases and chronic 
heart failure [9, 16]. In the cardio-respiratory domain, the 6MinWT is the test of 
choice (for reviews see [17, 18]). Indeed, in patients with primary pulmonary hyper-
tension the distance walked during 6minutes correlated strongly with peak oxygen 
levels [19]. Also in patients with chronic obstructive airways and asthma, the 
6MinWT correlated significantly with lung volume measurements [20]. This might 
be the reason why the 6MinWT has been applied to many different subject groups, 
with the aim of assessing cardiovascular endurance.  
 The 6MinWT has been tested for reliability in different patients groups. The 
6MinWT is considered reliable when tested in healthy children [21] and elderly 
subjects [22], as well as in subjects with stroke [23, 24], acquired brain injury [25, 
26], cerebral palsy [27], fibromyalgia [28, 29], multiple sclerosis [30] and cardiopul-
monary disease [31, 32].  
 In patients with heart failure, the responsiveness of the 6MinWT is controver-
sially discussed. In the RESOLVD study, the quality of life measures showed better 
responsiveness than the 6MinWT [32], while the responsiveness was considered 
good in elderly patients with heart failure [33]. In patients with chronic obstructive 
pulmonary disease, the endurance shuttle walking test was found to be more re-
sponsive compared to the 6MinWT [34]. Elderly subjects who underwent a func-
tional training program showed less change in 6MinWT compared to a physical 
performance test [35]. However, the 6MinWT showed good responsiveness in pa-
tients with fibromyalgia [29]. Best initial estimates of small meaningful changes in 
elderly subjects were near 20m and of substantial change near 50m for 6MinWT 
[36]. For clinical use, small changes in the distance walked during 6minutes are 
detectable [36]. 
Validity, reliability and responsiveness of the 6MinWT in SCI patients 
The 6MinWT has been applied to SCI patients in several studies [7, 13, 37-42] (for 
review, see also [11]). Concerning construct validity, the strength of the hip flexors 
at the less affected side correlated well with the distance walked during 6minutes 
[39]. Bilaterally, hip flexor and abductor muscle strength correlated best with the 
6MinWT and gait speed [39]. A concurrent validity study showed that the 6MinWT 
correlated well with the WISCI II (ρ=0.60), the 10MWT (ρ=-0.95) and the TUG (ρ=-
0.88) [7]. 
 While interrater reliability can be considered good, intrarater reliability showed 
an improved 6MinWT performance between the first and second trial [7]. 
 The responsiveness of the 6MinWT can be considered good in SCI subjects. 
Chronic SCI subjects who underwent a locomotor training program using a driven 
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gait orthosis improved their distance walked during 6minutes and gait speed, while 
the WISCI II showed no change [41]. In addition, in a small group of SCI subjects, 
both the 6MinWT and the 10MWT improved between 1 and 3 months and 3 and 6 
months after SCI, while the WISCI II showed improvement only between 1 and 3 
months [13]. 
Critical reflection of the 6MinWT 
The standardization of the 6MinWT is more difficult compared to the 10MWT, as it 
depends strongly on the facilities. In some studies, the subjects performed the 
6MinWT by walking up and down a pathway of a specific length. This has the advan-
tage that it could also be applied in settings with limited space. However, walking 
speed might be negatively influenced by the turns. Indeed, in stroke patients who 
had to walk up and down, the 10MWT speed overestimated the 6MinWT speed 
[43], while when they walked in a square, the speeds were comparable [44]. There-
fore, this test should be performed with the least amount of turns possible. Fur-
thermore, as encouragement had a substantial impact on the distance walked dur-
ing 6minutes in both cardiac and the respiratory patients [9], the test instructions 
should be rigorously standardized. 
 Although the reliability of the 6MinWT has been reported to be high, several 
studies indicated that the 6MinWT performance improved significantly after the 
first trial in healthy subjects [45] as well as in patients with cerebral palsy [27], fi-
bromyalgia [29], SCI [7] and cardiopulmonary problems [9, 31]. It is therefore rec-
ommended that the subjects perform at least one test trial, before performing the 
actual measurement. 
 The 6MinWT appears to be redundant in some groups of patients with neuro-
logical disorders. Patients with stroke [44] and SCI [14, 39] showed no difference 
between short duration walking speed and speed during 6MinWT. This was even 
the case when tested at maximum walking speed [14]. It might indicate that in pa-
tients with neurological deficits, the distance walked during 6 minutes is not limited 
by cardiovascular impairments, but by other deficits, for example sensorimotor 
deficits. Indeed, in patients with stroke, there was no relationship between the 
6MinWT and cardiovascular endurance [46]. Even in patients with severe lung dis-
eases, the 6MinWT was rather related to muscle function than to cardiac or ventila-
tory impairment [47]. 
 A selection bias could occur, as not all patients who are able to walk (WISCI II 
>1) perform the 6MinWT. Physical therapists tend not to test subjects who have 
poor walking ability, although these patients are allowed to take a rest during the 
6MinWT. Especially at onset of the rehabilitation, this leads to a small number of 
patients who have performed the 6MinWT. Thus, especially in patients with poor 
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walking ability, a discrepancy might exist between short and long duration walking 
speed, which has not been assessed so far.  
General validity, reliability and responsiveness of the 10MWT 
The 10MWT represents a quick and easy measure and can be applied to any popula-
tion able to ambulate the required distance (see also [11]). Reference values for gait 
speed exist for different ages and gender, although these were not derived from 10 
meter testing [48]. The 10MWT was subject to concurrent or construct validation. It 
has been applied to both healthy subjects (e.g. elderly subjects [49]) and different 
patient groups with neurological disorders such as Parkinson’s disease [50, 51], 
stroke [52-54] and multiple sclerosis [55]. In patients with cerebral glioma, the 
10MWT correlated well with the Barthel Index [56]. In children with neuromuscular 
disease, the 10MWT correlated well with a 10minute walk, although the self-
selected speed was higher for the 10MWT [57]. It has also been applied in patients 
with orthopedic disorders, e.g. with lower limb amputation [58]. Patients with a 
transtibial amputation walked faster compared to those with a transfemoral ampu-
tation [59].  
 The 10MWT showed good reliability in patients with mixed neurological diagno-
ses (ICC=0.93) [60], stroke [52], multiple sclerosis [30] and Parkinson’s disease [50]. 
The 10MWT also showed good responsiveness in acute stroke patients [53, 61, 62], 
although the 5 meter walk test appeared to be more responsive compared to the 
10MWT [63]. 
Validity, reliability and responsiveness of the 10MWT in SCI patients 
Concerning construct validity, the strength of the hip flexors at the less affected side 
correlated well with gait speed [39]. Bilaterally, hip flexor and abductor muscle 
strength showed the highest correlations with gait speed [39]. Concerning concur-
rent validity, the 10MWT correlated well with the 6MinWT (ρ=-0.95), TUG (r=0.89) 
and WISCI II (ρ=-0.68) [7]. Compared to the TUG and 6MinWT, it showed better 
inter- and intrarater reliability in SCI, as the subjects’ gait speed did not change 
between the first and second trial [7]. The 10MWT was more responsive than the 
WISCI II in SCI subjects. It assessed changes during SCI rehabilitation between 
month 3 and 6 after SCI [13] and in chronic SCI, it detected improvement in gait 
performance due to automated treadmill training [41], both unrevealed by the 
WISCI II. 
A s s e s s m e n t  o f  w a l k i n g  c a p a c i t y  a f t e r  S C I  
 77 
Critical reflection of the 10MWT  
Walking speed is considered a surrogate for the overall quality of gait (and motor 
function) [44]. However, gait speed is difficult to interpret. What is a meaningful gait 
speed for daily life and which increment in speed can be considered relevant? Gait 
speed has not been correlated with disability scales in SCI. It is therefore difficult to 
determine its relevance for daily life. The speed needed to safely cross a street was 
found to be 0.6m/s [64]. This was used to separate SCI subjects into functional and 
non-functional walkers. In elderly subjects, among several variables, a walking 
speed above 1.0m/s was associated with an independent lifestyle [65]. Perera et al. 
[36] found in elderly subjects that the best estimates of small, meaningful changes 
in gait speed were near 0.05m/s, while  substantial changes were near 0.10m/s. 
Similarly to the 6MinWT, the 10MWT has a floor effect for those subjects who are 
unable to walk 10meters. In addition, a ceiling effect might occur for those subjects 
who can walk a longer distance at the same speed. The latter effect is expected to 
be less for the 6MinWT. 
 In stroke, it has been shown that the 10MWT speed overestimated the long 
distance walking speed [43]. This was also the case for children with neuromuscular 
disease [57]. However, in a recent study, these findings could not be confirmed for 
SCI subjects [14]. The 10MWT speed did not differ from the 6MinWT speed 1, 3 and 
6 months after SCI. This is in line with a recent study in stroke [44]. 
General validity, reliability and responsiveness of the TUG 
The Get up and Go test [66] was modified by introducing a timed component 
(Timed Up and Go, TUG) [10]. The test was validated in frail, elderly subjects and 
was shown to correlate moderately with gait speed, the Berg Balance Scale and the 
Barthel Index [10]. Concurrent validity was good in patients with chronic stroke [67]. 
In patients with multiple sclerosis, the TUG correlated well with other static and 
dynamic balance tests, although all tests showed poor discriminative ability be-
tween fallers and non-fallers [68]. The discriminative ability of the TUG to predict 
falls was good in subjects with stroke [69], but contradicting findings exist in com-
munity-dwelling elderly people (Lin et al. [70] versus Shumway-Cook et al. [71]). The 
TUG could discriminate between geriatric subject groups who used different walk-
ing aids [72]. In children, the TUG could differentiate well between children with 
cerebral palsy or spina bifida and healthy ones, as well as between children of dif-
ferent ages [73]. Good concurrent validity was found in patients with lower limb 
amputation [74]. 
 Reliability was excellent in young [73] and elderly [49, 70] healthy subjects, as 
well as in subjects with Parkinson’s disease [75], chronic stroke [67] and lower limb 
amputations [74]. Reliability was poorer in patients with total hip and knee arthro-
plasties [76] and in elderly subjects, cognitive impaired or unimpaired [77]. 
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The responsiveness of the TUG was good in young children in that it detected 
change over a period of five months [73]. It was also responsive in older subjects 
participating in geriatric rehabilitation [72]. It also detected deterioration and im-
provement in the early post-operative period after total hip and knee arthroplasty 
[76]. In patients with acute stroke, the responsiveness of the TUG was less com-
pared to, for example, the 5meter walk test [63]. 
Validity, reliability and responsiveness of the TUG in SCI patients 
Concurrent validity is good as a strong correlation was found between the TUG and 
the WISCI II (ρ=-0.76), the 6MinWT (ρ=-0.88) and the 10MWT (r=0.89) [7]. Reliability 
was high (r>0.97), but the Bland-Altman analysis showed that SCI subjects per-
formed the second trial better than the first one, when tested by the same rater [7]. 
To our knowledge, no information exists about the responsiveness of the TUG in SCI 
subjects. 
Critical reflection of the TUG  
In patients with Parkinson’s disease [50, 75] or SCI [7], test performance increased 
between the first and second trial, which influences reliability. It is therefore rec-
ommended that similarly to the 6MinWT, the subjects should perform a test trial at 
least once before performing the measurement. 
 The TUG correlated excellently with the 10MWT, which might indicate redun-
dancy [7].  
 A slight disadvantage of the TUG is that it cannot be converted into speed, as 
can be done with the 10MWT and 6MinWT. The speed of subjects unable to per-
form the 10MWT or 6MinWT can be set at 0m/s. This is not possible for the TUG 
and makes statistical analyses more difficult. 
 An advantage of the TUG is that a more complex task is tested rather than ‘just’ 
walking, which might better reflect daily life activities. However, as it combines 
several important tasks in one test, it scores the whole composite of standing up, 
walking, turning and sitting down, which might decrease the sensitivity of the in-
formation gained. It might be more accurate to test the different phases separately: 
the sit-to-stand-to-sit test could be performed to test standing up and sitting down 
(see for example Csuka and McCarty [78]; Newcomer et al. [79] and Bohannon [80]). 
As this test should be performed with crossed hands, it might be more related to 
upper leg strength than the TUG, in which the subject can use the arms when stand-
ing up and sitting down. Walking could be tested by the 10MWT. Turning might be 
tested by timing and counting the number of steps needed to turn 360°, which has 
successfully been applied to elderly people [81] and patients with Parkinson’s dis-
ease [82].  
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Aims of this study 
This overview shows that the assessment of walking capacity has been extensively 
investigated in a variety of patient populations, but much less assessed in SCI pa-
tients. The aims of this study were to investigate: (1) which WISCI II categories apply 
to the EM-SCI subjects and (2) the relationship between the TUG and the 10MWT, 
as results from a previous study [7] might suggest that these tests provide similar 
information. 
METHODS 
Retrospective analyses were performed of the EM-SCI database. At the time of 
analysis, the EM-SCI database contained data from 917 subjects. The numbers of 
missing observations were largest at two weeks after SCI (difficult to assess at this 
early time point in most European centers) and 12 months (unfinished follow-up). 
To investigate which WISCI II categories applied to the SCI subjects, the frequency of 
each category was presented as a percentage for each time point. The percentages 
of each WISCI II category were averaged for all time points.  
 The walking tests were applied by trained physical therapists. The SCI subjects 
performed the 10MWT with a “flying start”, i.e. they walked about 14 meters, while 
the intermediate 10 meters were measured to compensate for acceleration and 
deceleration effects. The TUG was performed according to a previous study [10]. 
However, the SCI subjects initiated the test themselves, instead of responding to a 
“go” signal. The relationship between the 10MWT and the TUG was investigated 
using linear regression and correlation analyses. Again, separate analyses were 
performed for each time point. 
RESULTS 
Several WISCI II categories (Fig.5.1) applied rarely to the EM-SCI subjects (Table 5.1). 
Each of the categories 2, 7, 10, 14 and 18 applied on average to less than 1% of the 
SCI subjects with some walking ability (WISCI II >0; final column Table 5.1). In addi-
tion, the categories 3, 6, 11, 15, 17 and 19 applied to less than 2% of the SCI sub-
jects with a WISCI II above 0. These 11 categories applied to 11% of walking EM-SCI 
subjects. In contrast, a large proportion (71%) of the SCI subjects with some walking 
ability could be categorized into the items 1, 8, 13, 16 and 20.  
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Table 5.1 Frequencies of WISCI II categories 
2 weeks 1 month 3 months 6 months 12 months Averagea 
WISCI II n % n % n % n % n % % 
 0 504  646  485  333  213   
 1   5 18.5  15 10.0  13  5.2   6  2.8   1  0.6  7.4 
 2   0.0   0.0   0.0   0.0   0.0  0.0 
 3   1  3.7   2  1.3   4  1.6   2  0.9   1  0.6  1.6 
 4   2  7.4  12  8.0  12  4.8   5  2.3   2  1.1  4.7 
 5   2  7.4   8  5.3  10  4.0  10  4.6   1  0.6  4.4 
 6   0.0   6  4.0   7  2.8   2  0.9   1  0.6  1.7 
 7   0.0   1  0.7   3  1.2   1  0.5   2  1.1  0.7 
 8   3 11.1  11  7.3  18  7.3  18  8.3   6  3.3  7.5 
 9   1  3.7   5  3.3   7  2.8  11  5.1   2  1.1  3.2 
10   0.0   0.0   2  0.8   0.0   0.0  0.2 
11   1  3.7   5  3.3   2  0.8   4  1.8   0.0  1.9 
12   0.0   3  2.0  22  8.9  15  6.9  14  7.8  5.1 
13   1  3.7  18 12.0  22  8.9  14  6.5  11  6.1  7.4 
14   0.0   0.0   2  0.8   2  0.9   1  0.6  0.5 
15   0.0   0.0   3  1.2   3  1.4   4  2.2  1.0 
16   0.0   9  6.0  26 10.5  26 12.0  21 11.7  8.0 
17   0.0   7  4.7   1  0.4   4  1.8   1  0.6  1.5 
18   0.0   0.0   0.0   0.0   3  1.7  0.3 
19   0.0   0.0   5  2.0   5  2.3   8  4.4  1.8 
20  11 40.7  48 32.0  89 35.9  89 41.0 101 56.1 41.2 
Total 531  796  733  550  393   
Missing 386  121  184  367  524   
Grand total 917  917  917  917  917   
a The average percentage was calculated over all 5 time points for those SCI subjects with a WISCI II score 
>0 (some ability to stand or walk).  
Abbreviations: n, number; %, the percentage of SCI subjects that have a WISCI II score >0. 
 
Relationship between TUG and 10MWT 
The relationships between the TUG and the 10MWT are shown in Figure 5.3. The 
non-parametric correlations (chosen to adjust for outliers) varied between 0.81 and 
0.96. At 2 weeks after SCI (Fig. 5.3a), according to the linear regression model, 96% 
of the variation in TUG could be explained by knowing the variation in the 10MWT 
results (this is the explained variance; Fig. 5.3f). However, as the number of obser-
vations was small, the non-parametric correlation might be more applicable. At 1 
month after SCI (Fig. 5.3b), the linear regression model showed the poorest ex-
plained variance. Over half of the variation in TUG could be explained by knowing 
the 10MWT results. The equation (Fig. 5.3b) showed that considerably more time 
was needed to perform the TUG compared to the 10MWT (11.6 seconds+0.68 times 
the time needed to perform the 10MWT). 
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Figure 5.3 Relationships between TUG and 10MWT. Scatter-plots showing the relationships between 
the Timed Up and Go (TUG) and 10 Meter Walk tests (10MWT) 2 weeks (a), 1 month (b), 3 months (c), 6 
months (d) and 12 months (e) after spinal cord injury. Please note the logarithmical scale and the differ-
ences in scales between the figures. More detailed information about the regression analysis is provided 
in f.  
Abbreviations: ρ, Spearman’s non-parametric correlation coefficient; *, P<0.05; ***, P<0.001; N, num-
ber of observations; R2adj., adjusted explained variance; lower and upper limits of the 95% confidence 
interval (95%CI) are presented for the constant b0 and the regression coefficient b1 of the regression 
equation y = b0 + b1 × x. 
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At 3 and 6 months after SCI (Fig. 5.3c, d), similar results were obtained. The ex-
plained variance was about 75% and the time needed to perform the TUG was still 
longer compared to the 10MWT. However, it decreased about 2seconds from 3 to 6 
months after SCI. Finally, at 12 months after SCI (Fig. 5.3e), the TUG was found to 
take 1.25 times longer than the 10MWT. 
DISCUSSION 
The main findings of this study were the following: (1) Many EM-SCI subjects were 
categorized in a limited number of WISCI II items, while half of the WISCI II catego-
ries applied to a small number of subjects. (2) In general, the TUG correlated excel-
lently with the 10MWT, but the relationship changed over time. 
 As the rehabilitation process continued the number of SCI subjects with a low 
WISCI II score tended to decrease, while higher WISCI II scores applied more fre-
quently to the EM-SCI subjects. The items 1, 8, 13, 16 and 20 applied frequently to 
SCI subjects with walking ability. These findings are in line with those from Morganti 
et al. [12], who found that most walking SCI subjects could be scored 13, 16 or 20 
after rehabilitation. 
 In contrast, about half of the WISCI II categories applied to 11% of the EM-SCI 
subjects. Redundancy of the WISCI II has already been previously addressed [12], as 
the WISCI II correlated excellently with the SCIM II mobility category for short dis-
tances. The high correlation of 0.97 [12] indicated that 94% of the variation of the 
WISCI II (which has 21 items) could be explained by the SCIM II (which has 9 items). 
The present results indicate that if a shorter version of the WISCI II would be de-
sired, the categories 1, 4, 5, 8, 9, 12, 13, 16 and 20 (see Fig. 5.1) could describe the 
appropriate need of physical assistance and/or walking aids in 80.9% of the EM-SCI 
subjects with some walking ability.  
Relationship between TUG and 10MWT 
Although the TUG and the 10MWT correlated excellently with each other, the rela-
tionship was not fixed, but changed over time. The time needed to perform the TUG 
(compared to the 10MWT) decreases over time. Especially at 1 month after SCI, the 
TUG might provide additional information, as only half of the variation in the 
10MWT could explain the variation of the TUG. This difference might be related to 
an impaired balance, which is suggested to be related to the TUG [10]. However, 
over time, the TUG might become redundant as at least 75% of the variation in the 
TUG is covered by the 10MWT results. In the chronic stage (1 year), the TUG can be 
estimated by multiplying the time needed for the 10MWT by 1.25. 
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Aspects of walking capacity 
In SCI subjects, the assessment of walking capacity is relatively new and information 
is lacking. For example, maximum walking speed has rarely been tested in SCI sub-
jects [14, 83]. The preferred walking speed of SCI subjects may only partially reflect 
the potential to participate in the community. Maximum walking speed, for exam-
ple, which may be needed to catch a bus or cross a street, might be a better meas-
ure of daily life ambulatory capacity. Furthermore, walking capacity is tested in a 
simplified environment (i.e. a well-lit corridor, straight path, no disturbing factors 
etc.), which might be less applicable to daily life. New tests might assess the capac-
ity to adapt walking to external demands (walk over uneven floors, ascend or de-
scend slopes, avoid obstacles) or evaluate the influence of attention [84] on walk-
ing, by applying the dual task approach. 
 Furthermore, depending on the research question, different aspects of walking 
capacity might be relevant. For example, the application of functional electrical 
stimulation (FES) to improve walking ability is still controversially discussed [85]. 
However, FES systems are improving and might allow independent walking for sub-
jects who are normally wheelchair bound [86]. One goal could be to increase the 
maximal non-stop covered walking distance for SCI subjects (unrestricted for time). 
However, at present, we are unfamiliar with an appropriate standardized test pro-
tocol. 
Standardization of walking tests 
To ensure comparability of results (especially in multi-center trials), rigorously stan-
dardized assessment protocols are needed. We therefore propose instructions for 
the walking capacity tests discussed in this study and hope these proposals might 
initiate a discussion concerning the standardized assessment of walking tests in the 
field of SCI and perhaps even in rehabilitation in general. 
WISCI II 
While at present different instructions are available for the use of timed walking 
tests, there are clear guidelines available for the WISCI II at: http://www.spinalcord-
center.org/research/wisci/resources/wisci-guide.pdf. The scoring form and descrip-
tors are available at: http://www.spinalcordcenter.org/research/wisci/resources/-
wisci-scoring-form.pdf. 
Timed walking tests 
If more than one test is applied during a single session, we propose to perform the 
less fatiguing test first (e.g. preferred walking speed test before maximum speed 
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test, or the 10MWT before the 6MinWT). Sufficiently long rest periods between 
each test should be taken and dress shoes should not be allowed [87]. We suggest 
that the patient initiates the test and not that he/she should react on a “go” signal, 
as we do not intend to measure reaction time. A stopwatch with an accuracy of 
1/10 seconds is required. In addition to the timed tests, the WISCI II can be used to 
score the need for walking aids and assistance. For all tests, the investigator should 
be positioned next to the patient. In this way, the beginning and end point of the 
timed pathway can be better determined and assistance can be provided if re-
quired. 
6MinWT 
The environment for 6MinWT might be difficult to standardize. A flat, smooth, non-
slippery surface, with no disturbing factors is required and the pathway should con-
tain as few turns as possible (preferably a large round or oval shaped path). Dis-
tances should be marked at least every 5meters. The total distance should be writ-
ten down in meters. 
 Subjects are instructed to walk at their preferred (or maximum) walking speed 
(Fig. 5.4a). The subject initiates the start of the test. After each minute, the subject 
should be informed about the time left and should be encouraged to continue 
his/her performance (Fig. 5.4a). 
 Remarks: (1) If subjects are unable to walk for 6minutes, rest breaks are al-
lowed. After resting, the subject might continue with the test and the final distance 
is determined after 6minutes. In such a case, a remark about the rest period should 
be written down. (2) It will be difficult to assess a 6MinWT in subjects who are cate-
gorized to WISCI II scores of 2 to 5, as these subjects depend on parallel bars. 
10MWT 
The environment should be similar to that for the 6MinWT. The subjects are in-
structed to walk 14meters, while the intermediate 10meters should be marked on 
the floor. The measurement starts when the patient crosses a mark on the floor that 
indicates the onset of the 10meter pathway (“flying start”). After 10meters 
(32.8feet), the timer is stopped, but the patient continues until he or she has 
reached the end of the 14meter track. The time is written down to an accuracy of 
1/10 seconds. Subjects are instructed to walk at their preferred (or maximum) walk-
ing speed (see Fig. 5.4b).  
 Remarks: (1) A special condition occurs when the patient requires the use of 
parallel bars, as these are rarely 14meters long. We suggest recording the middle 
5meters between the parallel bars twice. The time of the first and second 5meter 
distances are summed and written down.  
 (2) This test application is comparable to the 50feet test that has sometimes 
been used in SCI patients [37], although time is only recorded for 10meters. 
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TUG 
In general, we would suggest to use most of the instructions of the modified TUG 
test as proposed by Podsiadlo and Richardson [10]. However, we propose that the 
subject should initiate the test (Fig. 5.4c). Comparable to the 10MWT, a similar envi-
ronment of at least 4meters long is required. The chair should have a seat height of 
46cm and armrests (67cm). The patient sits with his or her back against the chair, 
arms resting on the chair’s arm. As soon as the subject lifts up from the chair (but-
tocks), the time recording starts. The subject may use the armrests of the chair for 
support. After 3meters (9.8feet), the subject turns and walks back to the chair. The 
timer is stopped as soon as the buttocks touch the chair again. The time is recorded 
and written down at 1/10 second accuracy. 
 
 
 
Figure 5.4 Proposals for standardization of the timed walking tests. Proposed instruc-
tions for the (a) 6 minute walk, (b) 10 meter walk and (c) Timed Up and Go tests performed 
at (A) preferred and (B) maximum walking speed. 
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CONCLUSIONS 
There is a need for valid, reliable and responsive tests to assess walking capacity in 
SCI subjects. Clinically relevant changes in walking ability are important for the indi-
vidual patient, while sub-clinical changes (on the population and individual level) 
become important when evaluating new treatments for efficacy and safety. We 
presented four walking tests that are applied in the EM-SCI. We presented their 
positive and negative aspects, as well as new results showing that most SCI subjects 
could be categorized into a limited number of WISCI II items and that the TUG corre-
lated well with the 10MWT, but that this relationship changed over time. We sug-
gest that, at present, the 10MWT might be the best choice for assessing walking 
capacity in SCI subjects. Furthermore, we recommend the additional assessment of 
the dependence of the SCI subjects on walking aids or personal assistance. 
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ABSTRACT 
Background. Persons with spinal cord injury who are able to walk are at risk for falls. 
Objective. The objectives were to investigate if the Berg Balance Scale (BBS) can 
discriminate those with a propensity to fall; to determine whether the BBS is associ-
ated with mobility measures, fear of falling, and muscle strength; and to assess 
interobserver reliability. Methods. The measurement tools used were the BBS, the 
Spinal Cord Independence Measure, the Falls Efficacy Scale (FES-I), the Walking 
Index for Spinal Cord Injury, the 10-m walk test, and the standard neurological clas-
sification including motor scores (MS). Falls were recorded retrospectively for the 
previous month and prospectively for the subsequent 4 months. To determine in-
terobserver reliability, BBS performance was videotaped and analyzed by additional 
physical therapists. Associations between BBS and the number of falls, measures of 
mobility, FES-I, and MS were calculated using Spearman correlations. The interob-
server reliability was quantified using Kendall’s coefficient of concordance and in-
traclass correlation coefficients (ICCs). Results. Forty-two participants were included 
of whom 26 sustained 1 or more falls. BBS performance correlated with measures of 
mobility, FES-I, and MS (rs = -.83 to .93; P < .001) but not with the number of falls (rs 
= -.17; P = .28). The interobserver reliability was excellent, both for single items (.84-
.98, P < .001) and for the total score (ICC = .95; 95% confidence interval = 0.910-
0.975). Conclusions. The BBS proved to be reliable and to relate well with other 
mobility measures, fear of falling, and muscle strength. However, it was unable 
discriminate between people who did fall and people who did not fall. 
 
Keywords. Spinal cord injuries, Risk assessment, Accidental falls 
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INTRODUCTION 
It is estimated that 10 to 83 persons out of every 1 million experience a spinal cord 
injury (SCI) every year and that 223 to 755 per million people live with a SCI1. Ap-
proximately 50% of these patients suffer an incomplete lesion, meaning that sen-
sory and/or motor function is partially preserved below the level of the lesion [1, 2]. 
The prognosis for regaining ambulatory function among initially incomplete SCI 
patients ranges from 50% to 95%, depending on the extent of the lesion [3]. From a 
European cohort of 178 patients with complete and incomplete SCI about one third 
regained ambulatory function within six months after the SCI onset [4].  
 As a result of the motor and sensory impairment with incomplete SCI, balance 
can be affected. Partial loss of the ability to balance can result in falls and fall-
related injuries. Brotherton and colleagues reported that 75% of 119 patients with 
incomplete SCI sustained at least one fall within one year [5]. As a consequence of 
the falls, 45% of these patients were restricted in their ability to go out into the 
community, and in 18% of the patients, a fracture resulted from the fall. The au-
thors pointed out that the incidence of falls is markedly higher in this population 
than in elderly healthy individuals (75% vs. 25-35%, respectively) [5]. In SCI rehabili-
tation there are clinical assessments for sensory and motor function [6], independ-
ence [7] and walking ability [8, 9] but there is no validated test to assess balance 
and future propensity to fall. In order to identify patients who are prone to falls and 
intervene with fall prevention programs for patients at risk, a valid test is required. 
 For the elderly, the Berg Balance Scale (BBS) was developed to assess balance 
ability and to monitor changes in this ability over time [10]. It comprises 14 tasks 
testing postural stability, including static balance (e.g. standing unsupported with 
feet together) and dynamic balance (e.g. placing alternate foot on a step while 
standing unsupported). Depending on the performance, each task is rated with zero 
(unable to perform the task) to four points (best performance) with a total score 
ranging from zero to 56 points. It has been shown that lower scores on the balance 
scale are associated with a past history of falls [11]. The BBS proved to be a valid 
assessment tool when compared to laboratory measures of postural control, and 
clinical measures of balance and mobility [11]. Since its development, it has been 
validated for patients with stroke [12-14], brain injury [15], Parkinson’s disease [16, 
17], multiple sclerosis [18] and learning disabilities [19]. 
 The primary aim of this study was to assess criterion-related concurrent validity 
and inter-observer-reliability of the BBS. In order to compare the risk of falling as 
measured using the BBS, the number of falls experienced within the study period 
was adopted as the external criterion. In addition the BBS scores were compared to 
measures of mobility, motor scores and fall related self-efficacy. It is hypothesized 
that fewer falls, higher grades of mobility, higher motor scores and higher self-
efficacy are associated with higher scores on the BBS. Specifically, the objectives 
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were: 1. to determine to what extent the performance on the BBS was associated 
with the number of falls experienced over a period of five months; 2. to determine 
the degree of association between the BBS and the Walking Index for Spinal Cord 
Injury, gait speed, Spinal Cord Independence Measure-domain mobility and the 
motor scores (MS) test; 3. to assess the association between the BBS and the Falls 
Efficacy Scale-International Version (FES-I); 4. to explore which cut-off score on the 
BBS is critical for discriminating people with a risk of falling; and finally 5. to assess 
the inter-observer reliability when four physical therapists (PT) rate the videotaped 
BBS. 
METHODS 
This study was approved by the local Ethics Committee and all subjects gave writ-
ten, informed consent before participation. 
Participants 
Participants were selected based on records of the physical therapy ward from the 
Spinal Cord Injury Center of the Balgrist University Hospital Zurich, Switzerland. All 
participants received either inpatient rehabilitation or outpatient physiotherapy 
between January 1998 and September 2007. All patients who experienced a spinal 
cord injury (SCI) at least one year prior to enrollment and who were able to walk for 
a minimum distance of 15m were eligible to participate in the study. Exclusion crite-
ria included subjects with known problems of the vestibular system, severely im-
paired vision or non-SCI-related impairments affecting standing or walking function 
(e.g. joint replacement surgery of the lower limbs, severe lower back pain or diabe-
tes) and patients younger than 18 years or older than 65 years of age.  
 Within the time frame of January 1998 to September 2007, 99 persons were 
identified as potential participants in the study. Of these subjects, 20 could not be 
contacted, 20 were excluded and 17 refused to participate. The primary reasons 
given for non-participation were lack of time and distance to travel for the meas-
urement session. There was no difference in age, etiology, injury level, American 
Spinal Injury Association (ASIA) Impairment Scale, time since injury and sex between 
participants and those who declined to participate or could not be contacted. Each 
participant received a small monetary compensation for travel expenses. 
Procedures 
The measurements took place between July and November 2007, with 42 partici-
pants with SCI. 
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Participants were invited to one measurement session at the rehabilitation center 
where the BBS, the Spinal Cord Independence Measure II (SCIM II), the Falls Efficacy 
Scale-International Version (FES-I), the Walking Index for Spinal Cord Injury II (WIS-
CI), the ten-meter walk test (10MWT), and the ASIA standard classification including 
the motor score (MS) were performed. During that visit, the number of falls the 
patient had experienced during the previous one month was recorded by interview. 
From that visit onwards, a four months prospective recording of the number of falls 
started using a specifically designed assessment calendar. 
Instruments 
The 14 tasks of the BBS were assessed by a physical therapist (PT) and simultane-
ously videotaped. To assess inter-observer reliability, three additional PTs working 
in the same institution rated the videotaped BBS performance of all subjects inde-
pendently. Contrary to the first rater, these raters were blinded regarding the falls 
history of the person. Since the BBS was developed for a different population, some 
criteria have the potential for misinterpretation when the test is applied in patients 
with SCI. For this study, the use of walking aids e.g. crutches or walking frames was 
considered as external help. This was done after consultation with Dr. Katherine 
Berg. Prior to the reliability study the participating PTs were instructed how to as-
sign the ratings. The recordings of all raters (ie. the PT who initially rated the pa-
tients as well as those PTs who subsequently rated the patients on the video re-
cordings) were included in the analysis. 
 The SCIM II is an instrument to assess SCI-related disability [7]. Its items are 
subdivided into three parts, i.e. self-care (subscore 0-20), respiration and sphincter 
management (0-40), and mobility (0-40). For this study, the SCIM II mobility domain 
was obtained by interview and used for further analyses. 
 The FES-I is a self-reported measure of fall-related self-efficacy developed for 
elderly persons [20]. Subjects are asked to rate their self-perceived fear of falling 
when carrying out each of 16 activities on a four-point scale (1=not at all concerned, 
4=very concerned). The total score ranges from 16 to 64 points. After a short intro-
duction, patients completed the FES-I on their own while the examiner left the 
room. 
 The WISCI II is an instrument to assess a patient’s ability to walk using 20 ordi-
nal categories [8]. The rank order of the categories is based on the requirement of 
personal assistance and/or walking aids or braces. Zero represents no and 20 unre-
stricted walking function. 
 For the 10MWT [9] participants were asked to walk at their preferred comfort-
able and safe pace. The distance was marked on the wall of a straight walk-way. 
Subjects started approximately two meters before the 10 meter distance and 
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stopped again two meters after the 10 meter mark. Time was taken using a manual 
stop watch. The mean of two trials was the score. 
 An experienced physician examined the participant to determine the actual 
ASIA motor score and impairment rating according to the standard procedure [6]. 
 In order to assess the current fall status of the participants, falls were recorded 
one month retrospectively and four months prospectively. For the recording of the 
latter, patients were instructed about the definition of a fall and how to keep re-
cords of falls sustained. According to The Prevention of Falls Network Europe Con-
sensus a fall was defined as an unexpected event in which the participants come to 
rest on the ground, floor, or lower level [21]. Participants received a monthly calen-
dar containing the definition of a fall, and examples of how to record a fall. Falls 
were marked either as a fall without injury, or a fall with an injury to the skin, joint 
or bone. Additionally the mode of treatment (either by a physician or at a hospital) 
was recorded. At the end of every month a letter was sent to the subjects contain-
ing the calendar for the new month and an envelope to return the calendar for the 
previous month. A reminder phone call was made when a calendar was not re-
turned within one week. 
Analysis 
Spearman’s rank correlations were calculated for the analysis of the relationships 
between the BBS and the number of falls, SCIM mobility score, FES-I, WISCI, gait 
speed and MS, respectively. Scatter plots were used to visualize these relationships. 
 In order to find an optimal cut-off value of the BBS, which differentiated be-
tween fallers and non-fallers, a receiver-operating characteristic (ROC) curve was 
applied and the area under the curve was calculated. An optimal cut-off value 
would identify fallers with the highest accuracy (i.e. with high sensitivity (true fall-
ers) and specificity (true non-fallers)). For this analysis, subjects were categorized as 
fallers if they sustained one or more falls within the observation period. Subjects 
who had experienced no falls within the same period were considered as non-
fallers.  
 Finally, for inter-observer reliability of the individual items of the BBS the Kend-
all coefficient of concordance was calculated, whereas for the total score the intra-
class correlation coefficient using the two-way random effects model type absolute 
agreement was calculated. The level for statistical significance was set at 0.05. Mi-
crosoft Excel 2002 (Microsoft, Redmont, Washington) and SPSS for Windows 12.0.1 
(SPSS Inc, Chigaco, Illinois) were used for the analysis. 
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RESULTS 
For detailed characteristics of the 42 included subjects, see Table 6.1. About one 
third of the participants achieved maximum scores on the BBS, SCIM, FES-I, WISCI 
and MS. Thirty-one subjects were ambulatory for distances beyond 100m outdoors, 
while 11 subjects required a wheelchair for this task and were only capable of walk-
ing indoors for short distances using assistive devices. Twenty-six participants ex-
perienced one or more falls over the study period of five months. The total number 
of falls was 270. Seventeen falls sustained by eleven subjects resulted in injury (Ta-
ble 6.2). Among the participants there were eight subjects who fell more than ten 
times, with one participant reporting 52 falls. Four participants sought a general 
practitioner or a hospital for treatment of fall-related injuries. 
 
Table 6.1 Characteristics of the subjects included in the study (n=42) 
 Frequency (%) Mean (±SD) Median (Range) Lower  
Quartile 
Upper  
Quartile 
Age (years)  49.3 (11.5) 51.1 (24-65) 41.3 60.3 
Gender 
 female 
 male 
 
 9 (21.4) 
33 (78.6) 
    
Level 
 cervical 
 thoracic 
 lumbar 
 
16 (38.1) 
 9 (21.4) 
17 (40.5) 
    
ASIA impairment scale 
 A 
 C 
 D 
 E 
 
 2 (4.8) 
 2 (4.8) 
35 (83.3) 
 3 (7.1) 
    
UEMS  49.1 (2.0) 50 (41-50) 50 50 
LEMS  40.5 (11.4) 46.5 (16-50) 30 50 
Etiology 
 traumatic 
 ischemic 
 hemorrhagic 
 
33 (78.6) 
 6 (14.3) 
 3 (7.1) 
    
Time since SCI (months)  66.5 (66.2) 62.7 (12-426) 21.4 86.3 
Abbreviations: ASIA: American Spinal injury Association; SCI: spinal cord injury; UEMS: Upper extremity 
motor score; LEMS: Lower extremity motor score; SD: standard deviation 
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Table 6.2 Berg Balance Scale, mobility scores and falls data 
 Frequency (%) Mean (±SD) Median (Range) Lower 
Quartile 
Upper 
Quartile 
Berg Balance Scale  41.1 (15.2) 44 (11-56) 30 55 
SCIM total score  90.7 (8.9) 92.5 (69-100) 83 99 
SCIM mobility score  32.3 (7.8) 35 (17-40) 26 40 
Falls Efficacy Scalea  30.7 (12.1) 30.5 (15*--55) 19 38 
WISCI  16.9 (3.4) 18.5 (11-20) 13 20 
Walking speed (m/s)   0.93 (0.48)  0.87 (0.12-1.67)  0.56  1.43 
Falls without lesion 253 (93.7)     
Falls with lesion  17 (6.3)     
 Skin abrasion   8 (3)     
 Joint sprain   7 (2.6)     
 Bone fracture   2 (0.7)     
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, standard deviation; WISCI, Walking Index 
for Spinal Cord Injury. 
aMissing one item in one patient. 
Berg Balance Scale and falls 
There was no relevant association between the number of falls and the score on the 
BBS (Fig. 6.1). This holds true for both falls without and falls with injury (Table 6.3).  
 A post hoc analysis including only those participants who achieved less than the 
maximum score on the BBS, or only restricted walking function (i.e. a WISCI score 
less than 20), still revealed that there was no association between the BBS and the 
number of falls. 
Berg Balance Scale and mobility measures 
The BBS correlated strongly and significantly with the SCIM mobility score, WISCI 
and with the 10MWT (Table 6.3). The results indicate that higher scores on the BBS 
were associated with a higher grade of mobility in terms of independence of walk-
ing aids and walking speed. 
Berg Balance Scale and motor score 
Participants with high values on the BBS also rated significantly higher on the MS.  
 99 
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Berg Balance Scale and Falls Efficacy Scale International-Version 
Higher scores on the BBS were significantly associated with lower scores on the FES-
I. This correlation suggests that patients who had a better ability to balance showed 
less fear of falling and hence were able to make a realistic self-assessment (Table 
6.3) 
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Figure 6.1 Relationship between total Berg Balance Scale (BBS) 
score and the number of falls sustained over a period of 5 months. The 
maximum score of the BBS is 56 (note that there are data points which 
represent more than one subject and are superimposed: 4 participants 
with BBS=56, and no falls, 2 with BBS=56 and one fall and 3 with 
BBS=55 and no falls). 
 
Table 6.3  Correlation matrix expressing the relationship between Berg Balance Scale and falls, the fall 
related self-efficacy, mobility- and motor scoresa 
 Falls total Falls without 
lesion 
Falls with  
lesion 
SCIM  
mobility  
score 
WISCI Walking  
speed 
FES-I MS 
BBS -0.17 (0.28) -0.17 (0.28) -0.16 (0.32) 0.89 (<0.001) 0.82 (<0.001) 0.93 (<0.001) -0.81 (<0.001) 0.62 (<0.001) 
Falls total  0.96 (<0.001) 0.52 (<0.001) -0.14 (0.38) -0.03 (0.84) -0.10 (0.52) 0.28 (0.07) -0.17 (<0.001) 
Falls without lesion  0.42 (<0.001) -0.14 (0.38) -0.06 (0.73) -0.10 (0.54) 0.25 (0.1) -0.10 (0.54) 
Falls with lesion   -0.10 (0.52) 0.10 (0.52) -0.13 (0.4) 0.31 (0.04) -0.16 (0.31) 
SCIM mobility score    0.81 (<0.001) 0.89 (<0.001) -0.78 (<0.001) 0.59 (<0.001) 
WISCI      0.81 (<0.001) -0.71 (<0.001) 0.66 (<0.001) 
Walking speed      -0.83 (<0.001) 0.60 (<0.001) 
FES-I        -0.74 (<0.001) 
Abbreviations: BBS, Berg Balance Scale; SCIM, Spinal Cord Independence Measure; WISCI, Walking Index 
for Spinal Cord Injury; FES-I, Falls Efficacy Scale International Version; MS, Motor Scores. 
aSpearman correlation coefficients are presented with corresponding p-values in parentheses. 
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Berg Balance cut-off score 
In order to determine an optimal value that discriminated fallers from non-fallers, 
the ROC procedure was applied. The area under the curve was 0.48 (95%CI=0.29-
0.67). This means that the BBS cannot discriminate beyond the chance of coinci-
dence between participants who fall and those who do not. Therefore determina-
tion of a cut-off score to optimize sensitivity and specificity was irrelevant. 
Inter-observer reliability 
In addition to the rater (first author) who obtained the BBS directly from the pa-
tients, three additional physical therapists rated the BBS independently, based on 
video recordings. Of the 42 recordings, two could not be included in the analysis 
due to technical problems. Since all participants achieved the maximum score on 
item three, hence there was no variance, and this item was excluded from the anal-
ysis. The average professional experience of the physical therapists at the time of 
the study was 12.5±6.6 years, ranging from 5 to 19 years. Their experience with 
individuals with spinal cord injuries was 10.8±7.2 years (range: 4 to 17years). The 
agreement among the raters, relating the items as calculated using Kendall’s coeffi-
cient of concordance, ranged between 0.838 and 0.979 (p<0.001). For the total 
score, the ICC was 0.953 (95%CI: 0.910-0.975). Both results indicate excellent inter-
observer agreement. 
DISCUSSION 
The aim of this study was to examine whether the BBS score is associated with the 
risk for falls and the level of mobility in persons with SCI who are able to walk, as 
well as to assess the inter-observer reliability of the BBS.  
Berg Balance Scale and falls 
Our data show no significant association between the number of falls and the scores 
achieved on the BBS. In addition, the effort to find a cutoff score which discrimi-
nated between fallers and non-fallers revealed that there is no such score and that 
the discriminative power was not better than chance. The recordings of our study 
showed that about one third of the included subjects recovered to full mobility, 
according to the applied assessments. This may have led to a ceiling effect. Never-
theless the same analyses including only those participants who achieved less than 
the maximum score on the BBS, or WISCI, still revealed that there was no associa-
tion between the BBS and the number of falls. 
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Our assumption was that people with a lower BBS score would be at a higher risk of 
falling. There are two possible explanations why this was not observed. First, par-
ticipants may be aware of their risk. This is supported by the finding that the FES-I is 
highly associated with the BBS. Obviously persons with impaired balance have 
learned to handle their risk for falls. One of the inclusion criteria was that patients 
had lived with their SCI for more than one year, which we consider a sufficient pe-
riod of time to find strategies for avoiding falls. The results may differ in a sample of 
recently injured participants. 
 Second, the recordings of our study revealed that about one third of the in-
cluded subjects recovered to full mobility, according to the applied assessments. 
This may have led to a ceiling effect. Nevertheless the same analyses including only 
those participants who achieved less than the maximum score on the BBS, or WISCI, 
still revealed that there was no association between the BBS and the number of 
falls. 
 The construct behind falls in patients with SCI seems to differ from that of eld-
erly persons, who were the original target population for the use of the BBS [10]. 
Balance was considered as an important component of fall risk [10, 22]. In the ab-
sence of a gold standard for balance, several ways have been adopted to establish 
criterion-related validity, (eg. laboratory measures [12, 15, 22, 23], other measures 
of balance or measures of mobility [13, 16-18, 23-25], measures which assess the 
impact of a specific disease [16] or length of stay in a hospital and discharge desti-
nation [14]). Some of these studies also compared the performance on the BBS with 
the fall status of the included subjects [11, 17, 18, 22, 24, 25]. These results are 
somewhat controversial and seem to depend on the included subjects. Some stud-
ies found that the BBS was able to discriminate fallers from non-fallers. Those stud-
ies included mostly elderly persons [11, 22, 25]. A significant difference in the sum 
scores of the BBS between fallers and non-fallers was also found in a sample of 45 
patients with Parkinson’s disease [17]. However, in accordance with our results, in 
two studies that included participants with stroke [24] or multiple sclerosis [18], no 
clear difference in the performance on the BBS between fallers and non-fallers was 
found. 
 Multiple factors have been identified as contributors to fall risk. Brotherton and 
colleagues performed a mail survey and identified several factors associated with 
falls in individuals with incomplete SCI [26]. Beside these self-reported factors, addi-
tional studies are required that include direct measures of impairment in order to 
characterize fallers and to find or create useful clinical assessments to identify per-
sons at higher risk for falls. 
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Berg Balance Scale and mobility 
The results show that the sum scores of the BBS correlate highly with measures of 
mobility (i.e. SCIM sub score mobility, WISCI and gait speed). The BBS has been used 
as a measure of balance along with other assessments in the Spinal Cord Injury 
Locomotor Trial (SCILT), which included 146 patients with incomplete SCI [27]. In 
line with our study, the authors reported significant correlations between the BBS 
and the WISCI, gait speed and MS, respectively. This association indicates that the 
BBS tasks seem to measure the construct underlying ambulatory function and that 
voluntary muscle strength, as measured with the ASIA Motor Score, is an important 
factor regarding balance. 
Fall risk 
Sixty-two percent of the included subjects fell once or more during the observation 
period of five months. Among the fallers, there were 42% who sustained an injury 
as a consequence of a fall.  
 Brotherton and colleagues found a fall incidence of 75% within one year for 
persons with an incomplete SCI [5]. Compared to the sample of Brotherton et al, our 
sample was slightly younger (49.3y vs. 51.6y) and the time since injury was shorter 
(5.5y vs. 13.6y). Besides the shorter observation period, the smaller risk for falls in 
our sample corresponded with a greater amount of persons able to walk outdoors 
(74% vs. 70%). In spite of these differences, the increased risk for falls within the 
population of patients with SCI who are able to walk was confirmed.  
Inter-observer reliability 
Similar to the results of previous studies [10, 18, 19, 28-30], we found excellent 
inter-observer reliability for the individual items, as well as for the total score on the 
BBS. A number of participants in our study used a walking aid (crutch or walking 
frame) to perform the BBS. After consulting with the developer of the BBS, the use 
of such assistive devices was considered as an external help and was rated accord-
ingly.  
Methodological issues 
In our study, the recording of falls was initially retrospective for one month, fol-
lowed by prospective collection for an additional four months. The retrospective 
survey, even though widely used, may be inaccurate due to recall bias [31, 32]. We 
performed a comparison of the means of month one with the means of months two 
to four. This analysis showed no significant difference, indicating that the fall re-
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cords as a whole can be considered as consistent. The true risk for injurious falls 
may be underestimated by the fact that the records were based on self-report only. 
 The circumstances of falls (e.g. time of the day, environment, and activity) were 
not recorded. This information would have allowed an insight into the mechanisms 
and circumstances of the fall events. The months where falls have been collected 
ranged from summer to spring. Weather and seasonal influences may have affected 
the mobility behavior of the participants. However, there was no correlation be-
tween the number of falls and the order of inclusion as a measure of a chronological 
order. 
 Bias may have arisen from the fact that we included a convenience sample from 
a single rehabilitation center rather than a random sample from multiple centers. In 
addition, the number of participants may be too small since approximately one third 
achieved maximum scores on the BBS, and hence, the central and lower range of 
the scale may be underrepresented. 
 For the reliability analysis there was concern as to whether video recordings 
would be sufficient for rating all items of the BBS, especially those items where 
standby support could influence the judging. A review of the results showed that 
there was a similar concordance among the ratings in all items. 
 Finally, concern may arise that the measurements were influenced by the fact 
that the same assessor was engaged in the administration of the test and measures. 
The lack of blinding pertaining to the fall status could have influenced the admini-
stration of the BBS. Patients with a history of falls would likely be scored lower than 
those who reported no falls. 
CONCLUSIONS 
The BBS as a measure for mobility in persons with chronic SCI who are able to walk 
demonstrated excellent inter-rater reliability and correlations with other mobility 
measures. However, the BBS score was not associated with the number of falls and 
was not able to discriminate fallers from non-fallers. Nevertheless, this study has 
revealed that persons with chronic SCI who have the ability to ambulate have a 
markedly increased incidence for falls and fall-related injuries. For the population 
with SCI able to walk, further studies are required to identify factors contributing to 
falls and to analyze the circumstances surrounding the occurrence of falls. These 
studies will help to create assessments that are able to estimate the risk for falls and 
to develop preventative measures to reduce this risk. 
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ABSTRACT 
This chapter covers the various aspects related to the application of rehabilitation 
robots. The starting point for developing any novel therapeutic device should be the 
specific requirements of the users. Users in this case are patients with neurological 
conditions, but also therapists. Both claim different requirements, which need to be 
united. Modern neurorehabilitation is grounded in the premise that activity is bene-
ficial. Robots are valuable tools to apply intensive active training in terms of the 
number of repetitions and task specificity-. The complexity of robotic devices is 
mainly determined by the residual functions of the patient. In patients with muscu-
lar weakness a simple weight support system might be sufficient, whereas in pa-
tients with severe paralysis actively driven exoskeletons with multiple degrees of 
freedom are necessary. Robots must comply with general regulatory and safety 
standards. Robotic devices have to be adjustable to a wide range of anthropometric 
properties and to the amount and the characteristics of their impairment. The user-
friendliness of the robot’s human-machine interface consisting of the mechanical, 
the control and the feedback interfaces determines whether a device becomes 
integrated in the rehabilitation program or not. An inherent advantage of the more 
complex rehabilitation robots is their ability to use angular and force sensor signals 
for assessment and documentation. These are important to objectively control the 
course of the training, to legitimate and shape the training and to document pro-
gresses or deteriorations. In the future devices which allow the continuation of a 
robotic therapy at home will further enlarge the range of applications. 
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INTRODUCTION 
This chapter focuses on aspects which need to be considered when technologies are 
applied to subjects. Technical devices are developed in order to support humans in 
many ways. Tower cranes are able to lift and manipulate heavy loads. Submarine 
robots work in an environment which is not compatible with human life. Smart 
controllers inflate airbags within split seconds in order to protect the driver of a car. 
There is also a long list of technical devices which have been applied in medicine 
e.g. infusion pumps, blood pressure measuring devices or electric stimulators for 
the treatment of pain. One kind of machines is driven by the force of the person 
using it e.g. strengthening apparatus. These are considered as passive devices. Oth-
er systems include electric drives or other actuators e.g. pneumatic devices and can 
apply supporting, assisting or resistance forces. Such actuated devices are referred 
to as active systems. Devices can act on their own by means of a controller which 
follows predefined algorithms e.g. for the surveillance of vital functions such as 
heart rate monitors. Not only in daily life the technology becomes smarter but also 
in the field of treatment and rehabilitation. After an accident or a disease highly 
sophisticated devices are applied. These devices help the human physician to draw 
meaningful conclusions out of a number of figures or to eliminate muscle trembling 
during a subtle surgical intervention. The focus of this chapter is set on rehabilita-
tion technologies including robotic devices which became established within the last 
decade for patients with neurological conditions e.g. spinal cord injury or stroke. 
These robotic assistive devices enable to start a functional and goal oriented train-
ing earlier as compared to the conventional approaches. In addition an intensive 
application of adequate afferent feedback and a high number of repetitions of func-
tional movements support the rehabilitation of function such as walking or arm use. 
Robots not just perform movements repeatedly, but they allow the introduction of 
task variation and provide feedback in order to maintain an adequate level of chal-
lenge for the patient. The issues discussed may partially also be valid for other types 
of rehabilitation and assistive technologies. 
 The starting point for developing any new device should be the specific re-
quirements of subjects. Subjects in this case are patients with neurological condi-
tions and it is intended that they will profit from a more effective way of training 
meaning that they achieve their individual goals within a shorter period of time. 
Subjects are also therapists who, by using robotic devices, experience physical relief 
and can use assessment systems for quantification of functional improvements 
which are less prone to subjective influence. Patients and therapists claim different 
requirements which need to be united in a meaningful way. Those requirements 
should be in the focus as opposed to technical feasibility which does not always 
comply with a rehabilitative demand. This may be different if robots are in the de-
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velopmental stage. However, the potential clinical application has to be borne in 
mind throughout the whole developmental process. 
 Beside the specifications which are framed by patients and therapists there are 
several technological issues and principles regarding the clinical application of ther-
apeutic robots. Both aspects will be covered in the next sections. 
HUMAN ISSUES 
Patient 
The clinical presentation of a spinal cord injury (SCI) or a stroke comprises motor 
weakness or complete paresis, complete or partial loss of sensory function and a 
more or less pronounced derailment of the vegetative functions [1-3]. The latter 
include lack of bladder and bowel voiding function, lack of blood pressure adapta-
tion as a response to upright position (orthostatic hypotension) etc. Patients in the 
early stage after such an event generally have a poor condition which needs to re-
cover to a certain extent before intensive rehabilitation can be initiated. Beside the 
vegetative symptoms patients have a reduced vital capacity which may become 
evident in upright standing and during exercise. Also in the acute phase after stroke 
patients stability in terms of circulation, mood and motivation is impaired. Robotic 
devices should account for those instable situations in such a way that subjects can 
be evacuated from the device within a short period of time. Fittings must be de-
signed that they can be removed quickly and the whole device must be removable 
in order to get access to the patient or to transport an unconscious patient from the 
device without constraints. Patients with SCI have a marked propensity to faint once 
they are elevated in an upright position. The possibility to position patients horizon-
tally when the blood pressure starts to drop is therefore crucial. After a traumatic 
SCI the spine becomes instable in most cases. In addition extremity fractures can 
occur. Rehabilitation therapists have to make sure that the musculoskeletal system 
is stable enough to tolerate the applied load and forces as it is the case in robotic 
devices which are used to train walking function. This holds also true in cases where 
fractures and instabilities have been treated surgically. The partial lack of sensibility 
has to be taken into account when a patient with a neurological condition is trained. 
After every training session the spots where forces are exchanged between the 
robotic device and the patient have to be inspected visually. Any sign of strain must 
be documented and carefully controlled. Robotic devices enable intensive and long 
training sessions with a large number of repetitions. Some patients may react to 
that amount of workload with signs of overload e.g. joint swelling, increased spas-
ticity or pain. In older patients with a known history of osteoporosis the training 
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intensity has to be set carefully. The repeated stress on bony structures may result 
in a fatigue fracture. 
 Patients who experience an impairment of their cognitive function e.g. dis-
torted self-perception might not be able to cooperate with a robotic device. Even 
though some devices use virtual environments which are very alike the real world 
and the control of these environments is intuitively patients still require the ability 
to abstract. In order to completely cope with robotic devices and to make use of the 
numerous ways of training modalities patients need to have only mild cognitive 
deficits.  
 The population experiencing a SCI is becoming older [4]. Patients with stroke 
are typically of advanced age. These subjects are generally not used to work with 
new information technologies and may be reluctant to train in a robotic device. 
Without complete confidence in a training device the success of the intervention 
gets endangered. It is therefore important that patients are able to acknowledge 
robotic training as an important component on the way to their maximum possible 
independence. For future generations who are much more used to computers and 
robots from their lives before the neurological incident this item might be less an 
issue. 
Therapist 
Usually the usage of robotic devices is not a subject in basic physiotherapy training. 
The reason for that is that the field of rehabilitation robot is growing rapidly and a 
large number of new devices become developed every year. Different robots are 
available and to date no standard devices are established. However, the proper use 
of robotic devices is critical for the success of the training. A sufficient period of 
time should be scheduled for the instruction of therapists. It is important that every 
therapist does as many one-to-one trainings under supervision of an expert user as 
needed until she or he is able to apply the device accurately and safely. It is recom-
mended that in a given institution special safety procedures become defined. It 
must be ensured that every person who trains with a robotic device has been in-
structed properly beforehand. The emergency procedures should be trained practi-
cally. Liability issues for the case of an accident must be clarified. Some devices are 
easy to use and a basic instruction is sufficient. However, other devices require 
extensive training and experience in order to respond to variations and irregulari-
ties. It must be evaluated if multiple or only few therapists are assigned to use a 
device. In the case of a large number of users a single therapist will never become 
confident with the device. On the other hand when only few staff members know 
how to run the device experience can be cumulated in a shorter period of time. 
Additionally knowledge exchange is easier among a smaller group of users. There 
are also mixed models where an experienced user does the setup for a given patient 
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during an initial training session. The subsequent trainings will then be performed 
by a therapist with less specific knowledge, usually the therapist who trains the 
patient with non-robotic interventions. If required the more experienced colleague 
provides supervision in that phase. The advantage of such a model is that a thera-
pist who knows a patient from the “conventional” therapy can also perform the 
robotic training as opposed to a therapist who is skilled using the robot but doesn’t 
know the peculiarity of the patient. 
Principles of robotic training 
At the current stage robots do not introduce completely new rehabilitation strate-
gies [5]. Robotic devices rather enhance and amend existing approaches. Electro-
mechanical devices can generate and apply greater forces for a longer period of 
time and follow more precisely predefined trajectories. In addition robots can 
measure far more accurately and free from subjective perception than human ther-
apists. However, robotic devices usually measure forces only in one plane or degree 
of freedom. A human therapist is able to perceive forces in acting in multiple direc-
tions, in particular rotational forces. There are also approaches where a patient can 
train on a robotic device at his home without direct supervision of a therapist. In 
that case patient and therapist are connected through the internet where the ther-
apist can monitor the progress of his patient and adapt the training protocol [6]. 
 The question pertaining to the principles behind robotic training is the question 
regarding the principles of neurological rehabilitation. In recent years there have 
been many reports on the principles and strategies on which neurological rehabilita-
tion is based [7-13]. Most reports which have been published regarding this topic 
relate to the stroke population since this is one of the most common conditions for 
acquired neurological disability. Nevertheless, from an empiric point of view most of 
the described principles can be transferred to other groups of patients e.g. SCI, 
multiple sclerosis or M. Parkinson. One major and persistent principle of neurologi-
cal rehabilitation is that of Motor Learning [11, 12, 14]. During rehabilitation pa-
tients have to relearn motor tasks in order to overcome disability and limitations in 
the completion of daily activities. These processes are initiated by task specific train-
ing which support either true recovery of lesioned areas within damaged neural 
structures or compensation [11, 15]. Regardless the underlying mechanism the 
principles of motor learning apply in both cases [12, 16]. These principles comprise 
among others: task specificity, goal orientation, meaningfulness and most impor-
tantly a high amount of practice. Rehabilitation robots allow task specific training 
early after a neurological incident. For the training of gait function robotic devices 
are applied which support the patient to perform leg movements during walking. At 
such an early stage patients cannot stand up independently and are not or only 
partially able to perform leg movements on their own. Studies have shown that 
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adequate proprioceptive afferent input is critical for training functional tasks e.g. 
walking in patients with SCI [17-20]. The reciprocal unloading and loading of the legs 
as well as hip extension seem to be task specific afferents for the appropriate facili-
tation of neural structures which are involved in the control of walking.  
 Also, devices for the training of upper limb functions are most valuable for the 
rehabilitation. These robots assist patients to follow task specific trajectories. There 
are upper extremity robots which are designed for the use in a very early stage 
when the patient still lies in his bed for most of the time [21]. A number of devices 
work in conjunction with a display on which the patient completes meaningful tasks 
of daily living within a virtual environment [22]. An advantage of such a training 
using virtual environment is that patients do not focus on the learning of specific 
movements itself but on the effects of these movements. This so called external 
focus is beneficial for the learning of task automatism [23, 24]. Other approaches 
aim at minimizing the lack of coordination between shoulder and elbow joint during 
reaching movements [25].  
 Without the support of electromechanical devices patients won’t be able to 
start these exercises at an early stage or may get exhausted after a short while and 
little number of repetitions. Compared to the human therapist who might get tired 
while providing extensive amount of support to patients who are dependent on 
help for completing task oriented exercises robotic devices allow longer training 
durations and a higher number of repetitions. Studies have shown that augmented 
exercise results in an improved outcome [26]. However, it seems not sufficient just 
to repeat a specific movement or completion of a task. Task variability improves the 
acquisition of that task [14]. Robotic devices which have been developed so far offer 
numerous ways to adapt and vary training. The introduction of virtual environments 
wherein the patients take over control enables multiple ways of tasks and task vari-
ation within the same robotic setup. Further possibilities to adapt tasks are the 
number of degrees of freedom which are under control of the patient. The amount 
of support to control a given degree of freedom e.g. hip flexion or extension could 
be adapted according to the patient’s abilities. Robots may not only provide assist-
ing forces but in later stages also resisting forces. Increased resistance perpendicu-
lar to a defined trajectory help to guide a patient through a desired movement path. 
The changes of movement velocity entail a different level of challenge. Walking 
within a robotic device allow dynamic walking at a nearly normal walking speed as 
opposed to walking within parallel bars or other walking aids where speed is mark-
edly slowed down. Walking speed during training is considered important to war-
rant further improvements [27].  
 In order to control movements and for safety reasons robots are equipped with 
sensors. These sensors measure positions, velocities and accelerations on one hand 
and torques and forces on the other hand. These signals can be used for a specific 
feedback for both, patients and therapists. Feedback can be provided using various 
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cues such as auditory, visual or haptic. Based on the forces patients exert on the 
machine selected actions occur in the virtual environment e.g. an avatar walks left 
or right or a virtual hand grasps an object. In such a way robotic devices act as an 
interface between the real and a virtual world. The raw signals however serve the 
therapist to survey the level of activity of the patient and to document the progres-
sion within a training series. However, to date only little is known how these figures 
translate to unsupported activities without a robot. 
 After all it is the skill of the human therapist to integrate various signals and 
expressions and hence to perceive the actual state of the patient. Based on those 
findings therapists will shape exercises and set up conditions in a way that patients 
are challenged and motivated without being overstrained. For therapists and pa-
tients robotic devices offer a useful tool to implement the principles of neurological 
rehabilitation from the very beginning of rehabilitation and to measure and control 
the progresses. 
TECHNICAL ISSUES 
Complexity of robotic devices 
The main goal of a task-oriented neurorehabilitative training is to enhance neuro-
plasticity by enabling patients with neurological impairments to perform move-
ments of activities of daily living. A key factor for the success of the training is the 
number of repetitions and the generation of physiological afferent stimuli [28]. For 
achieving a meaningful improvement of motor functions by mass practice therapy 
regimes supportive devices are beneficial and valuable tools. The complexity of 
these devices is mainly determined by the residual functions of the patient group in 
the focus. In patients with minor to moderate impairments passive devices may be 
sufficient to enable the execution of relevant tasks. This is especially true for the 
upper extremity, where passive devices like the Swedish help arm (also known as 
Helparm, Swedish Sling, Deltoid Aide or OB Helparm), the Freebal device or the 
recently commercialized ARMON orthosis (Mircogravity Products BV, Rotterdam, 
Netherlands) are used to reduce or eliminate the effects of gravity and thereby 
allowing the user to effectively use his weak muscles for performing functional tasks 
like eating, drinking or grooming. These devices may also help the patient retain or 
reestablish important proprioceptive information about the achievable workspace 
that the impaired limb should be able to reach as recovery progresses. Since the 
purely passive devices are relatively simple in their construction they are affordable 
also from the patient her/himself and are easy to use. The main disadvantage of 
these simple passive devices, which are mainly based on springs or counterweights, 
is that they basically provide a constant amount of weight reduction regardless of 
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the position of the extremity. Even in positions of the arm, where less or no support 
is necessary, the patient is supported. Additionally, the desired movement trajec-
tory cannot be predefined and therefore the user may train a wrong, unphysiologi-
cal movement pattern. In the worst case the patient cannot complete a desired 
movement at all. To overcome this limitation passive devices are often used during 
occupational therapy sessions under supervision of a therapist, who actively sup-
port the movements to ensure that a physiological movement trajectory is 
achieved.  
 To free therapist from this physically exhausting and mechanistic work of man-
ually guiding the movements and to perform a therapy in a more standardized way 
active robotic devices with integrated actuators have been introduced. The active 
components of the robots consist nowadays mainly of electric motors or pneumati-
cally driven actuators in combination with spindles, gears or bowden cables. Within 
the class of active devices there are technically more simple devices, which are 
mainly based on an end-effector approach, and complex devices, in which several 
degrees of freedom (DOF) of several joints are actively driven independently. 
 The end-effector based systems use dedicated hand grips or footplates and 
guide the movements of the hand or foot in space [29-31] (Fig. 7.1). Their main 
advantage is their easy setup since no technical joints of the device has to be 
aligned with the anatomical joints of the human body. Furthermore they only use 
one or two drives per extremity to generate a 2D-planar motion. However, the 
movements originate from the most distal segment of the extremity and therefore – 
though the kinematic movement pattern looks similar to the physiological situation 
– the kinetics of the generated movements may not be perfectly physiological [32]. 
However, this seems to be crucial for the success of the therapy [20]. Additionally, 
only information about forces and / or position of the most distal part of the Exam-
ples of machines based on the end-effector approach for the upper extremity are 
the MIT Manus [33] approach and for the lower extremity the gait trainer [34] (Fig. 
7.1).  
 A physiological movement of all joints of an extremity can only be achieved by 
the use of active drives, which support the movements of every DOF of a dedicated 
joint. Additionally an individualized setup of a joint and movement phase related 
resistance is only possible with actively driven exoskeletons. Locomotion robots are 
often constructed as actuated exoskeletons which operate in conjunction with a 
system for partial body weight unloading and a moving treadmill [35-38]. Since 
active components form the most expensive parts of a robotic device usually a 
compromise between costs and functionality in terms of perfectly following a given 
trajectory has to be made. Therefore robotic locomotion training machines are 
mainly generating movements in the sagittal plane whereas movements in the fron-
tal or transversal plane are restricted to passive movements. 
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Figure 7.1 The Gait Trainer GT I assists the pa-
tient during gait training using an end-effector-
based approach combined with a system for partial 
unloading of the body weight.  
 
A general challenge of the application of exoskeletons is their proper adjustment 
and alignment to the anatomical constraints of the different types of joints. Due to 
their mechanical complexity the exoskeletons are often time-consuming in their 
initial setup and in everyday applications. Examples for actively driven exoskeletons 
are the Lokomat and Lopes devices for the lower extremity [18, 19] and the ARMIN 
and RUPERT device for the upper extremity [39, 40]. 
 Though actively driven exoskeletons represent the state of the art of robotics 
technology they still leave room for improvement. Most of the systems are operat-
ing in an open-loop position control mode, which means that the actively driven 
joints follow predefined reference trajectories. Hence the patients’ movements are 
supported even during phases where the voluntary force of the patient would be 
sufficient. In these cases the robotic device does not help, but hinders a patient to 
perform a movement task. Therefore a closed loop “assist-as-needed” control 
scheme should be implemented into the active devices to challenge the patient as 
much as possible and to provide support, when and where it is needed [41]. Special 
focus should be put on the fact that a physiological movement does not consist of a 
highly reproductive movement pattern, but contain some variability [42]. Therefore 
also robotic devices should incorporate a control scheme that does allow for small 
deviations from the reference trajectory, e.g. like the nonlinear control scheme of 
the “force fields” implemented in the T-/Pneu-WREX device [43] or an impedance 
control scheme of the Lokomat [44]. In this way a true cooperative robot-assisted 
therapy will become reality. 
 Nevertheless all motor-driven orthotic devices only generate muscle move-
ments in a passive way. However, from the results of pilot studies it may be con-
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cluded that an additional activation of muscles by externally applied electrical cur-
rents lead to a better outcome [45, 46]. Therefore the combination of Functional 
Electrical Stimulation and an actively driven exoskeleton may enhance neuroreha-
bilitation in the future. From a technical viewpoint this combinatorial approach 
causes additional problems since two force generating systems – the muscles and 
the external drives – contribute to the same movement and appropriate, robust 
control schemes have to be developed and tested. 
 However such hybrid systems offer the possibility that not only a training of 
restricted or lost motor function can be performed, but that the same system can 
also be used for substitution of permanently lost motor functions [47]. To achieve 
this functionality novel light-weight drives and multichannel, dry electrode concepts 
have to be introduced. 
Regulatory and safety issues 
Robotic training devices and all of their subsystems including software are medical 
products and therefore have to comply with the International Standard IEC 60601-1, 
which has become the global benchmark for medical electrical equipment. Compli-
ance with the IEC 60601-1 International Standard and/or the relevant national ver-
sions does not equal medical device approval. However, it is a recognized step to-
wards medical device approval in nearly all markets across the world. As a result, 
many companies view compliance with IEC 60601-1 as a de facto requirement in 
most markets for product registration, “CE” “UL” “CSA” marking, contract tenders 
and defense against claims in the event of problems etc. The biggest upgrade in the 
3rd edition of the standard published in 2005 [48] is that it requires a manufacturer 
to have a formal risk management process in place which complies with ISO 14971. 
The following, not exhaustive list summarizes the most important standards that 
apply in particular to therapeutic robotic systems. 
1. IEC 60601-1-1: Medical electrical equipment, General requirements for basic 
safety and essential performance; 
2. IEC 60601-1-2: Medical electrical equipment, Electromagnetic compatibility; 
3. IEC 60601-1-4: Medical electrical equipment; Programmable electrical medical 
systems; 
4. IEC 60601-1-6: Medical electrical equipment, Usability; 
5. ISO 13485: Medical devices, quality management system; 
6. ISO 14971: Medical devices- application of risk management to medical devices. 
 
In parts also the “ISO 9241: Ergonomics of human-system interaction”, which con-
tains substandards for user-centered design, applies to the design of robotic de-
vices. It has to be emphasized that devices used in clinical applications have not 
necessarily to be certified. However, if these not certified machines are intended to 
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be used in human applications then additionally to the application to an ethical 
committee a special insurance has to be procured, which covers the risks of adverse 
events caused by the application. By all means a risk analysis according to ISO 14971 
is mandatory to obtain ethical approval. Additionally to the safety manufacturers 
have to prove in a clinical testing that the device is efficient in order to introduce 
the device in the European and US market. Since therapeutic robots are highly inno-
vative products in most cases no data can be taken from literature, which prove 
their efficiency. Therefore clinical trials, preferably with a controlled and random-
ized study design, have to be performed. This fact has to be considered especially by 
small or medium sized companies, because a proper efficacy study may cause addi-
tional costs in the range of the device development before the introduction of the 
novel device to the market. 
 Within the framework of the IEC 60601 no dedicated substandard for robotic 
training devices has yet been introduced. Thus, the potential risks of harming the 
patient by the robotic training or the device itself has carefully to be considered. In 
general active orthotic devices inherently bury the risk of causing severe injuries to 
the musculoskeletal system, e.g. bone fractures, capsule injuries, ruptures of muscle 
fibers etc. This risk has to be minimized by a joint-related limitation of the maximum 
torque, which may be generated by the drives. Since a model based estimation of 
the drives’ torques is often not precise enough redundant force or torque sensors 
have to be foreseen to ensure that the applied forces in every DOF stay in a safe 
range. In case the reference trajectory cannot be followed with maximum torque 
the robot may either switch off, halt the movement or limit the applied torque to a 
safe amount. In case of end-effector based robotic systems only the net force of 
several joints can be measured, which may lead to false switch off episodes of the 
machine or in the worst case to a exceeding of safe torque limits.  
 The most apparent adverse events of robotic devices in particular of active 
exoskeletons for locomotion training are skin erythema [49]. Though skin erythema 
are not a life-threatening condition they may severely affect the compliance of the 
patient since the training may be interrupted a few days to allow for healing. There-
fore the main focus of the mechanical design of robotic devices has to be put on the 
parts that are in direct contact with the patient. It is highly recommendable to avoid 
the occurrence of shear forces in the orthotic components with direct skin contact 
by design, in order to minimize the risk for skin erythema in case of misalignment of 
the human and the machines joint centers. 
 Depending on the onset of training after a CNS lesion and the cardiovascular 
status of the patient episodes of presyncopes or syncopes may occur during verti-
calization for locomotor training. For adequate handling of a patient in this case of a 
medical emergency safety mechanisms for quick evacuation of an uncooperative 
patient are necessary.  
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Despite the automatic deactivation of the device in case of excessive torques sev-
eral emergency stops or enabling mechanisms have to be foreseen [50]. This will 
allow to check for attendance of the therapist or to give the patient the opportunity 
to stop the training on his own will. The latter is especially important if the patient 
performs the training on his own without supervision of a therapist. 
 In summary, the best safety concept of a machine is useless, if it does not work 
properly due to defective mechanical or electrical components. Thus, a highly quali-
fied technical support has to be available to perform regular check-ups and mainte-
nance of the device. 
Customization 
Human beings vary to a great degree in their anthropometric data like size, weight 
and body proportions like length or widths of extremities. In order to perform the 
training in 95% of the population with one device the machine has to be adjustable 
to a large degree and in many ways. This means that e.g. in a locomotion exoskele-
ton the length of the shank and thigh, the width of the pelvis and the position of the 
trunk in all three directions must be adaptable to the individual patient. Also the 
continuous increase of the Body Mass Index of the population of industrial countries 
represents a challenge for the level of adaptability of orthotic and robotic devices. 
 Additionally to the differences in the properties of the body segments the 
amount of impairment of neurological patients vary to a high degree. This applies 
not only to individuals within the same patient group but also between different 
patient groups. For example in incomplete spinal cord injured persons the individual 
motor deficits may vary between subjects to a high degree ranging from an isolated 
drop foot on one side to an almost complete loss of motor function in both legs. In 
stroke survivors an increased spastic muscle tone may restrict the successful appli-
cation of a robotic training. In traumatic brain injury cognitive restrictions may occur 
additionally to the physical impairments, which reduce the cooperativeness of the 
patient to a minimum. All these patient related factors lead to an individualized 
setup of either the mechanical components of the machine or the training para-
digms including feedback modalities. Since a regular therapy session is for personnel 
resources reasons limited to 45-60minutes every effort has to be made to keep the 
changeover time at a minimum. In reality it takes one therapist about 5minutes to 
prepare an end effector-based robotic system to a patient and about 10-15minutes 
in case of an exoskeleton. A much higher amount of time has to be reserved, when 
the system is initially been setup.  
 Ideally a machine would automatically adapt to different patients or does not 
need any type of adjustment, since technically solutions have been provided which 
do not need manual interventions. Surprisingly, up to now not a lot of efforts have 
been made into this direction. 
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Also the machine has to provide the possibility for setup of a large variety of training 
paradigms in order to broaden its fields of application. Most importantly the func-
tion that is trained has to be the same as the one which should be improved. Recent 
developments in robotics for the lower extremities take this prerequisite into ac-
count and offer the possibility for training of stair climbing [22]. 
 Nevertheless, it has to be kept in mind that practically none of the robotic de-
vice is able to generate a fully physiological movement since not every DOF is 
equipped with an actuator and therefore cannot be controlled independently. 
HUMAN-MACHINE INTERFACE 
The user interface is a crucial part of a robotic therapy system since it determines to 
a large degree whether a device is regularly integrated in the rehabilitation program 
of neurological patients or not. Since the robotic systems are designed by research 
and development engineers the user interfaces they design tend to be complicated 
and are not intuitive to understand. This is a general problem of the human ma-
chine interface in almost every technical product intended to be operated by users 
with different technical expertise and non-technical professional background. 
Therefore the ISO 9241-210 standard, which refers to “Ergonomics of human-
system interaction -- Part 210: Human-centered design for interactive systems” may 
be a good starting point to continuously improve the human-machine interface of a 
technical system. The ISO 9241-210 standard defines the framework of an iterative 
approach to involve end users during all stages of development of a product and 
explicitly includes parts which are important for any type of assistive technology.  
 It has to be emphasized that in rehabilitation robotics the term “end user” in-
cludes therapists as well as patients. Therefore their feedback should be addressed 
very carefully by developers and implemented into novel designs for increasing the 
acceptance. 
Mechanical interfaces 
Special attention must be paid to the mechanical interfaces between robot and 
patient. At the points where the robot is attached to the patient high forces are 
transmitted depending on the mode of operation i.e. either a robot assists the per-
formance of movements or applies resistance forces. Force vectors have to be in 
accordance to the joint axes to allow pure rotational moments. The fixations of the 
robot have to be soft and mold to fit the respective part of the body in order to 
prevent the occurrence of pressure lesions or abrasions of the skin. In contrast to 
that requirement the interfaces must transmit the forces without loss e.g. by de-
formation or loose fit. This will ensure appropriate monitoring and modeling of the 
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forces which exert on the patient. This is especially important pertaining to the 
assessment features of robotic devices. Fixations have to be adaptable to a wide 
range of anthropometrics. The usage has to be unambiguous and easy. This is of 
importance in the case when a patient has to be removed from the device quickly. 
Control and feedback interfaces 
An important component of the robotic system is the control interface, which is 
used by the therapist to set and adapt the most important therapy parameters like 
speed, amount of support or range of motion, and the feedback interface, which is 
used to provide the patient with information about the current status and the pro-
gress of the training. The control interface has to provide a very intuitive graphical 
user interface, which can be handled by an operator during the therapy. Special 
focus has to be put on the limitation of the number and the selection of an appro-
priate size of the control elements on the screen or on the operator panel to avoid 
faulty parameter settings. A general requirement of the robotic device often de-
manded by therapists is a high degree of “transparency”, i.e. all of the machine 
parameter and options are accessible. However, a balance has to be found between 
maximal adjustability and easy handling. A possible way to meet both claims could 
be the common implementation of a standard and an expert mode together with 
the possibility for individualization of the graphical user interface. 
 Additionally to the graphical user interface the input device is of crucial impor-
tance, since keyboards and mice are not easy to handle while having the patient in 
the focus, which often results in mismatch of parameter settings. Therefore touch 
panel based interface systems are a proper choice in particular if the system is op-
erated by a patient without supervision. 
 Since most of the robotic machines are equipped with sensors, which provide 
feedback about the current state and performance of the patient, the implementa-
tion of an automated adaptation scheme would free the therapist from continu-
ously adjusting the relevant parameters of the therapy. In some cases such an adap-
tation scheme may allow a robotic therapy without the need for continuous super-
vision by a therapist. However, in this condition an adequate feedback has to be 
provided to the therapist and the patient, so that both are informed what the ma-
chine is doing and to give them the confidence that both have the machine under 
control and not vice versa. 
 At the current stage of knowledge the benefit of any neurorehabilitative ap-
proach seems to be based on the enhancement of spinal as well as supraspinal 
neuroplasticity. In order to enhance the supraspinal neuroplasticity the patient has 
to be provided with an adequate feedback of his current performance in particular 
in patients with sensory deficits. This is also most important for increasing motiva-
tion. Comparable to the situation in the control interface the number of dynamic 
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feedback parameters presented to a patient at a time have to be carefully chosen, 
since a patient is only capable to influence one or two parameters simultaneously. 
The feedback parameters have to individualized chosen according to the main func-
tional deficit and the most severe impairment respectively. In case of the lower 
extremities this might be a joint angle of a dedicated gait phase like swing or stance 
phase. The feedback should be provided in an absolute scale so that patients may 
be able to compare their current status to the status at the end of the last therapy 
session. Also feedback modalities other than visual may provide a more effective 
way to enhance the perception of the patient [51]. 
ASSESSMENT AND DOCUMENTATION 
Rehabilitation robots are not only equipped with motors but also with multiple 
sensors. The signals deriving from these sensors are used to control the operation of 
the robots but can also serve as feedback and to measure certain biomechanical 
properties. Angular sensors can measure range of movement, force or torque 
transducers voluntary strength of muscle groups (Fig. 7.2). 
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Figure 7.2 Example of a series of force measurements recorded with the Lokomat sys-
tem. The columns represent the maximum force in direction of unilateral hip flexion during 
successive sessions from a patient recovering from a Guillain-Barré syndrome (the respec-
tive value of healthy volunteer amounts to 74Nm). 
 
Combined signals can assess resistance against passive movements and where in 
the movement arc resistance occurs. Changes in resistance can be attributed to 
impaired muscular tone or spasticity. Assessments are important to control the 
course of the training, to legitimate training and to document progresses or deterio-
rations. Measurement results can be used to monitor the actual state of the patient 
and to shape the training accordingly. Some improvements may not be perceived by 
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the patient but are accessible for the sensors. Prove of gains are important factors 
to generate motivation [52]. However, for any assessment there are basic require-
ments which have to be met in order to be useful. Assessments have to be practical, 
reliable, valid and responsive to changes. The measurement within a robotic device 
is easy to perform since it can be performed along with training or as a part of the 
training. Nevertheless the assessment within a robotic device is restricted to that 
particular situation. E.g. a robot is able to measure the range of motion in the sagit-
tal plane but its mechanical construction does not allow measuring in the other 
planes. Appropriate software can record and compare the results to previous meas-
urements or normative values. On the first sight it seems obvious that a mechanical 
sensor has a higher accuracy than a human examiner. A reduction of error leads to 
increased reliability. Still there are more sources for error e.g. the instruction of the 
therapist or pain may influence measurements. Few studies pertaining to this issue 
affirmed feasibility and reliability [53-55]. The concept of validity states that a given 
testing procedure aims at measuring a specified property. Regarding range of 
movement and voluntary muscle strength there are no controversies as opposed to 
the measurement of spasticity. Even widely used tests such as the Manual Ashworth 
Scale (MAS) are under debate and may be improved if tested using a robot [56]. 
 Although only few studies addressed the issue of the quality of assessment 
recorded by rehabilitation training robots it can be stated that these devices meas-
ure practical and reliable. Appropriate measurements whose results can be trans-
ferred into daily functions need to be defined. 
CONTINUATION OF A ROBOTIC THERAPY AT HOME 
Due to increasing economical restrictions in the health care system the length of 
primary rehabilitation is getting shorter, i.e. in the US Model Spinal Cord Injury Sys-
tem the mean initial rehabilitation period of incomplete patients was 89 days in 
1975, which continuously decreased to 28days in 2005 [57]. It can be expected that 
this trend will continue in the future and lead to even shorter rehabilitation periods. 
With the help of robotic locomotion the sufficient intensity of task oriented gait 
training can be sustained in the clinical setting, whereas a dramatic reduction of the 
quantity and quality of the training occurs after the discharge from the rehabilita-
tion unit. This is especially true, if patients return to their home in rural areas. 
 Though systematic experimental investigations are missing, it may be concluded 
from review of the literature that long-term, mid-intensity locomotion training over 
several months is more effective than the application of training protocols with high 
intensity for only a few weeks [58, 59]. However, up to now only a few robotic train-
ing devices exist for home based locomotion training. A simple transfer of the exist-
ing robotic devices to the patients’ homes is not possible since most of them are 
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mainly restricted to the application in a clinical setting due to their size, weight and 
price. Furthermore most of the devices have to be operated by skilled therapist. 
 The main challenges of therapy devices for application in the home environ-
ment are safety issues and the self-operation of the device by the users themselves. 
This is especially true for the use of locomotion training devices. Whereas in the 
clinical environment the therapy is supervised by trained therapists, in the home 
environment a safe operation without the need for supervision has to be guaran-
teed.  
 Only a few studies exist which describe the development and application of 
dedicated home based robotic training systems [6, 60]. In locomotion robotics a key 
method to minimize the risk of injuries is to put the user in a safe training position, 
like a semi-recumbent position of the body in the MoreGait device (Fig. 7.3). 
 From the available results of a real home based training it may be concluded 
that a safe application without a high risk for serious adverse events is feasible and 
that the outcomes of the training are in the same range than of systems used in 
clinics. 
 
 
Figure 7.3 The MoreGait 
is a pneumatically actuated 
robot for the training of 
ambulatory function. The 
device allows the use at 
the patient’s home. 
 
Nevertheless a certain amount of supervision is necessary to assess the current 
status of the patient, to individually adjust therapy parameters to her/his progress 
and to help patients in solving small hardware problems. Here internet based tele-
monitoring methods are a cheap and effective tool for transfer of sensor data and 
diagnostic trouble codes of the machine to a centralized location e.g. a large reha-
bilitation center or an outpatient clinic. Personal video conferences between a ther-
apist and users or among different users are very valuable to keep patients moti-
vated and to share experiences. 
 A very promising way of performing a home based therapy especially in patients 
with minor motor and cognitive deficits is the use of conventional gaming consoles 
like Nintendo’s Wii or Microsoft’s Xbox in particular with the kinect option. The 
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latter allows for full body movement analysis and therefore a joint specific therapy 
without the need for dedicated markers or sensor fixed to the body. The main ad-
vantage of using such type of technology is the non-limited availability and the low 
price. 
 The gaming console based training relies mainly on the feedback principles of 
the external focus, which beneficial for the learning of task automatism. This form 
of training is motivating and provides the possibility for giving feedback about the 
current state of the functional impairment and the improvement over time to the 
user. However, up to now only a few studies exist, which evaluate the effect of a 
console-based training [61]. Furthermore it has to be investigated in the future, if 
the already implemented option for an internet based multiplayer mode may be 
used for a supervision of a home-based training by a qualified therapist. 
Financial aspects 
In the long run every novel therapeutic or diagnostic procedure will only become a 
standard, if a financial benefit for the health care or the welfare system can be 
achieved. This does not necessarily mean that the novel method has to be inexpen-
sive itself. The maybe most prominent counterexample is MRI, which is a cost inten-
sive diagnostic method, but saves a lot of money by providing the basis for a major 
improvement in clinical decision making.  
 The costs for the application of a robotic training are comprised by device’s 
costs, costs for personnel and its training, cost for infrastructural alterations and 
cost for technical support. The costs of the device are mainly based on its complex-
ity: The more complex, the more expensive. The price of a system is to a large 
amount dependent on the number of actuators it contains, since not only actuators 
but also sensors for safety issues have to be foreseen. Most of the people outside 
the neurorobotics field believe that – like in industrial robots – less personnel is 
necessary to perform a given therapy regime. This may be true for the lower ex-
tremities, where up to three therapists are needed to perform a conventional body 
weight supported treadmill training. However, this does not apply to upper extrem-
ity training settings, where one therapist is necessary to perform a manual training. 
By any means one therapist is necessary to supervise the robotic training therapy.  
 The justification for implementing robotic training machines into clinical routine 
is mainly based on the fact that in the given time frame for primary rehabilitation 
the patient achieves a higher level of independence by the use of robotic therapies 
[62], which in turn may save costs for care and prevent secondary complications.  
 Nevertheless, in most countries the robotic training sessions are not regularly 
compensated by insurance companies or sickness funds. Here additional efforts are 
needed in the future from industry as well as from health care providers to give 
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every patient with a motor disorder the chance to profit from such a type of train-
ing. 
CONCLUSIONS 
For the successful development, application and integration of robotic systems 
engineers, clinicians and end users have to work closely together. The devices’ spec-
ifications should be founded on rehabilitative goals and neurophysiological knowl-
edge. The characteristics of robotic devices should comply with the demands of 
patients and therapists. In order to justify the costs of rehabilitation robots, they 
should allow the adaptation to a wide range of patients with respect to anthropom-
etrics but also with respect to different grades of capabilities reflecting the actual 
state of rehabilitation. In the beginning supporting forces are required in later stag-
es a device may apply resisting forces in order to challenge patients appropriately at 
every level. The setup and operation of robots should fit in a clinical setting. Signals 
from sensors enable sophisticated feedback modalities and the surveillance of train-
ing progression.  
 Robotic devices are very useful enhancements of rehabilitation interventions by 
offering additional training as well as measurement options. Studies suggest that an 
advantage of therapy by robotic devices, compared with conventional therapies, 
may be an increase in repetitions during training. Robot-assistive training devices 
therefore allow a massed practice therapy paradigm, which is intensive, frequent 
and repetitive, and accords with the principles of motor learning. They offer for the 
first time the possibility to systematically investigate dose-outcome relationships 
since the variability, the physical constraints of therapists and their limitations in 
terms of guiding movements of several joints simultaneously can be overcome. 
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ABSTRACT 
Objective. To determine whether automated locomotor training with a driven gait 
orthosis (DGO) can increase functional mobility in individuals with chronic, motor 
incomplete spinal cord injury (SCI). Design. Repeated assessment of the same pa-
tients, or single case experimental design: A-B. Setting. Research units of rehabilita-
tion hospitals in Chicago, USA, Heidelberg, Germany, Basel and Zurich, Switzerland. 
Participants. Twenty patients with a chronic (> 2 yrs post injury), motor incomplete 
SCI, classified by the American Spinal Injury Association (ASIA) Impairment Scale 
with an ASIA C (n=9) and D (n=11) injury. Most patients were ambulatory prior to 
locomotor training (n=16). Intervention. Locomotor training was provided using 
robotic-assisted, body weight supported treadmill training (BWSTT) 3-5 times per 
week over a period of 8 weeks. Single training sessions lasted up to 45 minutes of 
total walking time, with gait speed between 0.42-.69 m/s and  body weight unload-
ing as low as possible (mean=37 ± S.D. 17%). Main Outcome Measures. Primary 
outcome measures included the 10-m walk (10 m), the 6-minute walk (6 min), the 
Timed Up and Go (TUG), and the Walking Index for Spinal Cord Injury –II (WISCI II) 
tests. Secondary measures included lower extremity motor scores and spastic mo-
tor behaviors to assess their potential contribution to changes in locomotor func-
tion. All subjects were tested pre-, mid- and post- training. Results. Locomotor train-
ing using the DGO elicited significant improvements in the subjects’ gait velocity, 
endurance and performance of functional tasks. No significant changes were ob-
served in the requirement of walking aids, orthoses or external physical assistance.  
There was no correlation between improvements in walking speed and changes in 
muscle strength or spastic motor behaviors. Conclusions. Intensive locomotor train-
ing on a treadmill with the assistance of a DGO results in improved overground 
walking function.  
 
Keywords. Body-weight supported treadmill training, Paralysis, Locomotion, Physical 
therapy 
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INTRODUCTION 
In the US alone, over 8000 individuals suffer from a traumatic spinal cord injury (SCI) 
each year [1-3]. Recent statistics indicate that more than 50% of individuals with SCI 
have motor incomplete lesions. Approximately half of motor recovery occurs within 
the first 2 months following initial injury [4-6], with a decreasing rate after 3-6 
months, and nearly complete recovery evident 2 years post-injury [7-9]. In patients 
with an initial motor incomplete SCI, over 75% regain some form of ambulatory 
function [10]. 
 While conventional rehabilitation programs certainly enhance performance of 
functional tasks [11], the loss of strength and coordination substantially limits the 
capacity for overground ambulation training [12, 13]. In the past two decades, body 
weight supported treadmill training (BWSTT) has been proposed as a useful adjunct 
to enhance locomotor function following motor incomplete SCI [14]. Such training 
consists of unloading a portion of a patient’s weight above a motorized treadmill 
using a counterweight-harness system, and providing manual facilitation to assist 
the patient to perform stepping movements on a treadmill. Use of BWSTT has been 
shown to improve coordination of electromyographic activity in the lower extremi-
ties and postural alignment [13], and allows increased practice of stepping behav-
iors with diminished or absent supraspinal control [15-17]. The benefits of such 
training in individuals with incomplete SCI have been reported in several studies 
over the last decade [18,19] (see recent reviews [20-22]). Specifically, on a cohort of 
individuals with acute and chronic SCI, Wernig and colleagues demonstrated sub-
stantial improvements in functional walking ability following task-specific treadmill 
training as compared to similar groups who received conventional rehabilitation 
[18]. While the results from a randomized trial comparing the effectiveness of 
BWSTT vs. conventional therapy are forthcoming [23], anecdotal reports have con-
firmed the positive benefits of performing such task-specific training [21, 24, 25]. 
 Despite the potentially positive benefits of BWSTT, its practice in a clinical set-
ting is physically demanding and uncomfortable to those providing assistance. Fur-
ther, BWSTT can require up to three individuals to facilitate upright posture and 
normal walking patterns [21]. Concerns that traditional rehabilitation approaches 
are arduous and labor-intensive have caused many researchers and clinicians to 
search for alternatives. A computer-controlled, driven (i.e., motorized) gait orthosis 
(DGO) has recently been developed to provide assisted locomotor training (please 
see Fig. 8.1). In the place of therapists, the exoskeletal apparatus assists individuals’ 
lower extremities through symmetrical, coordinated trajectories that mimic physio-
logical walking patterns.  In combination with body-weight support, the DGO may 
provide some of the critical sensory cues necessary for generating the appropriate 
locomotor pattern, as suggested by work in experimental animal models of SCI [26]. 
Use of such a device in the rehabilitation setting could potentially maximize locomo-
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tor function following motor incomplete SCI by increasing the total duration of 
training and reducing the labor-intensive and costly interventions provided by ther-
apists. 
 The primary aim of this multi-center study was to examine whether locomotor 
training using the DGO resulted in improved overground walking function and per-
formance of a multi-functional task in patients with chronic, motor incomplete SCI. 
In a subpopulation of participants in one setting, we further examined whether 
locomotor training affected lower extremity motor scores and spastic motor behav-
iors. Changes in locomotor performance in subjects with SCI following intensive, 
long-duration gait training using the DGO could establish the therapeutic benefits of 
automated, task-specific therapy following SCI. 
METHODS 
The study was carried out in five separate SCI rehabilitation units over a period of 
two years. The protocol of the study was approved by the local ethics committee 
(i.e., institutional review board) of each training facility, and all participants were 
informed and gave written consent. 
Subjects 
Twenty patients (18 men, 2 women), with a motor incomplete SCI with a neurologi-
cal lesion level of greater L1 or higher, with the primary neurological insult due to 
trauma or ischemia, participated in this study (please see Table 8.1 for a description 
of each patient). Mean age at the time of study enrollment was 40years (range: 16-
64years, standard deviation: ±14years). The average interval between SCI and the 
onset of DGO training was 5.9years (2-17years, ±4.9years; please see Table 8.1). 
Nine subjects were classified by the American Spinal Injury Association (ASIA) as 
ASIA C and 11 as ASIA D. Eleven of the subjects presented with tetraplegia and 9 
with paraplegia. Sixteen subjects were able to ambulate at least 10meters over-
ground with various assistive devices and the assistance of one person, although 
only four individuals used overground ambulation as their primary mode of locomo-
tion in the community. 
 Specific inclusion criteria included: greater than 2years since initial SCI; not 
currently enrolled in physical therapy or other training regimens; and, the ability to 
maintain their current anti-spastic medication dosage throughout training sessions. 
Under these conditions, the majority of changes in motor behaviors and functional 
ability were assumed to be due to the locomotor training provided by the DGO. 
Additional inclusion criteria consisted of the following: between 16 and 65years old, 
lower extremity weight bearing (standing and/or walking) as part of typical activities 
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of daily living; and, medical clearance to participate. Exclusion criteria included: 
presence of concurrent severe medical illness, unhealed decubiti, existing bladder 
or other infection, thromboembolic disease, significant osteoporosis (as indicated 
by history of fractures), severe lower extremity contractures or excessive lower 
extremity spasticity limiting range of motion or normal kinematics during locomotor 
training, history of significant obstructive and/or restrictive pulmonary disease, and 
inability to tolerate 45minutes of standing without orthostasis (i.e., decrease in 
blood pressure by 20mmHg systolic and 10mmHg diastolic). Size limitations for the 
DGO included femur length less than 35cm or greater than 47cm, and body weight 
greater than 150kg.  
 
Table 8.1 Description of the 20 study subjects 
Patient No Sex 
Lesion Level/ 
ASIA Grade 
Years  
Post-SCI 
Antispastic 
Medications 
 1 M C6/C  2 60 mg baclofen 
 2 M C5/C  4 none 
 3 M C5/C 13 none 
 4 M C6/D  3 none 
 5 F T8/D  4 none 
 6 M T10/C 17 none 
 7 M T9/C  8 none 
 8 M C5/C  2 none 
 9 M C7/D  4 30 mg baclofen 
10 M C3/D  3 none 
11 F C3/D  6 none 
12 M L1/D  2 none 
13 M L1/C  6 none 
14 M C5/D 16 none 
15 M T10/D  2 none 
16 M L1/D  2 none 
17 M C5/C  3 160 mg baclofen, 20 mg valium 
18 M T7/D  3 25 mg baclofen, 0.5 clonazepam 
19 M T8/D  3 none 
20 M C7/C 10 none 
Note. Subjects had a mean age of 40.5 years (range, 22-64y). 
Abbreviations: F, female; M, male 
Training paradigm 
A detailed description of BWSTT has been published previously [18, 27, 28]. Briefly, 
training involved unloading a subject over a motorized treadmill using a harness and 
overhead suspension system, with the amount of unloading adjusted to maximize 
lower extremity weight bearing while ensuring correct limb kinematics through 
stance and swing (minimizing excessive knee flexion during stance phase/weight 
acceptance) [21, 29, 30]. 
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To perform stepping patterns on the treadmill, subjects were assisted by the DGO 
(Lokomat®, Hocoma AG, Zurich, Switzerland; Fig. 8.1). The DGO is composed of 
bilateral, exoskeletal leg braces secured to the patient at the level of the pelvis and 
throughout the lower extremities by adjustable size cuffs attached to the exoskele-
ton (one cuff at the thigh, two at the shank). Leg lengths were adjusted to align each 
subject’s hip and knee joints to the axes of the exoskeleton. The ankle was secured 
in a neutral (i.e., 90 degree) position by elastic straps fixated around the metatarsal 
heads and attached. The pelvis and trunk were secured in place by Velcro® straps 
attached to backrest. 
 
 Figure 8.1 The DGO (Lokomat) 
 
The DGO is controlled by computer-programmed DC motors at bilateral hip and 
knee joints that provide an automated, reciprocal stepping pattern consistent with 
normal kinematics of human gait [25] and synchronized with the treadmill belt 
speed [32, 33]. Electromyographic recordings of selected lower extremity muscles 
measured during DGO-assisted treadmill training are similar to that obtained during 
manually assisted training in individuals with SCI [34]. 
 Training using the DGO lasted 8weeks, with 3-5training sessions each week as 
tolerated by the subjects (i.e., subjects typically could not attend >3session/week) . 
Each training session lasted up to 45minutes of walking time supervised by a li-
censed therapist or therapist assistant. The amount of body-weight support pro-
vided to each patient was adjusted independently, and decreased as tolerated 
without evidence of excessive knee buckling and toe drag. The speed of training was 
set at a comfortable level for each subject, and increased as tolerated, up to a 
maximum of 0.66m/s. The speed of training was limited by the gait pattern of the 
DGO at higher speeds, by subjective report of fatigue by the subjects, and the com-
fort level of the subject during training (e.g., increased spastic motor behaviors at 
higher speeds). 
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Outcome measures 
Primary: Locomotor performance tests were assessed at pre-, mid- and post- train-
ing evaluation sessions.  All outcome measurements were performed outside of the 
DGO. The Walking Index for Spinal Cord Injury II (WISCI II) was used to determine 
subjects’ ambulatory capacity by assigning a ordinal measure (range 0-20) with 
regard to amount of assistance required during ambulation, and use of assistive 
devices and/or lower extremity bracing [35, 36]. Category 0 indicates that the sub-
ject is not able to stand or walk, category 20 indicates that the subject is able to 
walk at least 10 m without devices, bracing or physical assistance.  
 Gait speed was assessed using the 10m walk test. Although multiple methods 
exist to test the 10-m walk test [37-40], walking time was recorded after the subject 
ambulated 2m, and stopped 2m prior to the finish line to account for potential ac-
celeration and deceleration effects [41]. Subjects were instructed to walk at a com-
fortable pace over the required distance in a straight line. Patients could use their 
preferred assistive device including minimal physical assistance as needed.  One of 
the four centers recorded the time required for the subjects to ambulate six meters 
while the other three centers recorded the time required to walk ten meters. De-
spite differences in protocol at the separate sites, the measurements remained 
consistent at each center. 
 The 6-minute walk test was used to determine gait endurance [42]. Subjects 
were asked to walk for 6minutes at their self-chosen pace, and were allowed to rest 
when they felt unable to continue. The total walking distance was recorded. The use 
of any physical assistance, bracing and/or devices was documented. Each subject 
used the same assistive device and/or bracing at all evaluation sessions. 
 The Timed “Up and Go” test (TUG) was performed to assess performance of 
multiple tasks, including sit to stand transfers, gait speed, and postural stability. In 
the TUG test, the time required for a subject to rise from a standard height arm 
chair, walk 3m, return to the chair and sit down has been used as an indicator for 
individuals at risk for falling [43]. 
 With the exception of the WISCI II, functional ambulation and balance measures 
are not specific for the population with incomplete SCI. The validity and reliability of 
these measurements have been assessed in other patient populations, and reflect 
general measures of ambulatory and functional performance [42-45].  
 Secondary: In a sub-population of the subjects enrolled in the study at one cen-
ter (n=10; subjects 1-9 and 17 in Table 8.1), we also assessed changes in lower ex-
tremity motor scores (LEMS) and the magnitude of spastic motor behaviors. For 
LEMS, manual muscle testing was performed according to the American Spinal In-
jury Association (ASIA) guidelines [45]. Five key muscle groups of the lower extremi-
ties were assessed bilaterally, including the hip flexors, knee extensors, ankle dorsi-
flexors, great toe extensors, and ankle plantarflexors. Each muscle group was grad-
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ed between 0 (no muscle contraction) to 5 (able to withstand maximal resistance) 
with the maximum score of 50. 
 For spastic motor behaviors, two types of involuntary movements are often 
present following SCI. Spasticity, or velocity-dependent resistance to externally 
imposed, passive muscle stretch, is common in individuals with lesions to descend-
ing motor pathways [46]. In distal musculature, this behavior may present as clonus, 
or periodic (6-8 Hz) muscle bursting with lengthening perturbations [47], although 
these behaviors can occur in the ankle without substantial changes in the length of 
the triceps surae [48]. In addition, subjects with SCI often experience “spasms”, 
which are manifested as hyperactive, multi-joint reflexes coexisting with spasticity 
[49]. In general, spasms are classified as either extensor spasms, distinguished as 
knee extension with ankle plantarflexion and hip co-contraction [50], or flexor 
spasms, characterized by ankle and great toe dorsiflexion, with knee and hip flexion 
[51]. 
 The Ashworth scale was utilized to assess spasticity, in which the involuntary 
resistance to single-joint passive movement is assigned an ordinal score (0-4) [52] 
with lower scores representing no spasticity and higher scores indicating increasing 
resistance to external perturbations. To evaluate spasms and clonus, the recently 
validated Spinal Cord Assessment Tools for Spasticity (SCATS) [53] was utilized by 
assigning ordinal score (0-3) describing either the duration or magnitude of spasm 
activity following specific manual perturbations (Table 8.2). Flexor spasms are elic-
ited by stroking the sole of the foot with the back of reflex hammer (i.e., Babinski 
test) with a subject in the supine position, and assigning scores according to the 
degree of great toe/ankle/hip movement observed. Extensor spasms and ankle 
clonus are determined by spasm duration with subjects in the supine position. Ex-
tensor spasms were triggered by passively flexing the knee and hip to 90degrees, 
then rapidly extending the limb and monitoring the duration of quadriceps contrac-
tion. With clonus, the ankle is rapidly dorsiflexed from an initial extended position 
and held in place, with the therapist determining the duration of clonus bursts. The 
degree and type of spastic motor behaviors vary across the population of SCI sub-
jects tested, and are not correlated with level, duration or completeness of injury 
[53]. Scores were determined on each lower extremity with the measurements from 
the more spastic extremity used for statistical analysis.  
 
Table 8.2 SCATS Rating Scheme 
Spasm type 0 1 (Mild) 2 (Moderate) 3 (Severe) 
Clonus NR 1-3 sec 3-10 sec >10 sec 
Extensor NR 1-3 sec 3-10 sec >10 sec 
Flexor NR <10° hip/knee flexion and/or 
great toe extension 
10-30° hip/knee  flexion  > 30° hip/knee 
flexion  
Abbreviations: NR, no response 
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Statistical analysis 
Measurements of motor performance and functional abilities were assessed prior to 
and following 4 and 8weeks of treadmill training. Inclusion of subjects with neuro-
logical levels of injury below T11 (3 subjects) and those prescribed anti-spastic med-
ications (4 subjects) presented two potentially confounding factors for enhancing 
locomotor ability with repeated treadmill training. Statistical analyses were there-
fore performed using all subjects and following exclusion of the sub-population of 
subjects described above. 
 The lack of normally distributed measurements (determined by the Shapiro-
Wilk test) required use of non-parametric statistical methods to detect changes in 
locomotion function and motor impairments throughout training using both ordinal 
and ratio data. The Friedman ANOVA by ranks and subsequent pair-wise compari-
sons using the Wilcoxon Signed Ranks tests were performed to assess differences in 
pre-, mid- and post-training measures, with the family-wise error rate noted at 
P<0.017 to account for multiple comparisons (pre- to mid-, mid- to post-, and pre- 
to post-training). Statistical analysis was performed for the absolute changes in all 
clinical measurements. For the 10m, 6min, and TUG tests, the relative changes in 
performance (percentage change from initial evaluation) were also calculated and 
reported. Specific relationships between changes observed between the evaluation 
periods (i.e., between the first 4weeks vs. second 4weeks of training) were deter-
mined using the Wilcoxon Ranked Signs Test, with significance also noted at P<0.05. 
Spearman correlation coefficients were calculated to assess for correlations be-
tween the initial performance on locomotor and functional assessments vs. changes 
in performance of these tasks (absolute and relative), and between changes ob-
served in LEMS, Ashworth, and SCATS measurements with functional improve-
ments. 
RESULTS 
The mean (±S.D) total number of sessions for all subjects was 26±4.3 sessions during 
the 8weeks (range: 24-37). The average distance ambulated during single training 
sessions was 1279±282 m (range: 200-1893) at a walking speed of 0.55±0.03 m/s 
(range: 0.42-0.67). Mean unloading during treadmill training was 37±17% (range: 0-
85) of body weight (Fig. 8.2). 
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Figure 8.2 Mean training speed and percentage body weight throughout training. 
Error bars indicate standard error (SE). 
Abbreviation: BWS, body weight support 
 
Primary outcome measures 
Improvements in walking ability as determined by WISCI II scores were observed in 
only 2 out of 20 subjects. One subject who used two crutches before the training 
series could walk with only one cane after training, but still required a leg brace 
(WISCI II score increased from 12 to 15). In another subject, a single straight cane 
was utilized prior to training, although no assistive devices were required following 
8weeks of locomotor therapy (WISCI II score change from 19 to 20). All individuals 
who were non-ambulatory prior to training did not regain locomotor function. No 
significant difference was found for the WISCI II (χ2=3.0; P=0.22) across all ambula-
tory subjects or following exclusion of subjects prescribed anti-spastic medications 
or subjects with lesion levels below T11 (all individuals in these latter groups did not 
change their WISCI II scores).
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For overground gait assessments, improvements in speed and endurance were 
observed in nearly all subjects following locomotor training using the DGO (Fig. 8.3). 
Using the 10m walk test, there was a significant increase in mean gait speed 
(0.11±0.10 m/s) following locomotor training (χ2=20.1; P<0.0001). This change cor-
responded to a 56±60% improvement over initial, control (pre-training) values. Of 
the five subjects who, prior to training, were able to walk faster over-ground than 
the maximal speed of the Lokomat (0.66m/s), three individuals improved in their 
gait speed post-training. Significant changes across all subjects were observed from 
pre- to mid-training evaluations (i.e. 0 to 4weeks; P<0.0001), and from mid- to post-
training assessments (i.e. 4 to 8weeks; P<0.0001) across the population tested, with 
no difference observed in the rate of improvement when comparing the initial vs. 
final 4weeks of training (P=0.79). 
 Gait speed increased significantly following exclusion of individuals with injury 
levels below T11 or those prescribed anti-spastic medications. Specifically, the mean 
increase in gait speed in individuals with lesion levels at or above T11 was .09±0.09 
m/s (P<0.001) vs. 0.16±0.12m/s in individuals with lesions below T11. Despite this 
large relative difference between groups, statistical differences were not calculated 
due to the small sample size.  The average increase in gait speed in individuals not 
prescribed anti-spastic agents was .09±0.09 m/s (P<0.001), which was also less than 
in the group of ambulatory subjects prescribed these agents (0.13±0.10 m/s). 
 Similar results were observed for the 6-min walk test, with 15/16 subjects dem-
onstrating improvements in their walking distance. The mean increase in distance 
ambulated across the subject population was 32.3m±37.5 (relative increase of 
53±50%; χ2=26.4; P<0.0001). Similar to the 10-m test, significant differences were 
noted during the initial (P<0.01) and final 4weeks of training (P<0.001), with no 
difference between the rate of improvements observed during these periods 
(P=0.46). Significant differences were also noted following exclusion of subjects with 
lesion levels below T11 (46±39m; P<0.001, vs.37±24 m in subjects with <T11 lesions) 
and prescribed anti-spastic medications (47±38 m; P<0.001, vs. 30±22m in subjects 
prescribed agents). 
 For the TUG test, improvements were observed in all but two of the ambulatory 
subjects tested. The mean decrease in time to perform the TUG test was 25±30 s 
(32±19%; χ2=22.1, P<0.001), with the largest changes observed following the first vs. 
second 4weeks of training (mean decrease =20±26s, P<0.01 vs. 5±6s, P<0.01, re-
spectively). The difference in the rate of improvements in the performance of the 
TUG was significantly different (P<0.001), however. Improvements in the TUG were 
slightly less in individuals with lesion levels >T11 (21±18s) and in those not pre-
scribed anti-spastic medications (24±32s), although the differences were both sta-
tistically significant (P<0.001). 
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Figure 8.3 Changes in (A) 10MWT, (B) 6MWT, and (C) TUG test before and after 4 and 8 weeks of 
robotic-assisted locomotor training. 
Error bars indicate SE. 
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Figure 8.4 Initial versus relative (ie, percentage) changes after locomotor training in (A) 10MWT; 
(B) 6MWT; and (C) TUG test. 
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For the observed changes in locomotor ability during the 10-m, 6-min, and TUG 
tests, significant correlations between the initial pre-training performance and the 
magnitude of the improvements were observed (Fig. 8.4). As compared to the rela-
tive (i.e., percentage) change from the initial value prior to locomotor training, cor-
relation coefficients revealed significant negative relationships for 10m walk (rs=-
0.67, P<0.01) and the 6min walk (rs=–0.51, P<0.05), indicating that the slower ambu-
lators demonstrated the greatest relative improvement. This was not the case for 
the TUG as the correlation coefficient only approached significance (rs=0.44, 
P=0.08). 
Secondary outcome measures 
In addition to gait and functional assessments, LEMS and spastic motor behavior 
tests were performed at only one of the four test centers. For LEMS, the mean im-
provement in total scores for 10 subjects tested prior to, and the mid-point, and 
following locomotor training was 2.5 (LEMS initial =32 vs. final =35, n=10; χ2=13.4, 
P=0.016), with significant differences observed only between the 4week and 8week 
assessments. Changes were not specific to any individual muscle groups tested. For 
nine ambulatory subjects, changes in LEMS were not correlated to the absolute or 
relative changes in performance on the 10 m walk test, the 6min walk test and TUG, 
with the lowest coefficient observed for the changes in LEMS vs. relative changes in 
the 10m walk test (rs =–0.44, P=0.20). Notably, the correlation is negative, whereas 
a positive correlation between LEMS and gait speed changes was expected. An ex-
ample of this relation is shown in Fig. 8.5 for LEMS scores vs. the relative (i.e., per-
centage) increase in gait speed for the 10-m walk test. 
 For spastic motor behaviors, we evaluated the involuntary resistance to passive 
stretch of the quadriceps muscle groups using the Ashworth scale, and assessed 
clonus, and multi-joint extensor and flexor spasm activity using the SCATS. Averaged 
scores for each assessment prior to and following 4 and 8weeks of locomotor train-
ing are presented in Fig. 8.6. Of these measures, only extensor spasm scores using 
the SCATS decreased substantially following 8 weeks of training (P<0.01). Changes in 
all spastic motor assessments were not correlated to changes in relative or absolute 
measures of the 10-m, 6-min or TUG tests (smallest rs=0.41; P=0.27). 
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Figure 8.5 Change in LEMS versus change in gait speed after locomotor training. 
 
 
 
 
 
 
 
 
Figure 8.6 Changes in knee extensor Ashworth Scale scores and SCATS scores before and after 4 and 8 
weeks of robotic-assisted locomotor training. 
Error bars indicate SE. 
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DISCUSSION 
The primary aim of this study was to evaluate whether an intensive locomotor train-
ing using a robotic device (DGO) improved ambulatory and functional capabilities of 
individuals with chronic motor incomplete SCI. The main observations were three-
fold. First, there were no significant changes in WISCI II scores, indicating the degree 
of physical assistance, use of assistive devices, and lower extremity bracing. Signifi-
cant changes were, however, observed in functional limitations, including: a) in-
creased overground gait speed (10-m walk test), b) improved gait endurance (6-min 
walk test), and, c) decreased time necessary to perform the TUG test. Those ambu-
latory subjects whose locomotor and functional ability was most impaired experi-
enced the greatest benefit from the training, as demonstrated by higher relative 
and absolute gains in performance on the standardized assessments. Finally, im-
provements in LEMS and decreases in specific spastic motor behaviors (i.e., exten-
sor spasms) were observed, but were not correlated to changes observed in walking 
function. The results of this preliminary assessment of the effects of long-duration, 
locomotor training using the DGO in combination with BWSTT in subjects with mo-
tor incomplete SCI indicate that robotic treadmill training can elicit substantial im-
provements in overground functional ability. 
 The role of manual-assisted BWSTT to enhance motor recovery and improve 
ambulation following neurological injury has been studied intensively for the past 
15 years (recently reviewed [54]). Increases in lower extremity motor strength, 
walking ability and postural stability have been observed in individuals with motor 
incomplete SCI and stroke in the acute through chronic stages of recovery. Such 
changes have been compared favorably to conventional rehabilitation [18, 55-57], 
indicating that task-specific, manual-assisted BWSTT may maximize neurological 
recovery and gait restoration. One of the primary limitations of such therapy is, 
however, the labor-intensive efforts required on the part of the therapists. Manual 
facilitation of the lower extremities and trunk to generate appropriate kinematics 
associated with stepping behaviors can require substantial effort, especially during 
training of patients with significant weakness or spastic motor behaviors. As many 
as three individuals are often required to assist stepping behaviors, thereby limiting 
the extent to which such therapy can be performed in the clinical setting. 
 Robotic- and manual-assisted, body weight supported treadmill training are 
similar in their attempt to practice walking while facilitating kinematically correct 
stepping patterns. The noted advantage by delivering robotic-assisted training is 
that specific locomotor interventions can be carried out with the assistance of only 
one therapist, and can be performed for a longer duration, thereby increasing the 
amount of practice of stepping behaviors. The results from this study suggest that 
the improvements in locomotor function in our ambulatory subject population were 
statistically and functionally significant, with the mean increase in gait speed and 
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endurance greater than 50% of pre-training values. The improvements in ambula-
tory subjects were qualitatively similar to those observed in individuals with a simi-
lar diagnosis and chronicity of injury whom performed manual-assisted BWSTT [58]. 
Furthermore, similar to studies investigating the effects of manual-assisted, BWSTT, 
individuals in the chronic stages of injury who were not ambulatory prior to training 
did not regain functional, overground ambulation capability after training on the 
Lokomat® (c.f., [58]). Whether robotic-assisted BWSTT can elicit similar or greater 
functional improvements as compared to manual-assisted locomotor training or 
conventional therapy remains to be elucidated in future work. 
 Five caveats regarding the improvements in locomotor ability following robotic-
assisted treadmill training in individuals with chronic SCI should be addressed. First, 
despite improvements in at least one of the functional gait assessment in all sub-
jects, the extent of recovery was dependent on their initial ambulatory capacity. 
Specifically, individuals who demonstrated the greatest improvements in gait speed, 
endurance, and the TUG test were generally most impaired, as determined by the 
correlation coefficients between initial and relative improvements in functional 
performance. These results indicate that the locomotor training provided by the 
DGO may have been insufficient to elicit greater improvements in motor recovery of 
higher functioning patients, or that recovery in these individuals had maximized 
their neurological recovery. Indeed, four subjects with SCI ambulated at higher 
overground gait speeds than the DGO allowed, and demonstrated the smaller rela-
tive improvements. Future studies should address the most appropriate selection 
criteria of subjects for locomotor training using the DGO. 
 Second, enrollment of subjects with neurological injury levels below T11, or of 
individuals prescribed anti-spastic medications, presented two confounding factors 
that may have influenced the results of robotic-assisted training. Damage to lower 
extremity peripheral nerves (as may occur with lower level injuries) may reduce the 
conduction of afferent signals to the spinal cord thought to be essential to enhanc-
ing spinal plasticity associated with locomotor improvements. Further, various anti-
spastic medications have been shown to affect locomotor activity in individuals with 
SCI [59], and may alter the rate of locomotor recovery with training.  The results of 
this study indicate that the mean improvements in gait speed and endurance or the 
TUG were not altered considerably following exclusion of subjects with these poten-
tially confounding variables. Indeed, substantial locomotor improvements were 
demonstrated in all ambulatory subjects with lower level injuries or prescribed anti-
spastic agents, although the lower sample size prevents extrapolation to a larger 
subject population. The rate and extent of improvements in locomotor function in 
individuals with lower neurological level injuries or prescribed various pharmacol-
ogical agents that alter motor behaviors certainly requires future investigation. 
 Third, the assessment of walking ability in the present study demonstrates that 
the prediction of the improvement in walking capacity in individuals with SCI is lim-
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ited if it is only based on the assessment of static motor behaviors, such as volun-
tary muscle force or spastic motor behaviors, which represent standardized proce-
dure in patients with a SCI [45]. For example, despite previous studies suggesting a 
relationship between LEMS and overground walking ability [60, 61], there is some 
evidence to suggest that, following a specific treadmill training intervention, chang-
es in LEMS do not correlate with changes in over-ground walking speed [62], as 
demonstrated in this study. While the motor score is likely to reflect the spontane-
ous recovery of corticospinal function [63], the improvement of walking ability also 
reflects the plasticity of spinal neuronal centers below the level of lesion [15, 16, 
64]. Previous evidence suggests enhanced recruitment of lower extremity motor 
pools during voluntary treadmill stepping or multi-joint movements as compared to 
voluntary activity generated during single joint movements [64, 65], as assessed 
during ASIA classification. A comprehensive assessment of SCI patients should in-
clude tests which address the functional performance i.e. walking tests, as used in 
this study. 
 In addition, spastic motor activity was not significantly altered, except for the 
observed reduction in multi-joint extensor spasms, characterized by hip co-
contraction, knee extension, and ankle plantarflexion to imposed hip and knee ex-
tension in the supine position. The changes in functional performance reflect a sub-
stantial alteration in voluntary motor activity in the absence of changes in most 
clinical spasticity measurements. This observation in 10 chronic SCI subjects is in-
consistent with data presented in a case report illustrating reduction in spastic mo-
tor behaviors in an individual 5years post-injury following patterned neural stimula-
tion, including BWSTT [66]. 
 Further, in the present study, the WISCI II test did not detect changes in ambu-
latory function, while improvements in other standardized gait or functional as-
sessments demonstrated substantial improvements. The WISCI II test may be less 
sensitive to changes in specific interventions, or the extent of locomotor training 
may have been insufficient to generate substantial improvements in the subjects’ 
use of bracing and assistance. The 10-m walk, the 6-min walk and the TUG tests 
were more sensitive, however, reflecting improvements in nearly all subjects. While 
these latter tests were primarily developed to assess the mobility of geriatric pa-
tients, they nevertheless can reflect the walking and functional ability of ambulatory 
individuals with SCI. A further study is certainly required to evaluate the validity and 
reliability of these clinical assessments in patients with incomplete SCI. 
 Finally, the results of our study indicate that improvements in locomotor ability 
are evident for a particular subpopulation of subjects tested. While many subjects 
demonstrate considerable improvements in over-ground walking speed and endur-
ance, the significant correlation between relative changes in ambulation and initial 
overground walking speed and endurance indicate that the largest gains were ob-
served in the most impaired subjects. Considering the limits of the DGO used in this 
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study, it is likely that performance of BWSTT without robotic assistance in individu-
als walking at higher initial over-ground speeds, particularly those who walked at 
speeds faster than the maximal velocity of the DGO, could elicit greater improve-
ments in speed and endurance. With continued progress in the field of rehabilita-
tion robotics, the development of specific treatment algorithms will be necessary to 
assist clinicians in deciding which specific physical interventions are most appropri-
ate to help maximize recovery and function in patients with neurological injury. 
CONCLUSIONS 
The use of task-specific treadmill training with the DGO to improve functional over-
ground mobility is promising. Robotic devices that allow practice of BWSTT in the 
rehabilitation setting may reduce the number of personnel needed to provide such 
therapy and relieve therapists from the physical demands of the task. Robotic-
assisted BWSTT can be further enhanced by increasing the frequency and duration 
of training. Continued research however, is necessary to advance the development 
of both specific physical interventions and treatment algorithms to help clinicians 
decide which physical interventions are most appropriate for patients with specific 
functional limitations. 
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ABSTRACT 
Background: A large proportion of patients with spinal cord injury (SCI) regain am-
bulatory function. However, during the first 3 months most of the patients are not 
able to walk unsupported. To enable ambulatory training at such an early stage the 
body weight is partially relieved and the leg movements are assisted by two thera-
pists. A more recent approach is the application of robotic based assistance which 
allows for longer training duration. From motor learning science and studies includ-
ing patients with stroke, it is known that training effects depend on the duration of 
the training. Longer trainings result in a better walking function. The aim of the 
present study is to evaluate if prolonged robot assisted walking training leads to a 
better walking outcome in patients with incomplete SCI and whether such training is 
feasible or has undesirable effects. Methods/Design: Patients from multiple sites 
with a subacute incomplete SCI and who are not able to walk independently will be 
randomized to either standard training (3-5 sessions per week, session duration 
maximum 25 minutes) or an intensive training (3-5 sessions per week, session dura-
tion minimum 50 minutes). After 8 weeks of training and 4 months later the walking 
ability, the occurrence of adverse events and the perceived rate of exertion as well 
as the patients’ impression of change will be compared between groups.  Trial regis-
tration: This study is registered at clinicaltrials.gov, identifier: NCT01147185. 
 
Keywords. Spinal cord injuries, Walking, Exercise therapy 
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BACKGROUND 
The general prognosis for regaining ambulatory function after a traumatic SCI rang-
es from 3% in initially complete SCI patients (according to the Standard Classifica-
tion of the American Spinal Injury Association ASIA A [1]) to 95% in very incomplete 
lesions (ASIA D) [2]. It is reported that for patients with a motor complete and sen-
sory incomplete SCI (ASIA B) the chance to become ambulatory is 50%. Those sub-
jects with preserved algesia seem to recover to about the same extent as motor 
incomplete SCI subjects [3].  
 The basis for locomotor training after acute spinal cord injury (SCI) in humans is 
provided by animal experiments which showed training induced plasticity of spinal 
locomotor centers [4]. In humans with a clinically complete spinal injury walking-like 
EMG activity can be elicited when subjects perform bodyweight supported and 
assisted stepping on a moving treadmill [5]. In SCI rehabilitation body weight sup-
ported treadmill training (BWSTT) has become established within the last 2 decades. 
In severely affected SCI subjects movements of the patient legs have to be manually 
assisted by two therapists. In some cases a third therapist might be needed to stabi-
lize the pelvis. The shortcoming of such manual assisted BWSTT is that it is very 
exhaustive for the therapists and hence only allows for limited training time. In 
addition the application of movement assistance requires extra skills to maintain 
coordination between the two legs. In order to provide longer training sessions with 
a consistent movement pattern robotic gait devices were developed. These driven 
gait orthoses (DGO) become successively more established to treat individuals with 
a locomotor dysfunction such as incomplete SCI, stroke or traumatic brain injury [6]. 
A widely used DGO is the Lokomat (Hocoma AG, Volketswil, Switzerland, Fig. 9.1) 
[7]. It has been shown that locomotor training with the Lokomat is feasible and that 
patients with a chronic incomplete SCI could improve gait speed and endurance as a 
response to an intensive training which lasted 8 weeks [8]. 
 Patients with mild para- or tetraparesis become ambulatory within days or 
weeks without being trained using special forms of therapy e.g. BWSTT or Lokomat. 
In contrast, SCI subjects presenting with an incomplete but severe spinal paresis (i.e. 
ASIA B and C) are referred to an intensive and specific locomotor training by the 
Lokomat. So far this algorithm is based on expert consensus [9]. 
 The strategy of rehabilitation after SCI or stroke is based on the principles of 
motor learning. Important characteristics of exercises have been identified. Beside 
task-specificity, task-variability, feedback or contextual interference the amount of 
exercise seems to be a key element [10, 11]. The improvement of motor perform-
ance within rehabilitation may be due to true recovery or compensation [12]. Nev-
ertheless, the above mentioned principles are valid regardless the underlying 
mechanism [11]. 
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A meta-analysis including studies of patients with stroke showed that augmented 
exercise therapy had a favorable effect on activities of daily living [13] and longer 
training duration was correlated with improved walking performance (positive dose-
response relationship) [14]. One of the advantages of robotic devices like the Loko-
mat is the ability to prolong time for locomotor training compared to manually as-
sisted training [15]. Yet it is not clear whether longer training duration results in an 
improved outcome or if certain endpoints in terms of walking capacity can be 
achieved within a shorter period of time. 
 The aim of the present study is therefore to evaluate whether SCI patients with 
severe sensory-motor deficit after acute traumatic SCI (ASIA B and C) profit from 
prolonged Lokomat training compared to patients who undergo the usual training 
paradigm. The hypothesis is that patients with a severe but incomplete SCI who 
undergo a prolonged Lokomat training achieve higher grades of walking ability 
compared to their counterparts who complete the training as suggested by experts. 
The secondary aim is to evaluate how feasible prolonged locomotor training time is, 
i.e. whether there is an association between training intensity and adverse events 
e.g. increased spasticity or pain. 
 
 
Figure 9.1 The Lokomat is an actuated robotic exoskeleton for the training of ambulatory 
function on a moving treadmill. The patient is secured by an overhead suspension system 
which partially reliefs the body weight. Position sensors and force transducers are used to 
monitor the efforts of the patient (Picture by courtesy of Hocoma AG). 
E f f e c t s  o f  a u t o m a t e d  l o c o m o t o r  t r a i n i n g  i n  s u b a c u t e  S C I  
 157 
METHODS/DESIGN 
The design of the study was developed in accordance with the Consolidated Stan-
dards of Reporting Trials (CONSORT statement)[16].  
 This study will take place at multiple sites (i.e. Zurich/CH (leading center), Barce-
lona/E, Toledo/E, Heidelberg/D, Murnau/D, Nijmegen/NL and Glasgow/GBR). Local 
Ethics Committees at each center have approved (Barcelona, Toledo and Zurich) the 
study. Informed consent will be obtained from all subjects prior to participation. 
Patients will be included as they are referred to one of the participating centers 
(consecutive sample). 
Subjects 
Patients with a subacute traumatic SCI initially categorized as ASIA B or C with a 
motor level between C4 and T12 and who are only partially able to walk (Walking 
Index for Spinal Cord Injury-WISCI ≤5 [17]) will be eligible. Subjects should be able to 
start the training within 60 days after trauma. Patients who do not comply to the 
requirements of the Lokomat training device (i.e. bodyweight > 130kg, body height 
> 200cm, leg length diff > 2cm, osteoporosis, instable fracture of lower extremity, 
restricted range of motion, decubitus ulcer of lower extremity) or with concomitant 
injury limiting walking ability (e.g. lower extremity fractures, instable spine frac-
tures, Joint instability preventing weight-bearing, severe soft tissue lesion, traumatic 
brain injury) or with pre-existing medical conditions interfering with unrestricted 
walking (e.g. total joint replacement, chronic pain, osteoarthritis, polyneuropathy, 
cardiopulmonary disease) or who are older than 60 years or younger than 18 years 
will be excluded from participation. Patients who already participate in other reha-
bilitation or pharmacological study will also not be considered for participation.  
 In previous studies with stroke subjects [18-23] the mean difference in walking 
speed amounted to 0.0418m/s. This value was used to calculate the sample size 
further assuming a standard deviation of 0.05m/s, a statistical power of 0.8 and a 
significance level of 0.05. The calculation resulted in the requirement of 23 subjects 
in each group to be able to reject the null hypothesis. 
Randomization 
Patients will be randomly assigned to either the intervention or the control group 
using a computer generated 4-block randomization scheme. The allocation will be 
performed by an independent person not otherwise involved in the study. The re-
sponsible researchers at each center request the group allocation by mail. 
C h a p t e r  9  
 158 
Intervention 
The locomotor training with the Lokomat device should start within approximately 
30 days but not later than 60 days after the SCI. The observation period of the train-
ing for this study lasts 8 weeks. For the initial 5 trainings there are no defined speci-
fications. These trainings serve to optimize the setup and for the patients to famil-
iarize with the robotic locomotor training device. During subsequent trainings fol-
lowing guideline will be adopted to adjust the training to the actual capacity: body 
weight unloading will be reduced to the least tolerated amount (no knee buckling or 
toe dragging). The walking speed will be set within the range of 1.6 to 3.1km/h and 
the guidance force in the range from 100% (full assistance) to minimum tolerated. 
The training session will be shaped in the following way: 3 min walking without 
specification (warm-up period) after that, every 3rd minute either speed, visual 
feedback or guidance force will be changed. This will avoid that the training be-
comes monotone and lacks challenge. 
 Patients who will be assigned to the intervention group receive one or two 
Lokomat trainings per day on 3-5 days per week. The Lokomat walking time per day 
should not be shorter than 50min. 
Control 
Patients of the control group receive one Lokomat training per day on 3-5 days per 
week. The Lokomat walking time per day should not be longer than 25min. 
Outcome 
Outcome data will be assessed in the respective centers by therapists and medical 
doctors. Hereafter the data will be sent anonymously to the PI for analyses. Due to 
the characteristic of this study neither the therapists nor the assessors nor the pa-
tients can reliably be blinded regarding the group allocation. The principal investiga-
tor (PI) who is the first author of this report (MW) and will be involved in the analy-
ses will not be aware of the respective intervention. 
 In order to describe the characteristics of the included subjects, demographic 
and clinical data will be assessed. The primary outcome is the self selected walking 
speed using the Ten Meter Walking Test (TMWT) [24]. It will be assessed at base-
line, bi-weekly during training, and at the six months follow-up. In addition the fol-
lowing items will be assessed at baseline, bi-weekly during training, and after six 
months: the Walking index for spinal cord injury -WISCI [17] (an ordinal scaled index 
for the assessment of walking capabilities with 21 categories. Zero represents that 
the patient is not able to stand or walk, the maximum of 20 means that the patient 
can walk without bracing, walking aids or personal assistance), the maximum walk-
ing speed, the ASIA classification [1], the detailed Spinal Cord Independence Meas-
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ure-SCIM [25], the modified Ashworth scale-MAS [26] of hip and knee joints, and 
the Penn spasm frequency scale [27]. During the training period the mechanical 
stiffness and the maximum voluntary torque of the legs as well as the cooperation 
of the patient during the training will be assessed bi-weekly using the force trans-
ducers of the robotic training device. For every training the distance walked, walking 
speed, walking time and body weight unloading, the rate of perceived exertion as 
well as the occurrence of any events (e.g. skin breakdown or joint stress or schedul-
ing problems) will be assessed. At the end of the training period, i.e. after 8 weeks 
the patients subjective impression about the success of the training will be assessed 
using the Patients’ Global Impression of Change Scale-PGIC [28]. 
 Since at the time of the study all patients will undergo a rehabilitation program, 
they receive along with the Lokomat training the usual rehabilitative therapy (i.e. 
physio and occupational therapy). In order to assure that the standard rehabilitation 
program is comparable between the participating centers, therapy schedules of one 
week will be collected of four patients per center. These schedules should contain 
the amount of therapy and roughly the content of the therapies (e.g. focus on arm 
or leg or standing and walking or other activities).  
Analyses 
All analyses will be performed in the leading center by the PI. He receives the data 
in form of an electronically completed case record form after completion of the 
training. For the analyses, the data will then be incorporated into the statistical 
software (PASW statistics 17.0, IBM-SPSS Inc. Chicago/ IL).  
 In order to describe the characteristics of the sample, descriptive statistics will 
be applied. 
 For the analysis of training induced differences between intervention and con-
trol group, T-Test for independent groups or the non-parametric correspondent 
depending on the outcome variable will be applied. In addition, multilevel models 
will be used to evaluate potential confounding factors (e.g. center effects, age dif-
ferences, neurological level of lesion or ASIA) as required.  
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SPINAL CORD INJURY 
Heterogeneity 
A lesion of the spinal cord results in a complex conglomeration of signs and symp-
toms. The extent of such a lesion depends on the level of the lesion (it may be of 
more or less severity and may affect different pathways or structures). Accordingly, 
patients with an SCI have a wide range of impairment and activity limitations. Addi-
tionally, SCIs rarely occur compared to other central nervous system conditions 
(e.g., stroke). These two factors lead to considerable issues in conducting clinical 
research studies. The main issue is that an insufficient number of eligible patients 
can be recruited and included, resulting in underpowered studies. This is of accen-
tuated relevance when certain subgroups of SCI patients should be studied, as we 
did in our study presented in Chapter 4 [3]. 
 
One approach to this problem is to create interventional studies that are not ran-
domized but instead follow a pre-post comparison design. This design may enable 
the research to show beneficial effects, for example, in our locomotor training study 
addressed in Chapter 8 [7]. However, this study design does not allow the re-
searcher to attribute the observed changes to a specific intervention since the com-
parison to a control (unspecific) intervention is lacking. 
 
Another possibility for overcoming a small inclusion rate is to build up networks of 
rehabilitation centers that treat the same patient groups. Many of the studies in-
cluded in this thesis [2-4, 8] were or are being conducted within the network of the 
European Multicenter Study about Spinal Cord Injury (EMSCI). This study follows 
patients with an SCI over one year. Since its start in 2001, about 1,400 patients have 
been included and completely documented with comprehensive and valid assess-
ments. 
Spontaneous recovery 
Within the first six months after an incomplete SCI, patients show marked sponta-
neous recovery of function [9]. Changes in voluntary motor strength and walking 
function can be observed [2, 10, 11]. This strong spontaneous recovery influences 
clinical intervention studies. 
 
The specific effects of a given intervention might be masked because the recovery 
that is taking place in the sub-acute phase outperforms the changes achieved with a 
specific training [12]. From a scientific point of view, it would be interesting to de-
prive a control group of neurorehabilitation since such a design would allow clearer 
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understanding of a specific rehabilitation measure’s effectiveness. However, this 
sort of study design is impossible for ethical reasons. It is therefore true that clinical 
studies taking place during primary rehabilitation are diluted not only by spontane-
ous recovery but also by the routine rehabilitation interventions applied in parallel. 
 
Due to spontaneous recovery, patients with an initially motor incomplete SCI may 
improve regardless of the rehabilitation measures [13]. Other patients (i.e., those 
with a complete SCI) experience only limited changes. Further research is needed to 
discern responders from non-responders to a particular intervention. 
AMBULATORY TRAINING 
Assisted locomotor training, activation of spinal locomotor centers 
Right after the onset of severe forms of incomplete SCI, the neurological deficits are 
most prominent. This is expressed, for example, by absent or weak voluntary leg 
muscle activation. During that period, patients are not able to stand and walk with-
out substantial support. Such support is provided in functional training by using 
body weight unloading systems and the provision of leg movement guidance during 
the step cycle. As we examined in our study (Chapter 2, [1]), such an assisted loco-
motor training resulted in coordinated leg muscle EMG activation, even in patients 
presenting with a clinical and electrophysiological complete SCI (i.e., AIS A). The 
EMG amplitude increased in response to a series of assisted locomotor trainings. 
When the training stopped after discharge, the EMG activity decreased in those 
patients who were not able walk in daily life. 
 
These results support the concept of neural networks within the spinal cord that can 
be activated by an appropriate proprioceptive sensory afferent input from the pe-
riphery, even in the case of a loss of supraspinal input [14]. The background of the 
concept of spinal locomotor centers derives from numerous animal experiments 
(for review, see [15]). The modality of the sensory input seems critical for maximally 
activating the spinal locomotor centers [16]. While the nature of these sensory cues 
(i.e., loading and hip extension) of the assisted locomotor training are well under-
stood, it is unclear how the intensity of training poses an effect on the outcome. 
Basic research suggests that higher numbers of repetitions are associated with im-
proved outcome [17-19]. To evaluate the dose-response-relationship of locomotor 
training, we are conducting the study presented in Chapter 9 [8]. 
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Training-induced neural plasticity 
The results of the study from Chapter 2 are in line with the concept of training-
induced neural plasticity, which has become a basis for neurorehabilitation (for 
examples, see [10, 20-23]). This plasticity can exhibit beneficial but also deleterious 
effects. Learned non-use is a concept introduced in stroke rehabilitation that de-
scribes maladaptive neural plasticity as a response to disuse of the affected arm 
[24]. A similar phenomenon can be observed in patients with SCIs. The non-use of 
the spinal neural networks involved in locomotion leads to a neural dysfunction 
expressed by a decreased leg muscle EMG activation (as shown in Chapter 2) and an 
alteration of the polysynaptic reflex responses [25]. This implies that assisted loco-
motor training is a useful intervention specifically during the early phase after an SCI 
and after the resolution of the spinal shock. It is also acknowledged that early after 
an injury, the central nervous system is in a state of increased plasticity and is there-
fore more susceptible to targeted rehabilitative interventions [21]. 
 
However, in patients with severe incomplete or complete SCIs, the observed leg 
muscle EMG amplitude during assisted locomotor training cannot be perceived 
manually and is too weak to lead to a movement. As shown in animal experiments, 
it is likely that the effects of such training attain a clinically relevant threshold when 
they are combined with other interventions [21, 26, 27]. An open question remains 
as to whether an early start of ambulatory training using assisted locomotion results 
in a better walking-related outcome or whether a certain endpoint is achieved with-
in a shorter rehabilitation period. 
Lacking standards 
Within the SCI rehabilitation field there is broad acceptance of certain achievable 
goals [28] and relevant assessments [29]. Surprisingly, there is only limited evidence 
about how these goals are being achieved. There is no standard content or intensity 
of rehabilitative measures. Only recently have studies been undertaken to empiri-
cally map the currently applied interventions [30, 31]. Further research needs to 
scrutinize the effect of timing and the intensity of functional training [23]. 
ROBOTIC DEVICES 
Robots have become increasingly common in rehabilitation. The advantages of 
these technical devices are obvious: robots can assist movements in a controlled 
way and with a high number of repetitions. The movements resemble everyday 
activities (e.g., walking) and therefore comply with the premise of task-specificity. 
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These two characteristics (i.e., high number of repetitions and task-specificity) make 
robots ideal tools for neurorehabilitation since these elements are recognized to be 
crucial for achieving improvement of function after CNS damage [19]. 
 
Mechanical sensors can measure some features more precisely than humans can 
and the measured signals serve as a basis for feedback given to the patient and 
therapist. Virtual reality (e.g., game-like scenarios) can be introduced to keep pa-
tients’ motivation high. At the same time, parameters and variables related to train-
ing and measurement of function can be stored and are available for analysis and 
documentation. 
Finding the correct settings 
We are using the Lokomat gait robot (Hocoma Inc., Volketswil/Switzerland) for our 
research therapy. It was developed at the Laboratory of the Spinal Cord Injury Cen-
ter of Balgrist University Hospital Zurich/Switzerland. The company was founded as 
a spin-off and now the device is commercially available. Although the Lokomat can 
be used in daily clinical routine, it is still at an early stage of development and cer-
tain aspects need to be considered for further improvement. The Lokomat is a com-
plex device that requires thorough instruction and experience to apply correctly. 
Although it is able to measure various parameters, the device itself does not give 
hints about how to improve the settings. 
Control strategy 
The movements of the Lokomat are position-controlled (i.e., the joints move 
through a range of predefined angles). This occurs regardless of whether the patient 
is active or passive. When patients have impaired proprioception, such a form of 
imposed walking can help: patients perceive the movement pattern in a tactile-
kinesthetic way. However, this control strategy has its limitations in training ses-
sions where the goal is facilitating a patient’s activity. When patients feel that their 
legs are moved for them, they tend to become passive. The Lokomat provides too 
much assistance. It would be desirable to add a control strategy where the robot 
supports the patient as needed, meaning that the patient has to perform the initial 
movement which is then supported by the robot. As soon as the patient became 
passive, the support would fade away. The result would be that the patient would 
always be active at a certain level. This level could be set by the patient, the thera-
pist or the controlling computer that constantly determines the optimal level (i.e., a 
learning system). 
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No errors 
The trajectories of the movements supported by the Lokomat have consistent tem-
poral and spatial characteristics. In the motor control literature (e.g., [32]) it is ac-
knowledged that mastering factors such as gravity, inertial forces or the control of 
an increasing number of degrees of freedom are critical elements in relearning 
movement. In general terms, patients need to adapt to errors or the mismatch be-
tween intended and performed movement. The robot does not include these ele-
ments. Partially this is due to the fact that technical devices used for medical pur-
poses have to comply with strict regulatory and safety requirements. For example, 
stumbling could certainly encourage the patient to lift his or her foot higher, but it 
also entails the risk of twisting one’s ankle. 
Transferring skills 
Finally, attention has to be paid to the transfer of skills trained by a robotic device to 
daily life situations. In our study, which included patients with chronic SCIs [7], we 
observed two patients who were only able to stand but could not walk, even though 
the motor scores of their leg muscles were in a range where other patients could 
walk. We concluded that these patients required extra training to enable them to 
apply the walking capacity trained by the Lokomat to daily life. 
ASSESSMENT 
Since traditional SCI rehabilitation is focused mainly on impairment, the clinical 
measures currently applied include strength and sensitivity [33]. As shown in our 
study (Chapter 3, [2]), neurological impairment is not in a deterministic relationship 
with the limitations on performing activities. Thus, all domains (i.e., impairment and 
activity) must be included in a comprehensive assessment. Tests covering the do-
main of activities (i.e., the Functional Independence Measure; FIM) are more gen-
eral and not specific to the SCI population. The spinal cord independence measure 
(SCIM) [34], introduced in 1997, is an assessment that corresponds to the FIM but is 
targeted at the particular issues of the SCI population. It also includes a number of 
items addressing mobility. The description encompasses wheelchair mobility as well 
as walking mobility. In 2001, the Walking Index for Spinal Cord Injury (WISCI) [35] 
was published by authors in the USA [35]. 
Walking Index for Spinal Cord Injury 
The WISCI is broadly accepted and increasingly used in the literature. However, we 
were able to identify some limitations of the measure (Chapter 5, [4]). This study 
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was possible because it took place within the framework of the EMSCI. With the 
inclusion of 917 patients in the study, we had a solid basis from which to draw valid 
conclusions; 71% of the patients could be rated by only five of the 20 WISCI catego-
ries. 
Timed walking tests 
The WISCI scale proved to be less responsive to subtle changes in walking ability 
[36], so we introduced and validated timed walking tests (i.e., 10meters, 6 minutes 
walking and timed up-and-go tests) that originated from other patient populations 
(Chapter 5, [4]). We realized that clear instructions are crucial in maintaining high 
reliability. This is particularly important within the EMSCI network, where data is 
collected at multiple sites by many therapists. 
 
The timed walking tests seem to be valid and reliable. However, it is poorly under-
stood how the results of these clinically applied walking tests reflect walking activity 
during daily life. The environments in the different EMSCI rehabilitation centers are 
certainly more comparable than the environments in patients’ homes. A validation 
of the tests using activity monitors would add further knowledge. 
Identify the fall risk 
Studies have shown that patients with SCIs who regain ambulatory function are at a 
higher risk for falls (Chapter 6, [5]). We intended to validate a widely applied test for 
fall risk in a sample of SCI patients who were able to ambulate, but the findings 
showed that the test was not specific for detecting fall risk. Further research is re-
quired to find appropriate proxy markers to identify those patients who have an 
increased risk for falls and fall-related injuries. 
CONCLUSIONS 
Although SCI is a well-defined disorder, the group of SCI patients is quite heteroge-
neous. Only the collaboration of several rehabilitation centers enables the perform-
ance of valid studies. Ambulatory rehabilitation is an exemplary example of a 
physiotherapy field that is ripe for a shifting of the underpinning rationale. New 
knowledge derived from basic research has influenced both interventions and as-
sessments. In the near future, novel strategies aiming to repair human spinal dam-
age will be introduced. It is acknowledged that the effectiveness of these new inter-
ventions depends largely on a simultaneously applied functional training. More 
clinical research is required to more clearly understand how training effects can 
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further be enhanced. May the combination of training and the application of a new 
agent lead to improved quality of life for our patients. 
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ENGLISH SUMMARY 
This dissertation addresses ambulatory rehabilitation in patients with a spinal cord 
injury (SCI). Topics covered include neurophysiology, assessment of walking capacity 
and ambulatory training. 
 
Chapter 1 will introduce a background on the spinal cord’s anatomy and physiology 
as well as classification, causes and epidemiological data of SCI. The spinal cord and 
the brain make up the central nervous system. The spinal cord is involved in the 
transmission of information between the brain and peripheral organs. In addition, 
the spinal cord contains its own neural circuitry with the ability to control and gen-
erate elementary movements strongly involved in the walking function. These lo-
comotor centers are the focal point of ambulatory training in patients with SCI. 
 An SCI results in a partial or complete impairment of motor, sensory and auto-
nomic functions. The classification of an SCI is based on a standardized clinical neu-
rological examination (International Standards for Neurological Classification of 
Spinal Cord Injury- ISNCSCI) and defines the neurological level and the completeness 
of the SCI. An injury in the cervical spinal cord or the first thoracic segment leads to 
a tetraplegia while lesions below lead to a paraplegia. According to the Impairment 
Scale of the American Spinal Injury Association (ASIA) the completeness of the SCI 
ranges from A (complete SCI) to E (restitution ad integrum). In addition to tetraple-
gia and paraplegia, special forms of clinical presentations can be found depending 
on the location and extent of the spinal cord lesion. A SCI can be the result of either 
a severe trauma or a non-traumatic event. The condition can also be congenital. The 
most frequent occurring traumatic SCI is an incomplete tetraplegia. 
 After an acute SCI patients undergo a multidisciplinary rehabilitation whose 
primary aim is to maximize patients’ independence in performing daily life activities 
and participating in life situations. Lost functions are substituted using compensa-
tory strategies. Preserved functions such as voluntary muscle contraction in the legs 
are most impaired directly after the onset of the SCI. As a consequence of targeted 
rehabilitation training and spontaneous recovery processes these deficits become 
reduced. Ambulatory training is a main focus of physiotherapeutic interventions. 
With a supported program of ambulatory function training, spinal locomotor cen-
ters can be activated even in patients with severe pareses. For this purpose rehabili-
tation robots are applied. When patients eventually start to regain some voluntary 
control of their leg movements, the support can gradually be reduced. If during the 
period of impaired mobility the locomotor system will not be used a secondary 
worsening by maladaptive plasticity takes place, it may be expressed by a decreased 
activity of the spinal locomotor centers. 
E n g l i s h  s u m m a r y  
 175 
 
Chapter 2 comprises a study where the long term effects of a locomotor training in 
patients with incomplete and complete SCI were investigated. Patients underwent a 
supported ambulatory training on a treadmill. Support consisted of partial body-
weight unloading and leg movement assistance. As a result of the training electro-
myographic (EMG) activity of M. gastrocnemius increased in both groups of pa-
tients. In addition, ambulatory capacity was recovered in patients with incomplete 
SCI. During a period of more than three years after training, the level of leg extensor 
EMG remained about constant in incomplete SCI in those who regularly maintained 
locomotor activity. By contrast, the EMG fell in those with complete SCI.  
 The results suggest a training-induced plasticity of neuronal centers in the iso-
lated spinal cord. Ambulatory training activated these centers. Once the training 
and non-use of the ambulatory function ceased, activity decreased. 
 
The study in Chapter 3 includes a longitudinal analysis on the association between 
neurological deficit (motorscore) and walking function in three patient groups with 
SCI. Group allocation was based on measurements taken at the beginning of reha-
bilitation: A, motor complete; B, motor incomplete, non-walking; C, motor incom-
plete and able to stand. In addition, we performed a cross-sectional analysis evalu-
ating the influence of neurological level of injury on ambulatory capacity in two 
groups of patients: group 1 with limited walking; and group 2 with unrestricted 
walking function 6 months after SCI. The analyses revealed that only few patients of 
group A showed modest recovery of motor and walking function. In contrast we 
observed in group B that markedly more patients recovered and this to a greater 
extent. Even more pronounced recovery was observed in all patients of group C. 
The results showed that in groups B and C, the improvement of walking function 
was greater than improvements in motor score. The cross-sectional analysis showed 
that patients with tetraplegia required more muscle strength to achieve an equal 
walking function compared with patients with paraplegia.  
 The conclusions of this study are that neurological deficit and walking ability are 
linearly associated. A combined assessment of both components (i.e. body functions 
and activities) is important to comprehensively assess the functioning of patients 
e.g. for the evaluation of the effectiveness of any new interventional therapy. 
 
Chapter 4 contains a retrospective study in which the time-course of neurological 
deficit (i.e. muscle function); activities (i.e. walking function and daily life activities); 
impulse conductivity; and rehabilitation length of stay in subjects with central cord 
syndrome (CCS) and Brown-Séquard syndrome (BSS) were compared. Both syn-
dromes represent a special form of incomplete SCI. In humans the BSS is relatively 
rare compared to CCS. In basic science, a hemi section of the spinal cord is a fre-
quently used animal model for SCI. In contrast to the assumption of a better out-
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come for subjects with BS, no difference was found between the two incomplete 
SCI groups.  
 The findings are of interest with respect to the different potential mechanisms 
leading to a recovery of functions in these two SCI subgroups. This study included 
two distinct subgroups of SCI patients. The inclusion of a sufficient number of pa-
tients was only made possible by the collaboration of multiple SCI rehabilitation 
centers within the European Multicenter Study about Spinal Cord Injury (EMSCI). 
 
Chapter 5 includes an evaluation of four walking capacity tests for patients with SCI: 
Walking Index for Spinal Cord Injury (WISCI II), the 6 minute walk test (6MinWT), 10 
meter walk test (10MWT) and the timed up and go (TUG) test. We investigated 
which of the 20 categories of the WISCI II were applied to SCI subjects who partici-
pated in the European Multicenter Study of Human Spinal Cord Injury (EM-SCI) and 
the relationship between the 10MWT and the TUG. The walking tests were applied 
2 weeks and 1, 3, 6 and 12 months after SCI. In addition, we compiled positive and 
negative aspects of the respective walking tests. The analysis showed that only five 
categories of the WISCI II described 71% of the walking abilities. This indicates that 
some categories of the WISCI II are redundant, while some discriminate to an insuf-
ficient degree. In addition, there appear to be ceiling effects. The 10MWT correlated 
excellently with the TUG at each time point.  
 We conclude from this study that the 10MWT appears to be the best tool to 
assess walking capacity in SCI subjects. Additional valuable information is provided 
by assessing the needs for walking aids or personal assistance. To ensure that the 
tests are reliably assessed in the different centers, proposals for standardized in-
structions are presented. 
 
In chapter 6 we evaluated a clinical measurement. It assesses the risk for falls in 
patients with SCI who regained the ability to walk after their rehabilitation. Based 
on the literature these patients are at an increased risk for falls. If this risk could 
validly be measured a targeted fall prevention program might reduce future falls. 
For the study 42 patients were tested using the Berg Balance Scale (BBS). It has 
been shown that this test is associated with a risk for falls in the elderly. For the 
evaluation of the validity, the values of the BBS were compared to experienced falls 
and other variables.  
 The study revealed that also the included patients experienced an increased 
number of falls. However, the BBS was unable to discriminate between people who 
did fall and people who did not fall. Only falls in the past were associated with fu-
ture falls. The inter-tester reliability which was also addressed in this study proved 
to be high. The evaluation of the simultaneously assessed fear of falling showed that 
patients with impaired balance have adapted to their condition and thus behave 
accordingly.  
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In chapter 7 we collected important aspects of the development and implementa-
tion of rehabilitation robots. These encompass the needs of patients, users (thera-
pists) and the safe operation. The applications in an institution or at home are dis-
cussed. Rehabilitation robots should allow for a targeted training which is based on 
motor learning principles. Robotic devices have to be adjustable to a wide range of 
anthropometric properties and to the amount and the characteristics of their im-
pairment. Technical devices allow for longer training sessions. The associated in-
creased training load should not result in adverse events e.g. skin breakdown. The 
user-friendliness of the robot’s human-machine interface consisting of the me-
chanical, control and feedback interfaces determines whether a device becomes 
integrated in the rehabilitation program. An inherent advantage of the more com-
plex rehabilitation robots is their ability to use angular and force sensor signals for 
assessment and documentation. Based on such measurements training parameters 
can be adjusted to the actual ability of a given patient. In addition these values can 
be fed back to the patient to encourage his participation.  
 The collaboration between engineers and experienced clinicians (e.g. physio-
therapists) is important for the successful development of rehabilitation robots. 
 
The study presented in chapter 8 evaluated the effectiveness of a robot assisted 
ambulatory training in patients with incomplete SCI who were not able or only par-
tially able to walk. Patients were placed in a harness on a treadmill in an upright 
position with their body weight partially supported. The robot itself comprised an 
orthosis which was attached to the pelvis and both legs. Drives actuated the hip and 
knee joints supported leg movements during walking. In this study patients whose 
SCI occurred at least two years ago were trained. We observed an improved walking 
ability after eight weeks of training. Patients who were most severely affected prof-
ited most.  
 The study showed that the robot can be used to train and improve walking 
function even after spontaneous recovery has been completed. 
 
Chapter 9 describes the protocol of a study. Similar to the study in chapter 8 it in-
vestigates the effectiveness of a robot assisted ambulatory training. The goal of the 
study is the evaluation of training intensity in patients with acute incomplete SCI. It 
is a randomized, controlled, multicenter study design. The trainings of the interven-
tion group last at least 50 minutes while those of the control group last a maximum 
of 25 minutes. The walking ability after eight weeks of training and the occurrence 
of adverse events during the training period will be measured and evaluated. 
 
The discussion in chapter 10 comprises four parts: SCI, ambulatory rehabilitation, 
rehabilitation robots and assessments. An SCI is a clearly defined syndrome und 
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occurs rarely. The extent of such a lesion depends on the level of the lesion and may 
be of more or less severity. Accordingly, patients with an SCI have a wide range of 
impairment and activity limitations. The collaboration of multiple rehabilitation 
centers is essential for the conduction of valid studies especially when including 
certain subgroups. Ambulatory rehabilitation and the application of rehabilitation 
robots are typical examples of how scientific findings become integrated into clinical 
applications and, vice versa, physiotherapeutic interventions are subjected to scien-
tific evaluation. The assessment and documentation of functioning and training 
progress using valid and reliable clinical measurements form the basis of this proc-
ess. 
 The results and conclusions arising from the study of the ambulatory rehabilita-
tion may be relevant in the near future when new interventions that elicit (partial) 
regeneration of damaged nerves are applied in combination with walking training. 
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DEUTSCHE ZUSAMMENFASSUNG 
Diese Dissertation befasst sich mit der Rehabilitation der Gehfähigkeit bei Patienten 
mit Querschnittlähmung. Sie beinhaltet die Bereiche: neurophysiologischen Grund-
lagen, das Messen der Gehfähigkeit sowie das Gehtraining selbst. 
 
Kapitel 1 ist die Einführung und vermittelt die Grundlagen für das Thema. Es behan-
delt Anatomie und Physiologie des Rückenmarks sowie Klassifikation, Ursachen und 
Epidemiologie der Querschnittlähmung.  
 Das Rückenmark zählt zusammen mit dem Gehirn zum Zentralnervensystem. 
Neben der Weiterleitung von Nervenimpulsen zwischen Gehirn und Peripherie kön-
nen im Rückenmark lokalisierte Lokomotionszentren, angeregt durch adäquate 
afferente Signale, koordinierte Bewegungen erzeugen. Dieses Phänomen ist eine 
der Grundlagen für das Lokomotionstraining bei Patienten mit inkompletter Quer-
schnittlähmung. 
 Durch eine Querschnittlähmung werden die Funktionen der Motorik, Sensibili-
tät und des vegetativen Nervensystems teilweise oder vollständig beeinträchtigt. 
Die Klassifikation der Querschnittlähmung basiert auf einer standardisierten, kli-
nisch-neurologischen Untersuchung (International Standards for Neurological Class-
fication of Spinal Cord Injury- ISNCSCI) und beinhaltet Ort und Ausmass der Schädi-
gung. Eine Läsion des zervikalen Rückenmarks oder des ersten thorakalen Segments 
führt zu einer Tetraplegie, Verletzungen darunter zu einer Paraplegie. Das Ausmass 
der Rückenmarksverletzung wird gemäss Impairment Scale der American Spinal 
Injury Association (ASIA) unterteilt. Diese Skala reicht von A (komplette Lähmung) 
bis E (vollständige Erholung). Abhängig vom Ort der Schädigung werden neben Tet-
raplegie und Paraplegie weitere klinische Syndrome unterschieden. Eine Quer-
schnittlähmung kann durch Unfall oder Krankheit erworben werden, aber auch 
angeboren sein. Die häufigste Form einer unfallbedingten Querschnittlähmung ist 
die inkomplette Tetraplegie. 
 Nach einer Querschnittlähmung werden Patienten einer multidisziplinären Re-
habilitation zugewiesen. Das Ziel der Rehabilitation ist, dass die Betroffenen ihre 
möglichst grosse Selbständigkeit und Partizipation wiedererlangen. Verlorene Funk-
tionen werden durch kompensatorische Massnahmen ersetzt. Erhaltene Funktio-
nen, z.B. Willkürmotorik in den Beinen durch gezieltes Training gefördert. Sie sind 
direkt nach der Querschnittlähmung am stärksten ausgeprägt. Durch Training und 
spontane Erholungsprozesse bilden sich viele dieser Funktionsdefizite im Verlauf der 
Rehabilitation wieder zurück. Dabei ist das Training der Gehfähigkeit eines der 
Schwerpunkte der physiotherapeutischen Interventionen. Die beim Gehen invol-
vierten spinalen Lokomotionszentren können bei Patienten mit ausgeprägten Pare-
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sen durch unterstütztes Gehtraining aktiviert werden. Dabei kommen auch Rehabili-
tationsroboter zum Einsatz. Mit zunehmender Erholung wird die Unterstützung 
stufenweis abgebaut. Fehlende Reize bzw. fehlendes Training führen im Sinne einer 
unerwünschten Adaptation zu einer Abnahme der Aktivität dieser Zentren. 
 
In Kapitel 2 wurden die Langzeiteffekte des Lokomotionstrainings bei Patienten mit 
inkompletter und kompletter Querschnittlähmung untersucht. Dazu haben die Pati-
enten ein unterstütztes Gehtraining auf einem Laufband durchgeführt und gleichzei-
tig die Muskelaktivität gemessen. Unterstützt wurde das Training durch teilweise 
Körpergewichtentlastung und Assistenz der Beinbewegungen. Während des Trai-
nings stieg in beiden Patientengruppen die EMG-Aktivität des M. gastrocnemius 
medialis an. Patienten mit inkompletter Querschnittlähmung verbesserten gleich-
zeitig ihre Gehfähigkeit. In den drei Jahren nach Beendigung des Trainings blieb die 
EMG-Aktivität bei Patienten mit inkompletter Querschnittlähmung, die regelmässig 
gingen, ungefähr konstant. Im Gegensatz dazu nahm die EMG-Aktivität bei Patien-
ten mit kompletter Querschnittlähmung wieder ab.  
 Die Resultate deuten auf eine durch das Training ausgelöste Plastizität von neu-
ralen Zentren im isolierten Rückenmark hin. Das Training aktivierte diese Zentren. 
Nach Beenden des Trainings und Nichtgebrauch der Gehfunktion nahm die Aktivität 
ab. 
 
Bei der Studie in Kapitel 3 haben wir mit einem Längsschnitt-Ansatz untersucht, wie 
neurologisches Defizit (Muskelfunktion) und Gehfähigkeit in drei Gruppen von Pati-
enten mit Querschnittlähmung zusammenhingen. Die Gruppeneinteilung erfolgte 
aufgrund von Messungen zu Beginn der Rehabilitation. Gruppe A: motorisch kom-
plett; Gruppe B: motorisch inkomplett, nicht stehfähig; Gruppe C: motorisch in-
komplett und stehfähig. Zudem untersuchten wir in einer Querschnitt-Analyse den 
Ein-fluss der neurologischen Läsionshöhe auf die Gehfähigkeit in zwei Patienten-
gruppen: 1. beeinträchtigte- und 2. Nicht beeinträchtigte Gehfähigkeit sechs Mona-
te nach Unfall. Die Resultate der Längsschnitt-Studie zeigten, dass nur wenige Pati-
enten der Gruppe A sich bezogen auf Motorik und Gehfähigkeit gering erholten. Im 
Gegensatz dazu fanden wir, dass sich in Gruppe B deutlich mehr Patienten und in 
grösserem Ausmass erholten. Noch deutlichere Erholungen wurden bei allen Patien-
ten der Gruppe C beobachtet. Zudem zeigten die Resultate, dass in den Gruppen B 
und C die Erholung der Gehfähigkeit grösser war, als die des motorischen Defizits. 
Die Querschnitt-Analyse zeigte, dass Patienten inkompletter Tetraplegie mehr Kraft 
in den unteren Extremitäten benötigten, um die gleiche Gehfähigkeit zu erreichen 
wie Patienten mit Paraplegie.  
 Die Studie macht deutlich, dass neurologische Defizite und Gehfähigkeit nicht in 
einer eindeutigen Beziehung zueinander stehen. Die Erfassung beider Komponenten 
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(d.h. Körperfunktionen und Aktivitäten) ist wichtig, damit die Funktionsfähigkeit, 
z.B. im Rahmen von Interventionsstudien, ausreichend erfasst wird. 
 
Kapitel 4 beinhaltet eine retrospektive Studie, bei die Verläufe des neurologischen 
Defizits (Muskelfunktion), der Aktivitäten (Gehfähigkeit und Aktivitäten des tägli-
chen Lebens), der Impulsleitung (somatosensorisch evozierte Potentiale) und der 
Rehabilitationsdauer zwischen Patienten mit zentromedullärem Syndrom (ZMS) und 
Brown-Séquard Syndrom (BSS), beides eine Form einer inkompletten Tetraplegie, 
verglichen wurden. Beim Menschen ist das BSS im Vergleich zum ZMS selten. In der 
Grundlagenforschung jedoch ist die dem BSS entsprechende spinale Hemisektion 
ein häufig studiertes Verletzungs-Modell der Querschnittlähmung. Messungen wur-
den ein und sechs Monate nach dem Ereignis erhoben. Im Widerspruch zur Annah-
me, dass sich Patienten mit BSS besser erholen würden, unterschied sich keine der 
gemessenen Variablen zwischen den Gruppen.  
 Da den beiden Gruppen unterschiedliche Schädigungen zugrunde liegen, ist es 
wahrscheinlich, dass andere Mechanismen zu den beobachteten Erholungen führ-
ten. Diese Studie untersuchte zwei spezifische Patienten-Untergruppen. Eine genü-
gende Anzahl Patienten einschliessen zu können war nur durch die Zusammenarbeit 
mehrerer Rehabilitationszentren im Rahmen der European Multicenter Study about 
Spinal Cord Injury (EMSCI) möglich. 
 
Das Kapitel 5 befasst sich mit den vier klinischen Tests zur Erfassung der Gehfähig-
keit von Patienten mit Querschnittlähmung, die im EMSCI Netzwerk standardmässig 
eingesetzt werden: 1. Walking Index for Spinal Cord Injury II (WISCI II);  2. 6-Minuten 
Gehtest (6MinWT); 3. 10-Meter Gehtest (10MWT) und 4. Timed-Up-And-Go Test 
(TUG). Wir untersuchten, welche der 20 Kategorien des WISCI II die Gehfähigkeit 
der Patienten des EMSCI Netzwerks abbildeten sowie den Zusammenhang zwischen 
10MWT und TUG. Die Messungen wurden 2 Wochen sowie 1, 3, 6 und 12 Monate 
nach Eintritt der Querschnittlähmung erhoben. Zusätzlich wurden positive und kriti-
sche Aspekte aller Tests zusammengestellt. Die Analyse zeigte, dass nur fünf Kate-
gorien des WISCI II bereits 71% der Gehfähigkeit beschrieben. Das deutet darauf 
hin, dass einige der Kategorien redundant sind oder nicht genügend zu unterschei-
den vermögen. Ausserdem zeigte sich ein Deckeneffekt. 10MWT und TUG korrelier-
ten zu jedem Zeitpunkt sehr stark. Dieser Zusammenhang änderte sich zwar im 
Verlauf, blieb aber hoch.  
 Die Schlussfolgerung dieser Studie ist, dass mit dem 10MWT sowie der Be-
schreibung der benötigten Gehhilfsmittel und Assistenz durch Hilfspersonen die 
Gehfähigkeit ausreichend dokumentiert werden kann. Damit die Tests in den ver-
schiedenen Zentren einheitlich durchgeführt werden können, wurde dieses Kapitel 
mit einer standardisierten Instruktion für die Durchführung ergänzt. 
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Wie Kapitel 5 befasst sich auch das Kapitel 6 mit einem klinischen Test. Es ging da-
bei um die Testung des Sturzrisikos von Patienten mit Querschnittlähmung, die nach 
Abschluss der Rehabilitation ihre Gehfähigkeit wieder erlangten. Entsprechend 
anderer Studien haben diese Patienten ein deutlich erhöhtes Sturzrisiko. Wenn 
dieses gemessen werden könnte, liessen sich künftige Stürze durch geeignete Mas-
snahmen verhindern. Für die Untersuchung wurden 42 Patienten mit der Berg Ba-
lance Skala (BBS) getestet. Das ist ein Test, mit dem bei älteren Patienten das Sturz-
risiko ermittelt werden kann. Zur Evaluation der Testzuverlässigkeit wurden die BBS-
Werte mit den tatsächlichen Stürzen und weiteren Variablen verglichen. 
 Die Studie zeigte, dass auch die eingeschlossenen Patienten vermehrt stürzten, 
die BBS dieses Sturzrisiko aber nicht anzuzeigen vermochte. Einzig Stürze in der 
Vergangenheit waren prädiktiv für künftige Stürze. Die gleichzeitig evaluierte Inter-
tester-Reliabilität war hoch. Messungen der Sturzangst deuteten darauf hin, dass 
sich Patienten ihres Sturzrisikos bewusst waren und sich entsprechend weniger 
risiko-reich verhielten.  
 
In Kapitel 7 werden wichtige Aspekte für die Entwicklung und Einführung von Reha-
bilitations-Robotern behandelt. Diese betreffen die Bedürfnisse von Patienten und 
Therapeuten sowie die technische Sicherheit. Es werden Roboter für die Anwen-
dung in einer Institution und zu Hause diskutiert. Rehabilitationsroboter sollen ein 
gezieltes und den Prinzipien des Motorischen Lernens entsprechendes Training 
ermöglichen. Dabei müssen die Geräte an die unterschiedlichen Defizite und anth-
ropometrischen Variablen der Patienten angepasst werden können. Das erst durch 
den Einsatz von Robotern mögliche längere Training darf zu keinen unerwünschten 
Wirkungen wie z.B. Hautschäden führen. Benutzerfreundlichkeit der mechanischen 
Elemente und der Steuerungssoftware sind entscheidend dafür, dass die Geräte in 
die Rehabilitation integriert und regelmässig angewendet werden. Ein Vorteil kom-
plexer Rehabilitationsroboter sind ihre Sensoren, mit denen die Defizite und die 
Trainingsfortschritte gemessen und dokumentiert werden können. Solche Messun-
gen dienen auch der Anpassung der Trainingsparameter an den jeweils aktuellen 
Zustand. Zudem können die ermittelten Werte im Sinne eines Feedbacks verwendet 
werden, um die Motivation fördern.  
 Die Zusammenarbeit zwischen Ingenieuren und erfahrenen Klinikern (z.B. Phy-
siotherapeuten) ist die Voraussetzung für die erfolgreiche Entwicklung von Rehabili-
tationsrobotern. 
 
Die Studie in Kapitel 8 evaluierte die Effektivität eines durch Roboter assistiertes 
Gehtraining von nicht oder teil-gehfähigen Patienten mit inkompletter Querschnitt-
lähmung. Diese wurden mit Hilfe eines Traggurts in aufrechter Position auf ein Lauf-
band positioniert. Dabei wurde ein Anteil des Körpergewichts entlastet. Der Roboter 
selbst bestand aus einer Orthese, die an Becken und Beinen des Patienten fixiert 
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wurde. Motoren an Hüft- und Kniegelenken unterstützten oder übernahmen die 
Gehbewegungen beim Training. Für die Studie wurden Patienten, deren Quer-
schnittlähmung mindestens zwei Jahre zurücklag, trainiert. Nach acht Wochen Trai-
ning zeigte sich eine Verbesserung der Gehfähigkeit. Dabei profitierten die Patien-
ten mit den deutlichsten Defiziten am meisten.  
 Mit der Studie konnte gezeigt werden, dass bei Patienten mit abgeschlossener 
spontaner Erholung Gehroboter zur Verbesserung einer anfangs stark eingeschränk-
ten Gehfähigkeit eingesetzt werden können. 
 
Das Kapitel 9 beschreibt das Protokoll einer Studie. Dabei geht es wie in Kapitel 8 
um ein durch Roboter unterstütztes Gehtraining für Patienten mit akuter Quer-
schnittlähmung. Das Ziel dieser Untersuchung ist es, den Einfluss der Trainingsinten-
sität bei zu untersuchen. Es handelt sich um eine randomisierte und kontrollierte 
Multizenter-Studie. Die Patienten der Interventionsgruppe trainieren mindestens 50 
Minuten, diejenigen der Kontrollgruppe maximal 25 Minuten. Untersucht wird die 
Gehfähigkeit nach acht Wochen und das Auftreten von unerwünschten Wirkungen 
während des Trainings. 
 
Die Diskussion in Kapitel 10 umfasst vier Teile: Querschnittlähmung, Rehabilitation 
der Gehfähigkeit, Rehabilitations-Roboter und Assessments. Das Querschnittsyn-
drom ist eindeutig charakterisiert und kommt selten vor. Neurologische Defizite 
können in unterschiedlicher Ausprägung auftreten. Entsprechend handelt es sich 
um eine heterogene Patientengruppe. Für die Durchführung von validen Studien, 
speziell von Patienten-Untergruppen, hat sich die Zusammenarbeit von mehreren 
Rehabilitationszentren als unerlässlich herausgestellt. Die Rehabilitation der Gehfä-
higkeit und die Anwendung von Robotern sind exemplarische Beispiele, wie wissen-
schaftliche Erkenntnisse in die Therapie einfliessen und umgekehrt physiotherapeu-
tische Interventionen wissenschaftlich evaluiert werden. Die Messung und Doku-
mentation der Funktionsfähigkeit der Patienten und der Trainingsfortschritte mit 
validen und reliablen Messinstrumenten ist dabei wichtige Voraussetzung.  
 Die Erkenntnisse zur Rehabilitation der Gehfähigkeit sind möglicherweise in 
naher Zukunft relevant, wenn neue Interventionen, die eine (Teil-) Regeneration der 
Nervenverletzung bewirken, in Kombination mit dem Gehtraining angewendet wer-
den. 
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